Announcements

27 March 2024
Interview with Dr. Simone Battaglia—Winner of the Biomedicines 2023 Outstanding Reviewer Award

Join us as we engage with our third Outstanding Reviewer Award winner, Dr. Simone Battaglia, to discuss his scholarly insights and journey as a reviewer for Biomedicines (ISSN: 2227-9059).

Name: Dr. Simone Battaglia
Affiliation:
1. Department of Psychology, University of Turin, Turin, Italy; 2. Department of Psychology, University of Bologna, Bologna, Italy
Research Interests: NIBS techniques; TMS; skin conductance; heart rate variability; fear conditioning; fear learning; learning; neuropsychology; prefrontal cortex; amygdala; hippocampus; anxiety; depression; working memory; PTSD; skin conductance responses; psychophysiology; error-related negativity; EEG; tDCS; Alzheimer’s disease; PIT; stress-related disorders; Parkinson’s disease; resilience; memory; neurologic patients; cognitive decisions; fMRI; translational and molecular psychiatry

The following is an interview with Dr. Simone Battaglia:

1. Could you please tell us a little more about yourself and your current research?
Currently, I hold the position of assistant professor in psychology and neuroscience at the Center for studies and research in Cognitive Neuroscience, Department of Psychology “Renzo Canestrari”, University of Bologna. My academic journey began in 2015 when I enrolled at the University of Bologna as a Ph.D. student, subsequently transitioning to the role of postdoctoral researcher, focusing on the investigation of neural, physiological, and behavioral correlates of emotional learning and memories in humans and its implications for psychopathology. My research experience focuses on investigating the intricate functional interplay of different brain areas involved in emotional learning, action control, brain plasticity, decision-making, and a variety of cognitive tasks. To this end, my research activities primarily revolve around the utilization of non-invasive brain stimulation techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), in addition to employing various neuroscientific techniques to record physiological measures, including EEG, SCR, HRV, and EMG. I have conducted extensive research involving healthy individuals, where I examine intra/inter-individual differences, and patients with acquired brain injuries. In my investigations, I employ a multimodal approach that integrates behavioral assessments, electrophysiological measurements, and neurostimulation techniques. The overarching aim of my research is to develop innovative therapeutic protocols, with a particular focus on utilizing the cortico-cortical paired associative stimulation (ccPAS) method to facilitate neuroplasticity and enhance functional recovery.

2. How do you anticipate that winning this award will influence your research experiences or personal outlook?
Winning this award is incredibly meaningful to me, and I believe it will have a profound impact on both my research experiences and personal outlook. Firstly, receiving this recognition validates the hard work and dedication I've poured into my research endeavors. It reinforces my confidence in my abilities and motivates me to continue striving for excellence in my academic pursuits. Moreover, winning this award opens up new opportunities for collaboration and networking, not only within my field but also with other professionals with different backgrounds, thus promoting translational research. I anticipate that these interactions will not only enrich my research experiences but also broaden my perspective on various topics. On a personal level, winning this award instills a sense of pride and fulfillment. It serves as a reminder of the impact that perseverance and determination can have in achieving one's goals.

3. What aspects of your experience as a reviewer for Biomedicines have you found most rewarding or fulfilling?
Being a reviewer for Biomedicines has been both a pleasure and a means to broaden my horizons by being exposed to a wide range of research topics. The most rewarding aspect of this role is the feeling of having provided a contribution to research, achieved by providing feedback to fellow colleagues. Furthermore, the opportunity to peer-review these articles also coincided with a sense of personal growth, as it led to an enhancement of my critical thinking as well as analytical and communication skills, all required to appropriately share my expertise to foster excellence in research.

4. Can you share any positive interactions or experiences you've had with the editorial team at Biomedicines during the review process?
My interactions with the editorial team at Biomedicines during the review process have been overwhelmingly positive. They have consistently demonstrated professionalism, responsiveness, and a genuine commitment to facilitating a smooth and fair review process. Additionally, I appreciate the open communication channels established by the editorial team. They have been proactive in addressing any queries or concerns that arose throughout the review process, fostering a collaborative environment.

5. In your opinion, what are some of the qualities necessary for being a reviewer?
In my opinion, several qualities are necessary for being an effective reviewer. Naturally, the most important one may be expertise. In order to provide a meaningful and coherent revision, a solid understanding of the subject at hand is essential. Alongside this feature, a good reviewer must be objective and impartial, focusing solely on the quality and validity of the research presented. Furthermore, critical thinking is necessary to assess the strenghts and weaknessess of a manuscript, including the methodology, data analysis, and the interpretation of the results. Attention to detail is also crucial, in order to find inaccuracies and imprecisions that may go unnoticed upon a more superficial read. Finally, communication skills are key in order to convey the relevant suggestions with both respect towards the authors and authority, as well as timeliness in order to promote a smooth review process for both authors and the editors.

21 March 2024
Biomedicines | Sectional Reinvention

We would like to share with you an update on the Section structure of Biomedicines (ISSN: 2227-9059). After careful evaluation and analysis, we have made the decision to merge the Section “Drug Discovery” with the Sections “Drug Delivery”, “Drug Metabolism”, and “Pharmacogenomic and Personalized Medicines” to create a new Section “Drug Discovery, Development and Delivery”, and merge the Section “Biomedical Engineering in Human Health” with the Section “Biomedical Materials” to create a new Section “Biomedical Engineering and Materials”. All published papers and Special Issues as well as Topical Collections of the old Sections will be moved to the new Sections of the journal accordingly.

Moreover, the Sections “Cancer Biology and Therapeutics” and “Neurobiology and Neurologic Disease” will be individually renamed as “Cancer Biology and Oncology” and “Neurobiology and Clinical Neuroscience”. All published papers and Special Issues as well as Topical Collections will remain unchanged.

This decision was based on a comprehensive review of the Section’s substantial development. This strategic initiative aims to make the Section structure clearer allowing readers to better identify the articles, enhance the journal’s transdisciplinary focus, foster collaboration across diverse fields, and elevate the impact of published research.

We extend our heartfelt gratitude to the Editorial Board, MDPI leadership team, and all stakeholders for their invaluable contributions and support throughout this transformative process. Together, we are dedicated to advancing the biomedical field.

Biomedicines Editorial Office

20 March 2024
Interview with Prof. Dr. Ewa Tomaszewska—Winner of the Biomedicines 2023 Oustanding Reviewer Award

Delving into the realm of research and peer review, we were fortunate to connect with Prof. Dr. Ewa Tomaszewska, the recent winner of the Biomedicines Outstanding Reviewer Award 2023. As we explore her insights, we gain a perspective from a female researcher, shedding light on the diverse voices shaping academia today.

Name: Prof. Dr. Ewa Tomaszewska
Affiliation: Department of Animal Physiology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Lublin, Poland
Research Interests: animal model; bone quality and physiology; intestine function and physiology; nutrition; toxicology; egg quality; animal physiology

The following is an interview with Prof. Dr. Ewa Tomaszewska:

1. Could you please tell us a little more about yourself and your current research?
I am a long-time academic and teaching staff member and a physiologist. I work at the Department of Animal Physiology at the University of Life Sciences in Lublin. I am involved in a wide range of research topics, as seen in my work. However, my passion lies in prenatal programming, which I pursued after personal experiences related to pregnancy. Currently, I am focusing on conducting planned analyses from several experiments carried out over the past three years. These experiments were conducted on rats, pigs, and birds as animal models. I always strive to gather experimental material in a way that ensures the animals that have been euthanized do not give their lives in vain. Scientific work requires not only passion and dedication but also responsibility and empathy. Therefore, I endeavor to collaborate with various specialists and publish jointly across various fields.

2. Could you please share your sentiments about winning the award with us?
I am someone who has not achieved many awards in life. So, there is a moment of disbelief at first, followed by immense joy that is difficult to describe. It is a great honor and distinction to be chosen among many people from around the world. It is a culmination of work that brings joy, but the award gives it a different dimension. It is a wonderful feeling to see that others recognize and appreciate the efforts.

3. What initially drew you to become a reviewer for MDPI Biomedicines?
I have been a reviewer for MDPI since 11 September 2017, and Biomedicines since 30 December 2022. I actively participate in reviewing articles for various journals. Naturally, the subject matter of the papers I review must fall within my area of expertise. Being a physiologist, it is possible that I am able to tackle diverse challenges. Additionally, I collaborate with a medical university, conducting a variety of research together. This collaboration allows us to approach topics from different perspectives.

4. Could you share some insights into your approach to reviewing manuscripts? How do you balance thoroughness with efficiency?
I am not sure if I can consider myself precise and efficient. I have been working for thirty years. I have numerous publications and have conducted many reviews (approximately 130 per year in recent years). By writing scientific papers, responding to reviews, and reviewing other papers, I am able to systematically learn what to focus on and what an ideally prepared manuscript should look like. This practice of writing and reviewing allows me to continuously improve my skills and shape my perception of an ideally prepared experiment and manuscript. An additional advantage is the opportunity to work in a team with individuals possessing a broad knowledge base, who always provide me with support. When I encounter dilemmas regarding methodology or statistics, I can always count on their assistance. On the other hand, I realize that authors expect feedback just as I do from other reviewers. Therefore, I strive not to postpone reviews. It may contribute to my efficiency.

5. How do you believe your experience as a woman in this biomedical field has contributed to your success and the advancements you have made in your research?
I believe that being a woman has influenced many aspects of my journey. My experience as a woman has shaped everything. My research and passion focus on prenatal programming, as I mentioned before. I have taken on research challenges that bridge veterinary and medical sciences, requiring flexibility of thought. However, there is another question: can I be considered a successful woman? Honestly, I am not sure. I have never looked at myself in that way. I simply work in the field of science, and my work is quite intensive because it is my passion. I love what I do.

6. What advice would you offer to other aspiring female researchers in the field or facing similar challenges?
Never give up. Throughout my life, I have experienced various good and bad moments, and perhaps there are more ahead of me, but one must never give up. Take a moment to slow down, balance ambitions and strengths, take care of your family, and then resume action with new energy and determination. Regardless of what the future holds, it is important to adhere to these values and continue on the path with determination and optimism.

15 March 2024
Interview with Prof. Dr. Francisco Solano—Winner of the Biomedicines 2023 Oustanding Reviewer Award

We had the privilege of discussing some topics on research and peer review with Prof. Dr. Francisco Solano, who has recently been honored with the Biomedicines 2023 Outstanding Reviewer Award.

Name: Prof. Dr. Francisco Solano
Affiliation: Department of Biochemistry, Molecular Biology and Immunology, University of Murcia, Murcia, Spain
Research Interests: tyrosinase and melanogenesis proteins; melanin pigmentation; photoprotection and other melanin functions; polyphenols as antioxidants; oxidative stress and ROS; skin-lightening agents; ocular melanin; melanin as polymeric biomaterial; bacterial and fungal melanin

1. Can you please tell us a little more about yourself, and your current research?
I am a professor of biochemistry and molecular biology at the School of Medicine, University of Murcia, Spain. I am 69 years old. I divide my time between teaching and researching. My current research is related to several issues, as I advise young researchers completing their Ph.D. degrees. My main expertise over my decades as a principal investigator has been photobiology, particularly melanin biosynthesis, precursors, and regulation of that pathway. This includes cutaneous pigmentation, pigmentary disorders, and melanoma. I am also involved in research related to oxidative stress, antioxidants and antioxidant response, aging and metabolic nutrition, and the antifungal effects of natural antioxidants.

2. Can you please share with us your sentiments upon winning the award?
I was very happy to receive the news. During the last years, I have dedicated a significant part of my time to the peer review process. I do not need to dedicate all my time to my own research as it will no longer be the sole focus of my career. It’s very important to me that I share my experience with the authors, and I try to be honest throughout the process. Regarding my sentiments about the award, I feel that my time and efforts have been recognized, and I am overwhelmed with gratitude.

3. In your opinion, what are some key qualities that make a review outstanding?
The most important quality is will. I should be convinced that you want to do it to improve the document, both in the content and in the format. Another key quality is time. A good reviewer should take their time in doing a first reading, taking a general idea, and then writing comments and a list of details on the improvement of that idea. Other qualities include knowledge and experience in the field. In addition, reviewers should act with fair play and honesty. They should give authors the chance to discuss alternative opinions, although the scientific rigor should always be in mind. The comments should always be constructive and clear enough for introducing modifications or for making new experiments to solve possible ambiguities and pitfalls if the manuscript contains positive sections and it would provide a chance of a revised version. Regarding the format, the manuscript should follow the instructions for authors, with a logical development, appropriate references, and so on. The manuscript should be logical and well-ordered, as should the report.

4. What advice would you give to early career researchers who are interested in becoming reviewers for academic journals like MDPI Biomedicines?
Love for science, honesty, integrity, scientific rigor but comprehension, and patience are crucial. Reviewers should act the same as they would like other scientists to act with their work. Fair review is important and instructive. I would rather be a reviewer than an editor, and I dislike the fact that many scientists refuse to review other scientist’s research since they are busy with their own.

5. Biomedicines is an open access journal. How do you think being open access impacts authors?
This is a very important issue. Open access is a great idea which facilitated the free availability of science to scientists. Scientific literature has changed a lot since the appearance of open access; however, I believe open access journals should be regulated. Quality and veracity of science are very important. Impact factor, number of reading and citations, and many other bibliometric parameters are useful, but, in my opinion, the number of journals, or the number of issues published annually by invitation should be limited. Predatory journals and easy business are currently serious risks. Editors, as any other members involved in publishing scientific literature of the system, should be fair.

6. What are some topics within Biomedicines that you foresee trending in the coming years?
This is a crucial time in many fields, but biomedicine is one of the most promising topics. AI and the new genetic revolution using CRISPR/Cas9 editing and related techniques will be able to make miracles soon. The mRNA technology developed after the COVID-19 pandemic and the new coming vaccines are trends of the near future. Tridimensional details about protein structure and the design of specific inhibitors/activators of key proteins will also trend. No doubt, it will be amazing and exciting.

7 March 2024
Biomedicines | Aims and Scope Update

To further enhance the quality of Biomedicines and the papers published in it, under the guidance of our Editor-in-Chief, Prof. Dr. Felipe Fregni, the journal has updated and revised its aims and scope. The original scope and the updated version are listed below:

Aims (new version):

Aims (old version):

Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Topics include pathogenesis mechanisms of diseases, translational medical research, clinical studies and applications, biomaterial in biomedical research, natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology-driven products, targeted therapy, bioimaging, biosensors, biomarkers, biosimilars, and nano-biosimilars.

We encourage authors to publish their experimental, theoretical, and computational results in as much detail as possible. There is no restriction on the maximum length of papers or the number of electronic multimedia and supplementary files. For all articles, the full experimental details must be provided so that the results can be reproduced. Electronic files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as Supplementary Materials (including animated pictures, videos, interactive Excel sheets, software executables and others).

Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Topics include pathogenesis mechanisms of diseases, translational medical research, biomaterial in biomedical research, natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology driven products, targeted therapy, bioimaging, biosensors, biomarkers, biosimilars, and nano-biosimilars. The journal is open for publication of studies conducted at the basic science and preclinical research levels. We invite you to consider submitting your work to Biomedicines, be it original research, review articles, or developing Special Issues of current key topics.

Biomedicines publishes high-quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, development, and, ultimately, to clinical use. Therefore, laboratory medicine research, translation medicinal research, and comprehensive preclinical studies are all within the scope of the journal.

Scope (new version):

Scope (old version):

Biomedicines publishes high-quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, development, and, ultimately, to clinical use. Therefore, laboratory medicine research, translation medical research, comprehensive preclinical studies, and most clinical studies focused on development and early phase clinical trials are all within the scope of the journal. Some topics include the following:

  • Pathogenesis and mechanisms of diseases;
  • Cardiovascular diseases;
  • Biomaterial in biomedical research;
  • Novel targets in various therapeutic areas: cardiovascular, vascular, hematology, oncology, neurology, orthopedics, dermatology, ophthalmology;
  • Biomarker discovery and early diagnosis research;
  • Drug discovery and development, pharmacotherapy;
  • Basic and clinical pharmacology;
  • Biopharmaceutical biomedicine: biologics and biosimilars;
  • Nanobiotechnological advances in biomedicine: nanomedicine, nanoscaffold implants (synthetic vascular graft), biosensors, bioimaging, gene therapy, vaccine, cell therapy, and tissue engineering;
  • Neurobiology and clinical neuroscience;
  • Neuromodulation.
  • Pathogenesis and mechanisms of diseases
  • Translational medical research
  • Biomaterial in biomedical research
  • Novel targets in various therapeutic areas: cardiovascular, vascular, hematology, oncology, neurology, orthopedics, dermatology, ophthalmology
  • Biomarker discovery and early diagnosis research
  • Drug discovery and drug development, biomedicine, and pharmacotherapy
  • Biopharmaceutical biomedicine: biologics, and biosimilars
  • Nanobiotechnological advances in biomedicine: nanomedicine, nanoscaffold implants (synthetic vascular graft), biosensors, bioimaging, gene therapy, vaccine, cell therapy, and tissue engineering.

For more detailed information, please visit the following link: https://www.mdpi.com/journal/biomedicines/about.

Biomedicines Editorial Office

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

23 February 2024
Meet Us at the 144th Annual Meeting of the Pharmaceutical Society of Japan, 28–31 March 2024, Yokohama, Japan


Conference: The 144th Annual Meeting of the Pharmaceutical Society of Japan
Date: 28–31 March 2024
Location: Yokohama, Japan

MDPI will be attending the 144th Annual Meeting of the Pharmaceutical Society of Japan at Booth #79, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

The theme of the 144th Annual General Meeting is: “Creation of a Pharmaceutical Culture that Co-prosperity with “Genes” and “Environment”: Toward the Integration of Sustainable “Digital Therapy”.

With the introduction of vaccines, the sale of therapeutic drugs, and the establishment of treatment systems, the fight against COVID-19 has become a coexistent situation. We hope that this annual general meeting will be an opportunity for many researchers, medical professionals, and educators involved in pharmaceutical research to gather, present the latest research results, and discuss how pharmaceutical education should be. We hope that it will be an opportunity to create sustainable innovations for the future.

The following MDPI journals will be represented:

  • Biomedicines;
  • JPM;
  • Molecules;
  • Pharmaceuticals;
  • Pharmaceuticals.

If you are planning on attending this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://confit.atlas.jp/guide/event/pharm144/top.

2 February 2024
Biomedicines | Hot Papers in the “Drug Delivery” Section

This Section of Biomedicines (ISSN: 2227-9059) publishes reviews and original peer-reviewed papers of research on the development and application principles of drug delivery and targeting at molecular, cellular, and higher levels. It accepts research on the following topics:

  • All drug delivery systems, including oral, pulmonary, nasal, parenteral and transdermal delivery;
  • All modes of drug entry, such as controlled release systems;
  • Microcapsules, liposomes, vesicles, and macromolecular conjugates;
  • Antibody targeting;
  • Protein/peptide delivery;
  • DNA, oligonucleotide and siRNA delivery.

Read freely the following papers:

1. “Novel Chloro-Substituted Salicylanilide Derivatives and Their β-Cyclodextrin Complexes: Synthesis, Characterization, and Antibacterial Activity”
by Ioana Maria Carmen Ienașcu, Adina Căta, Mariana Nela Ştefănuț, Iuliana Popescu, Gerlinde Rusu, Paula Sfîrloagă, Daniel Ursu, Cristina Moşoarcă, Anamaria Dabici, Corina Danciu et al.
Biomedicines 2022, 10(7), 1740; https://doi.org/10.3390/biomedicines10071740
Available online: https://www.mdpi.com/2227-9059/10/7/1740

2. “coupled Hydrodynamic Flow Focusing (cHFF) to Engineer Lipid–Polymer Nanoparticles (LiPoNs) for Multimodal Imaging and Theranostic Applications”
by Felicia Roffo, Alfonso Maria Ponsiglione, Paolo Antonio Netti and Enza Torino
Biomedicines 2022, 10(2), 438; https://doi.org/10.3390/biomedicines10020438
Available online: https://www.mdpi.com/2227-9059/10/2/438

3. “Cyclodipeptides: From Their Green Synthesis to Anti-Age Activity”
by Veronica Mosetti, Beatrice Rosetti, Giovanni Pierri, Ottavia Bellotto, Simone Adorinni, Antonella Bandiera, Gianpiero Adami, Consiglia Tedesco, Matteo Crosera, Greta Camilla Magnano et al.
Biomedicines 2022, 10(10), 2342; https://doi.org/10.3390/biomedicines10102342
Available online: https://www.mdpi.com/2227-9059/10/10/2342

4. “Membrane Carriers and Transporters in Kidney Physiology and Disease”
by Marek Drozdzik, Maria Drozdzik and Stefan Oswald
Biomedicines 2021, 9(4), 426; https://doi.org/10.3390/biomedicines9040426
Available online: https://www.mdpi.com/2227-9059/9/4/426

5. “Novel Mucoadhesive Wafers for Treating Local Vaginal Infections”
by Ahmed Alzainy and Joshua Boateng
Biomedicines 2022, 10(12), 3036; https://doi.org/10.3390/biomedicines10123036
Available online: https://www.mdpi.com/2227-9059/10/12/3036

6. “Aqueous Heat Method for the Preparation of Hybrid Lipid–Polymer Structures: From Preformulation Studies to Protein Delivery”
by Natassa Pippa, Nefeli Lagopati, Aleksander Forys, Maria Chountoulesi, Hektor Katifelis, Varvara Chrysostomou, Barbara Trzebicka, Maria Gazouli, Costas Demetzos and Stergios Pispas
Biomedicines 2022, 10(6), 1228; https://doi.org/10.3390/biomedicines10061228
Available online: https://www.mdpi.com/2227-9059/10/6/1228

7. “Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance”
by Sérgio M. Marques, Lucie Šupolíková, Lenka Molčanová, Karel Šmejkal, David Bednar and Iva Slaninová
Biomedicines 2021, 9(4), 357; https://doi.org/10.3390/biomedicines9040357
Available online: https://www.mdpi.com/2227-9059/9/4/357

8. “Lipid-Based Nanocarriers in Renal RNA Therapy”
by Chi-Ting Su, Daniel H. W. See and Jenq-Wen Huang
Biomedicines 2022, 10(2), 283; https://doi.org/10.3390/biomedicines10020283
Available online: https://www.mdpi.com/2227-9059/10/2/283

9. “Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders”
by Ming-Jen Lee, Inyoul Lee and Kai Wang
Biomedicines 2022, 10(1), 158; https://doi.org/10.3390/biomedicines10010158
Available online: https://www.mdpi.com/2227-9059/10/1/158

10. “Reduced Thiamine Availability and Hyperglycemia Impair Thiamine Transport in Renal Glomerular Cells through Modulation of Thiamine Transporter 2”
by Aurora Mazzeo, Federica Barutta, Linda Bellucci, Marina Trento, Gabriella Gruden, Massimo Porta and Elena Beltramo
Biomedicines 2021, 9(4), 385; https://doi.org/10.3390/biomedicines9040385
Available online: https://www.mdpi.com/2227-9059/9/4/385

We would appreciate it if you would circulate the link of any of the papers you find appealing into your network. Furthermore, the following opportunities for collaboration may be of interest:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Proposals may be submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

2 February 2024
Biomedicines | Hot Papers in the “Drug Metabolism” Section

Metabolism is one of the most important processes in the body. It enables the body to produce energy, but also to convert exogenous substances such as drugs into compounds that can be removed. A patient’s health status, polytherapy, and genetic factors have a significant impact on the rate of drug metabolism. This Section of Biomedicines (ISSN: 2227-9059) is organized into the following topics:

  • Drug metabolism/biotransformation;
  • Pharmacokinetics and pharmacodynamics;
  • Toxicokinetics and toxicodynamics;
  • Drug–drug interaction/drug–food interaction;
  • Mechanism of drug absorption and disposition (including transporter);
  • Drug delivery system;
  • Factors affecting drug metabolism and transport;
  • Expression of genes for drug-metabolizing enzymes and transporters;
  • Pharmacogenetics and pharmacogenomics.

Read freely the following papers:

1. “Doppler Ultrasound Selection and Follow-Up of the Internal Mammary Artery as Coronary Graft”
by Pietro Scicchitano, Micaela De Palo, Giuseppe Parisi, Margherita Ilaria Gioia and Marco Matteo Ciccone
Biomedicines 2023, 11(1), 66; https://doi.org/10.3390/biomedicines11010066
Available online: https://www.mdpi.com/2227-9059/11/1/66

2. “Sex Differences in the Anti-Hypertensive Effect of Calcium-Channel Blockers: A Systematic Review and Meta-Analysis”
by Eveline M. van Luik, Esmée W. P. Vaes, Maud A. M. Vesseur, Nick Wilmes, Daniek A. M. Meijs, Sophie A. J. S. Laven, Zenab Mohseni-Alsalhi, Sander de Haas, Marc E. A. Spaanderman and Chahinda Ghossein-Doha
Biomedicines 2023, 11(6), 1622; https://doi.org/10.3390/biomedicines11061622
Available online: https://www.mdpi.com/2227-9059/11/6/1622

3. “Association between Antihyperlipidemic Agent Use and Age-Related Macular Degeneration in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study”
by Chun-Hao Chen, Hsiu-Chen Lin, Hsiu-Li Lin, Joseph Jordan Keller and Li-Hsuan Wang
Biomedicines 2023, 11(6), 1508; https://doi.org/10.3390/biomedicines11061508
Available online: https://www.mdpi.com/2227-9059/11/6/1508

4. “Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis”
by Nick Wilmes, Eveline M. van Luik, Esmée W. P. Vaes, Maud A. M. Vesseur, Sophie A. J. S. Laven, Zenab Mohseni-Alsalhi, Daniek A. M. Meijs, Cédric J. R. Dikovec, Sander de Haas, Marc E. A. Spaanderman et al.
Biomedicines 2023, 11(5), 1494; https://doi.org/10.3390/biomedicines11051494
Available online: https://www.mdpi.com/2227-9059/11/5/1494

5. “Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design”
by Takuo Ogihara, Kenta Mizoi and Akiko Ishii-Watabe
Biomedicines 2023, 11(5), 1456; https://doi.org/10.3390/biomedicines11051456
Available online: https://www.mdpi.com/2227-9059/11/5/1456

6. “The Representation of Females in Studies on Antihypertensive Medication over the Years: A Scoping Review”
by Zenab Mohseni-Alsalhi, Maud A. M. Vesseur, Nick Wilmes, Sophie A. J. S. Laven, Daniek A. M. Meijs, Eveline M. van Luik, Esmée W. P. Vaes, Cédric J. R. Dikovec, Jan Wiesenberg, Mohamad F. Almutairi et al.
Biomedicines 2023, 11(5), 1435; https://doi.org/10.3390/biomedicines11051435
Available online: https://www.mdpi.com/2227-9059/11/5/1435

7. “Effect of Low Protein Diet Supplemented with Ketoanalogs on Endothelial Function and Protein-Bound Uremic Toxins in Patients with Chronic Kidney Disease”
by George Chang, Hong-Mou Shih, Chi-Feng Pan, Chih-Jen Wu and Cheng-Jui Lin
Biomedicines 2023, 11(5), 1312; https://doi.org/10.3390/biomedicines11051312
Available online: https://www.mdpi.com/2227-9059/11/5/1312

8. “Reactive Oxygen Species Regulation of Chemoresistance and Metastatic Capacity of Melanoma: Role of the Cancer Stem Cell Marker CD271”
by Francesca Beretti, Martina Gatti, Manuela Zavatti, Sara Bassoli, Giovanni Pellacani and Tullia Maraldi
Biomedicines 2023, 11(4), 1229; https://doi.org/10.3390/biomedicines11041229
Available online: https://www.mdpi.com/2227-9059/11/4/1229

9. “Moderate-Intensity Exercise Improves Mesenteric Arterial Function in Male UC Davis Type-2 Diabetes Mellitus (UCD-T2DM) Rats: A Shift in the Relative Importance of Endothelium-Derived Relaxing Factors (EDRF)”
by Md Rahatullah Razan, Said Amissi, Rifat Ara Islam, James L. Graham, Kimber L. Stanhope, Peter J. Havel and Roshanak Rahimian
Biomedicines 2023, 11(4), 1129; https://doi.org/10.3390/biomedicines11041129
Available online: https://www.mdpi.com/2227-9059/11/4/1129

10. “Anaemia and Congestion in Heart Failure: Correlations and Prognostic Role”
by Pietro Scicchitano, Massimo Iacoviello, Antonio Massari, Micaela De Palo, Angela Potenza, Raffaella Landriscina, Silvia Abruzzese, Maria Tangorra, Piero Guida, Marco Matteo Ciccone et al.
Biomedicines 2023, 11(3), 972; https://doi.org/10.3390/biomedicines11030972
Available online: https://www.mdpi.com/2227-9059/11/3/972

We would appreciate it if you would circulate the link of any of the papers you find appealing into your network. Furthermore, the following opportunities for collaboration may be of interest:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Proposals may be submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

2 February 2024
Biomedicines | Hot Papers in the “Nanomedicine and Nanobiology” Section

This Section of Biomedicines (ISSN: 2227-9059) aims to rapidly publish contributions on the synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; and interactions of nanomaterials with cells, tissues, and living organisms.

Read freely the following papers:

1. “Perspectives of Microscopy Methods for Morphology Characterisation of Extracellular Vesicles from Human Biofluids”
by Mladenka Malenica, Marija Vukomanović, Mario Kurtjak, Valentina Masciotti, Simone dal Zilio, Silvio Greco, Marco Lazzarino, Vedrana Krušić, Marko Perčić, Ivana Jelovica Badovinac et al.
Biomedicines 2021, 9(6), 603; https://doi.org/10.3390/biomedicines9060603
Available online: https://www.mdpi.com/2227-9059/9/6/603

2. “Carbon Nanofibers versus Silver Nanoparticles: Time-Dependent Cytotoxicity, Proliferation, and Gene Expression”
by Beatriz Salesa, Marcelo Assis, Juan Andrés and Ángel Serrano-Aroca
Biomedicines 2021, 9(9), 1155; https://doi.org/10.3390/biomedicines9091155
Available online: https://www.mdpi.com/2227-9059/9/9/1155

3. “Targeting Cancer Cells Overexpressing Folate Receptors with New Terpolymer-Based Nanocapsules: Toward a Novel Targeted DNA Delivery System for Cancer Therapy”
by Elena Bellotti, Maria Grazia Cascone, Niccoletta Barbani, Daniela Rossin, Raffaella Rastaldo, Claudia Giachino and Caterina Cristallini
Biomedicines 2021, 9(9), 1275; https://doi.org/10.3390/biomedicines9091275
Available online: https://www.mdpi.com/2227-9059/9/9/1275

4. “Covalently Labeled Fluorescent Exosomes for In Vitro and In Vivo Applications”
by María Isabel González, Mario González-Arjona, Ana Santos-Coquillat, Javier Vaquero, Elena Vázquez-Ogando, Antonio de Molina, Héctor Peinado, Manuel Desco and Beatriz Salinas
Biomedicines 2021, 9(1), 81; https://doi.org/10.3390/biomedicines9010081
Available online: https://www.mdpi.com/2227-9059/9/1/81

5. “Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review”
by Sofia Teixeira, Maria Alice Carvalho and Elisabete M. S. Castanheira
Biomedicines 2022, 10(2), 486; https://doi.org/10.3390/biomedicines10020486
Available online: https://www.mdpi.com/2227-9059/10/2/486

6. “Nanostructure, Self-Assembly, Mechanical Properties, and Antioxidant Activity of a Lupin-Derived Peptide Hydrogel”
by Raffaele Pugliese, Anna Arnoldi and Carmen Lammi
Biomedicines 2021, 9(3), 294; https://doi.org/10.3390/biomedicines9030294
Available online: https://www.mdpi.com/2227-9059/9/3/294

7. “Gel-Forming of Self-Assembling Peptides Functionalized with Food Bioactive Motifs Modulate DPP-IV and ACE Inhibitory Activity in Human Intestinal Caco-2 Cells”
by Raffaele Pugliese, Martina Bartolomei, Carlotta Bollati, Giovanna Boschin, Anna Arnoldi and Carmen Lammi
Biomedicines 2022, 10(2), 330; https://doi.org/10.3390/biomedicines10020330
Available online: https://www.mdpi.com/2227-9059/10/2/330

8. “Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy”
by Antonella Barone, Nicola d’Avanzo, Maria Chiara Cristiano, Donatella Paolino and Massimo Fresta
Biomedicines 2022, 10(6), 1252; https://doi.org/10.3390/biomedicines10061252
Available online: https://www.mdpi.com/2227-9059/10/6/1252

9. “Ammonium Glycyrrhizinate and Bergamot Essential Oil Co-Loaded Ultradeformable Nanocarriers: An Effective Natural Nanomedicine for In Vivo Anti-Inflammatory Topical Therapies”
by Maria Chiara Cristiano, Nicola d’Avanzo, Antonia Mancuso, Martine Tarsitano, Antonella Barone, Daniele Torella, Donatella Paolino and Massimo Fresta
Biomedicines 2022, 10(5), 1039; https://doi.org/10.3390/biomedicines10051039
Available online: https://www.mdpi.com/2227-9059/10/5/1039

10. “Near Infrared Fluorescent Nanostructure Design for Organic/Inorganic Hybrid System”
by Kyohei Okubo, Masakazu Umezawa and Kohei Soga
Biomedicines 2021, 9(11), 1583; https://doi.org/10.3390/biomedicines9111583
Available online: https://www.mdpi.com/2227-9059/9/11/1583

We would appreciate it if you would circulate the link of any of the papers you find appealing into your network. Furthermore, the following opportunities for collaboration may be of interest:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Proposals may be submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

2 February 2024
Biomedicines | Hot Papers in the “Microbiology in Human Health and Disease” Section

Microorganisms are an essential part of life on earth and play an important role in almost every natural cycle. The “Microbiology in Human Health and Disease” Section of Biomedicines (ISSN: 2227-9059) focuses on microbiology in human health and diseases, including infectious diseases, the interaction between pathogenic microorganisms and hosts, bacteriology, mycology, virology and parasitology. This Section is based on the knowledge that microorganisms and public health are closely intertwined and that advances in one area will have positive consequences on the other.

Read freely the following papers:

1. “Antibacterial Effect of Silver Nanoparticles Is Stronger If the Production Host and the Targeted Pathogen Are Closely Related”
by Priyanka Singh and Ivan Mijakovic
Biomedicines 2022, 10(3), 628; https://doi.org/10.3390/biomedicines10030628
Available online: https://www.mdpi.com/2227-9059/10/3/628

2. “Oral Microbiome: Getting to Know and Befriend Neighbors, a Biological Approach”
by Cecilia Bacali, Romana Vulturar, Smaranda Buduru, Angela Cozma, Adriana Fodor, Adina Chiș, Ondine Lucaciu, Laura Damian and Mirela Liliana Moldovan
Biomedicines 2022, 10(3), 671; https://doi.org/10.3390/biomedicines10030671
Available online: https://www.mdpi.com/2227-9059/10/3/671

3. “Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2”
by Richard Vollenberg, Phil-Robin Tepasse, Joachim Ewald Kühn, Marc Hennies, Markus Strauss, Florian Rennebaum, Tina Schomacher, Göran Boeckel, Eva Lorentzen, Arne Bokemeyer et al.
Biomedicines 2022, 10(1), 171; https://doi.org/10.3390/biomedicines10010171
Available online: https://www.mdpi.com/2227-9059/10/1/171

4. “Heart Failure Severity Closely Correlates with Intestinal Dysbiosis and Subsequent Metabolomic Alterations”
by Martina E. Spehlmann, Ashraf Y. Rangrez, Dhiraj P. Dhotre, Nesrin Schmiedel, Nikita Chavan, Corinna Bang, Oliver J. Müller, Yogesh S. Shouche, Andre Franke, Derk Frank et al.
Biomedicines 2022, 10(4), 809; https://doi.org/10.3390/biomedicines10040809
Available online: https://www.mdpi.com/2227-9059/10/4/809

5. “Antimicrobial and Prebiotic Activity of Lactoferrin in the Female Reproductive Tract: A Comprehensive Review”
by Jolanta Artym and Michał Zimecki
Biomedicines 2021, 9(12), 1940; https://doi.org/10.3390/biomedicines9121940
Available online: https://www.mdpi.com/2227-9059/9/12/1940

6. “Genomic and Phylogenetic Analysis of Lactiplantibacillus plantarum L125, and Evaluation of Its Anti-Proliferative and Cytotoxic Activity in Cancer Cells”
by Konstantinos Tegopoulos, Odysseas Sotirios Stergiou, Despoina Eugenia Kiousi, Margaritis Tsifintaris, Ellie Koletsou, Aristotelis C. Papageorgiou, Anthoula A. Argyri, Nikos Chorianopoulos, Alex Galanis and Petros Kolovos
Biomedicines 2021, 9(11), 1718; https://doi.org/10.3390/biomedicines9111718
Available online: https://www.mdpi.com/2227-9059/9/11/1718

7. “Assessment of Antibiofilm Potencies of Nervonic and Oleic Acid against Acinetobacter baumannii Using In Vitro and Computational Approaches”
by Sagar Kiran Khadke, Jin-Hyung Lee, Yong-Guy Kim, Vinit Raj and Jintae Lee
Biomedicines 2021, 9(9), 1133; https://doi.org/10.3390/biomedicines9091133
Available online: https://www.mdpi.com/2227-9059/9/9/1133

8. “Characterization of the Gut Microbiota in Individuals with Overweight or Obesity during a Real-World Weight Loss Dietary Program: A Focus on the Bacteroides 2 Enterotype”
by Rohia Alili, Eugeni Belda, Odile Fabre, Véronique Pelloux, Nils Giordano, Rémy Legrand, Pierre Bel Lassen, Timothy D. Swartz, Jean-Daniel Zucker and Karine Clément
Biomedicines 2022, 10(1), 16; https://doi.org/10.3390/biomedicines10010016
Available online: https://www.mdpi.com/2227-9059/10/1/16

9. “Alterations of the Composition and Neurometabolic Profile of Human Gut Microbiota in Major Depressive Disorder”
by Alexey S. Kovtun, Olga V. Averina, Irina Y. Angelova, Roman A. Yunes, Yana A. Zorkina, Anna Y. Morozova, Alexey V. Pavlichenko, Timur S. Syunyakov, Olga A. Karpenko, George P. Kostyuk et al.
Biomedicines 2022, 10(9), 2162; https://doi.org/10.3390/biomedicines10092162
Available online: https://www.mdpi.com/2227-9059/10/9/2162

10. “Biocides as Biomedicines against Foodborne Pathogenic Bacteria”
by Eugenia Butucel, Igori Balta, Mirela Ahmadi, Gabi Dumitrescu, Florica Morariu, Ioan Pet, Lavinia Stef and Nicolae Corcionivoschi
Biomedicines 2022, 10(2), 379; https://doi.org/10.3390/biomedicines10020379
Available online: https://www.mdpi.com/2227-9059/10/2/379

We would appreciate it if you would circulate the link of any of the papers you find appealing into your network. Furthermore, the following opportunities for collaboration may be of interest:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Proposals may be submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

2 February 2024
Biomedicines | Hot Papers in the “Molecular Genetics and Genetic Diseases” Section

The Section “Molecular Genetics and Genetic Diseases” covers the basic and translational aspects of human genetic diseases and genomics research, from fundamental molecular investigation to preclinical animal models. In particular, this Section aims to facilitate the rapid publication of innovative research encompassing the genetic basis of human health and disease, as well as the treatment of genetic disorders, and heritable or acquired cancers. We welcome submissions that apply new and emerging technologies in the fields of genomics, transcriptomics and bioinformatic tools to advance knowledge in human genetic diseases. In this context, we are pleased to feature some recently published papers on molecular genetics and genetic diseases in Biomedicines (ISSN: 2227-9059), which provide valuable insights into this exciting field.

Read freely the following papers:

1. “Perspectives in Sports Genomics”
by Valentina Ginevičienė, Algirdas Utkus, Erinija Pranckevičienė, Ekaterina A. Semenova, Elliott C. R. Hall and Ildus I. Ahmetov
Biomedicines 2022, 10(2), 298; https://doi.org/10.3390/biomedicines10020298
Available online: https://www.mdpi.com/2227-9059/10/2/298

2. “Bilateral Adrenal Hyperplasia: Pathogenesis and Treatment”
by Benjamin Chevalier, Marie-Christine Vantyghem and Stéphanie Espiard
Biomedicines 2021, 9(10), 1397; https://doi.org/10.3390/biomedicines9101397
Available online: https://www.mdpi.com/2227-9059/9/10/1397

3. “Nonsense-Mediated mRNA Decay, a Finely Regulated Mechanism”
by Fabrice Lejeune
Biomedicines 2022, 10(1), 141; https://doi.org/10.3390/biomedicines10010141
Available online: https://www.mdpi.com/2227-9059/10/1/141

4. “UPF1: From mRNA Surveillance to Protein Quality Control”
by Hyun Jung Hwang, Yeonkyoung Park and Yoon Ki Kim
Biomedicines 2021, 9(8), 995; https://doi.org/10.3390/biomedicines9080995
Available online: https://www.mdpi.com/2227-9059/9/8/995

5. “Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure”
by Lorena Pérez-Carrillo, Isaac Giménez-Escamilla, Luis Martínez-Dolz, Ignacio José Sánchez-Lázaro, Manuel Portolés, Esther Roselló-Lletí and Estefanía Tarazón
Biomedicines 2022, 10(1), 135; https://doi.org/10.3390/biomedicines10010135
Available online: https://www.mdpi.com/2227-9059/10/1/135

6. “Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α”
by Elisa Rossini, Edoardo Giacopuzzi, Fabrizio Gangemi, Mariangela Tamburello, Deborah Cosentini, Andrea Abate, Marta Laganà, Alfredo Berruti, Salvatore Grisanti and Sandra Sigala
Biomedicines 2021, 9(6), 681; https://doi.org/10.3390/biomedicines9060681
Available online: https://www.mdpi.com/2227-9059/9/6/681

7. “Diagnostic Accuracy of Dehydroepiandrosterone Sulfate and Corticotropin in Autonomous Cortisol Secretion”
by Lindsay E. Carafone, Catherine D. Zhang, Dingfeng Li, Natalia Lazik, Oksana Hamidi, Maria Daniela Hurtado, William F. Young, Jr., Melinda A. Thomas, Benzon M. Dy, Melanie L. Lyden et al.
Biomedicines 2021, 9(7), 741; https://doi.org/10.3390/biomedicines9070741
Available online: https://www.mdpi.com/2227-9059/9/7/741

8. “Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome”
by Valentino Bezzerri, Laura Lentini, Martina Api, Elena Marinelli Busilacchi, Vincenzo Cavalieri, Antonella Pomilio, Francesca Diomede, Anna Pegoraro, Simone Cesaro, Antonella Poloni et al.
Biomedicines 2022, 10(4), 886; https://doi.org/10.3390/biomedicines10040886
Available online: https://www.mdpi.com/2227-9059/10/4/886

9. “Genetic Alterations in Benign Adrenal Tumors”
by Georgia Pitsava and Constantine A. Stratakis
Biomedicines 2022, 10(5), 1041; https://doi.org/10.3390/biomedicines10051041
Available online: https://www.mdpi.com/2227-9059/10/5/1041

10. “Cochlear Implantation Outcomes in Patients with Auditory Neuropathy Spectrum Disorder of Genetic and Non-Genetic Etiologies: A Multicenter Study”
by Pei-Hsuan Lin, Hung-Pin Wu, Che-Ming Wu, Yu-Ting Chiang, Jacob Shujui Hsu, Cheng-Yu Tsai, Han Wang, Li-Hui Tseng, Pey-Yu Chen, Ting-Hua Yang et al.
Biomedicines 2022, 10(7), 1523; https://doi.org/10.3390/biomedicines10071523
Available online: https://www.mdpi.com/2227-9059/10/7/1523

We would like to take this opportunity to thank all the research groups that submitted manuscripts to Biomedicines. We would appreciate it if you would circulate this document among your colleagues and network. Furthermore, the following opportunities for collaboration may be of interest:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Proposals may be submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 January 2024
Biomedicines | Hot Papers in the “Biomedical Materials” Section

The Section “Biomedical Materials” of Biomedicines (ISSN: 2227-9059) aims to rapidly publish contributions of studies focused on the preparation, performance, and evaluation of biomaterials; the chemical, physical, toxicological, and mechanical behavior of materials in physiological environments; and the response of blood and tissues to biomaterials. All relevant biomaterial topics, including the science and technology of alloys, polymers, ceramics, and reprocessed animal and human tissues in surgery, dentistry, artificial organs, and other medical devices, are welcome to be submitted.

Please feel free to read the following papers:

1. “In Search of Novel Degradation-Resistant Monomers for Adhesive Dentistry: A Systematic Review and Meta-Analysis”
by Vlasta Mocharko, Paulo Mascarenhas, Ana Mano Azul and António H. S. Delgado
Biomedicines 2022, 10(12), 3104; https://doi.org/10.3390/biomedicines10123104
Available online: https://www.mdpi.com/2227-9059/10/12/3104

2. “Influence of Pre-Treatment and Artificial Aging on the Retention of 3D-Printed Permanent Composite Crowns”
by Tobias Graf, Kurt-Jürgen Erdelt, Jan-Frederik Güth, Daniel Edelhoff, Oliver Schubert and Josef Schweiger
Biomedicines 2022, 10(9), 2186; https://doi.org/10.3390/biomedicines10092186
Available online: https://www.mdpi.com/2227-9059/10/9/2186

3. “In Vitro Molecular Study of Titanium-Niobium Alloy Biocompatibility”
by Laëtitia Chézeau, Alex Tchinda, Gaël Pierson, Pierre Bravetti, Luc Ferrari, Olivier Joubert, Mohamed Zaiou and Bertrand H. Rihn
Biomedicines 2022, 10(8), 1898; https://doi.org/10.3390/biomedicines10081898
Available online: https://www.mdpi.com/2227-9059/10/8/1898

4. “Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles”
by Yashna Chabria, Garry P. Duffy, Aoife J Lowery and Róisín M. Dwyer
Biomedicines 2021, 9(11), 1694; https://doi.org/10.3390/biomedicines9111694
Available online: https://www.mdpi.com/2227-9059/9/11/1694

5. “Characteristics of Dental Resin-Based Composites in Leukemia Saliva: An In Vitro Analysis”
by Alexandru Mester, Marioara Moldovan, Stanca Cuc, Ciprian Tomuleasa, Sergiu Pasca, Miuta Filip, Andra Piciu and Florin Onisor
Biomedicines 2021, 9(11), 1618; https://doi.org/10.3390/biomedicines9111618
Available online: https://www.mdpi.com/2227-9059/9/11/1618

6. “Experimental Bioactive Glass-Containing Composites and Commercial Restorative Materials: Anti-Demineralizing Protection of Dentin”
by Matej Par, Andrea Gubler, Thomas Attin, Zrinka Tarle, Andro Tarle and Tobias T. Tauböck
Biomedicines 2021, 9(11), 1616; https://doi.org/10.3390/biomedicines9111616
Available online: https://www.mdpi.com/2227-9059/9/11/1616

7. “Smart Hydrogels Meet Carbon Nanomaterials for New Frontiers in Medicine”
by Simone Adorinni, Petr Rozhin and Silvia Marchesan
Biomedicines 2021, 9(5), 570; https://doi.org/10.3390/biomedicines9050570
Available online: https://www.mdpi.com/2227-9059/9/5/570

8. “3D Collagen Hydrogel Promotes In Vitro Langerhans Islets Vascularization through ad-MVFs Angiogenic Activity”
by Monica Salamone, Salvatrice Rigogliuso, Aldo Nicosia, Simona Campora, Carmelo Marco Bruno and Giulio Ghersi
Biomedicines 2021, 9(7), 739; https://doi.org/10.3390/biomedicines9070739
Available online: https://www.mdpi.com/2227-9059/9/7/739

9. “Self-Supporting Hydrogels Based on Fmoc-Derivatized Cationic Hexapeptides for Potential Biomedical Applications”
by Carlo Diaferia, Elisabetta Rosa, Enrico Gallo, Giovanni Smaldone, Mariano Stornaiuolo, Giancarlo Morelli and Antonella Accardo
Biomedicines 2021, 9(6), 678; https://doi.org/10.3390/biomedicines9060678
Available online: https://www.mdpi.com/2227-9059/9/6/678

10. “Whey-Derived Porous Carbon Scaffolds for Bone Tissue Engineering”
by Raúl Llamas-Unzueta, Marta Suárez, Adolfo Fernández, Raquel Díaz, Miguel A. Montes-Morán and J. Angel Menéndez
Biomedicines 2021, 9(9), 1091; https://doi.org/10.3390/biomedicines9091091
Available online: https://www.mdpi.com/2227-9059/9/9/1091

We would much appreciate it if you could circulate the link of any papers you find appealing within your network.

Submit a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launch a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Join the Editorial Board:
We are looking for active scholars who have interests within and are passionate about this field to help with the selection of submissions; please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

26 January 2024
Acknowledgment of the Reviewers of Biomedicines in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Biomedicines. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Biomedicines received 11,476 review reports, from 6,668 reviewers. This past year, we worked with reviewers from 89 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Biomedicines family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. Ganesan Komuraiah Myakala
A. Valance Washington Konstantin Belosludtsev
Aamir Rasool Konstantin Yarygin
Abdul Sadiq Konstantinos Papadimitriou
Abdullah Gibriel Konstantinos Tosios
Abhishek Anant Kulkarni Koraljka Gall Troselj
Abhishek Bhattacharya Kornelia Kreiser
Abhishek Jha Koyeli Girigoswami
Abraham Pouliakis Krishna Kant
Abraham Wall-Medrano Krishna Yadav
Achille Aveta Krishnan Sriram
Addisson Salazar Kristian Leisegang
Adelina Vlad Krzysztof Czamara
Adi Sarig-Axelrod Krzysztof Skrzypkowski
Adina Magdalena Musuc Ksenia Babina
Adriana Albu Kui Zhang
Adriana Grigoraș Kumara Swami Konda
Adriana Morar Kun Chen
Adriano Murrone Kun Li
Agata Stanek Kunihiro Tsuchida
Agnieszka Bojarska-Junak Kurubaran Ganasegeran
Agnieszka Kuczaj Kyle Poulsen
Agnieszka Piegat Kyle Vining
Agnieszka Potęga Kyohei Kin
Agnieszka Zelek-Molik Lacramioara Popa
Agnishwar Girigoswami Laia Josa-Culleré
Agostino Guida Laikang Yu
Agostino Ognibene Lan Lin
Aguinaldo Fraddosio Lan Zhao
Agustín Herrera-May Lara Baticic
Ahmad M. Mansour Lars Ängquist
Ahmad Salti Lars Småbrekke
Ahmed Abu-Zaid László Hazai
Ahmed Bakillah Laszlo Jicsinszky
Ahmed Doghish László Szilák
Ahmed Elbestawy Laura Bulgariu
Ahmed El-Fiqi Laura Eadie
Ahmed Fatimi Laura Endres
Ahmed Noreldin Laura Evangelista
Ajay Pal Laura Vicente
Akihito Tsubota Laurent Dufossé
Akilavalli Narasimhan Laurent Mailly
Akira Umemura Laurentiu M. Pop
Akira Yamasaki Leander Corrie
Akylbek Sydykov Lei Wang
Alaa Adawy Lei Zhang
Alain Massart Leigh Plant
Alarico Ariani Leire Pedrosa
Alberto Porta Leny Jose
Alberto Rodriguez-Archilla Leonard Ionut Atanase
Alberto Zamora Leonel Pereira
Aldona Kasprzak Leszek Kotula
Alejandra García-Gasca Leszek Szablewski
Alejandro J. Alvarez Li Fu
Alejandro Schäffer Lia Mara Diţu
Aleksander Mendyk Lídia Gonçalves
Aleksandra Bondžić Lidija Savić
Aleksandra Czumaj Liewei Wen
Aleksandra Klisic Lifu Sheng
Aleksey Zaitsev Liliana Torres-López
Ales Blinc Lilya Dzhemileva
Alessandra Ammazzalorso Linda Peters
Alessandra Ferramosca Lin-Fu Liang
Alessandro Di Rienzo Lingchen Yang
Alessandro Tozzi Lingjun Tong
Alessia Pardo Linlin Guo
Alex Siu Wing Chan Livius D'Uscio
Alexa Klettner Lokesh Koodlur Sannegowda
Alexander Chizhov Lokesh Kumar
Alexander H. Maass Lorena Saelices Gomez
Alexander Lykov Lorenzo Faggioni
Alexander Meigal Lorenzo Schiavoni
Alexander Shinkov Luca Falzone
Alexander Shtil Luca Giacomelli
Alexander Timoshenko Luca Giovanni Locatello
Alexander V. Artem’ev Luca Raiteri
Alexander Winter Lucia Montenegro
Alexander Zemchenkov Lucia Pirvu
Alexander Zimmermann Lucia Stanciakova
Alexandra Craciun Luciana Baroni
Alexandre De Brevern Luciana Bordin
Alexandros Brotis Lucjusz Zaprutko
Alexandru Mester Ludmila Kazdova
Alexei Chukhlovin Ludovic Tricoire
Alexey Iordanskii Ludwig Wagner
Alexey Mittenberg Luidmila Yakimova
Alexey Rakov Luigi Auletta
Alexey Sumin Luigi Di Filippo
Alfonso Maria Ponsiglione Luis Apaza Ticona
Alfred Ankrah Luis Eduardo Almeida
Alfredo Bellon Luís Félix
Alfredo Caturano Luis Ibarra
Alfredo G. Casanova Luis Salazar
Alfredo J. Lucendo Luísa Romão
Ali Zarrabi Lukas Lacina
Alica Pizent Lukasz Dobrek
Alida Caforio Lukasz Szarpak
Alin Laurentiu Tatu Łukasz Szeleszczuk
Alina Deshpande Lyudmila Bel'skaya
Alma Villaseñor Maciej Przybyłek
Álvaro González Domínguez Maciej Serda
Amanda Iglesias Maciej Skotak
Amandeep Singh Maciej Socha
Amany Abdel-Rahman Maciej Zieliński
Ameer Fawad Zahoor Madankumar Ghatge
Amelia Maria Gaman Madhubanti Mullick
Amin Tamadon Madhuri Dey
Amir Ashoorzadeh Magdalena Aflori
Amir Mellati Magdalena Izdebska
Amirhossein Ahmadi Magdalena Mizerska-Kowalska
Amirreza Haghighi Magnus S. Ågren
Amit Goel Maha Nasr
Amitava Mukherjee Mahdi Mahdipour
Ammad Ahmad Farooqi Mahmoud Al-Khrasani
Ammar Saleem Mahmoud Balbaa
Amosy M'Koma Mahmoud Elsayed
Amr Abu Lila Mahmoud Kandeel
Amrita Sarkar Mahtab Nourbakhsh
Amritlal Mandal Mai Mostafa
Amro Amara Maja Jazvinšćak Jembrek
Ana Cazacu Maja Sabol
Ana Dascalu Maja Tomicic
Ana Fernández Majid Ghareghani
Ana Henriques Da Costa Makoto Endo
Ana Leticia Fornari Caprara Makoto Nakamura
Ana Luísa De Sousa-Coelho Makoto Tsunoda
Ana Sofia Vallés Małgorzata Jeleń
Ana Stupin Malgorzata Jerzak
Anabel Lostao Małgorzata Przybyło
Anamaria Savu Małgorzata Szczuko
Anand Singh Man Qu
Anastasia Spiliopoulou Manesh Nautiyal
Anastasios Serbis Manhai Long
Anatoly Zherdev Manikandan Samidurai
Anbazhagan Sathiyaseelan Manoj Neog
Anca Bobirca Manoj Pandey
Anders Lade Nielsen Manthar Ali Mallah
Andre Luiz Costa Manuel Durán-Poveda
André Maia Manuel Lis
Andre Obenaus Manuel Muro
Andrea Amaroli Manuela Chiper
Andrea Brancaccio Maochun Wang
Andrea Giannini Mara Carsote
Andrea Godino Marc Herb
Andrea Mastinu Marc Since
Andrea Ragusa Marc Vasse
Andrea Tinelli Marc-André Lécuyer
Andreas Brodehl Marcel Leutenegger
Andreas G. Tsantes Marcello Pinti
Andree Hartanto Marcin Kozuch
Andrei Adrian Tica Marco Alves
Andrei Khlebnikov Marco Carmignani
Andrei Vasile Nastuta Marco Cavaco
Andrej Belančić Marco Cosentino
Andrej Savic Marco Fogante
Andres Tittarelli Marco Germanotta
Andrey Markov Marcos Brioschi
Andrey Maslivets Marcus Mareel
Andrey Nagdalian Marek K. Bernard
Andrey Plotnikov Marek Kiliszek
Andrey Ratushnyy Marek Murias
Andrey Sudarikov Marek Wesolowski
Andrey Zamyatnin Margarida Duarte-Araújo
Andrzej Kasperski Margarita Apostolova
Aneta Ostróżka-Cieślik Margarita Ivanova
Ang Li Margarita Terentjeva
Angel Josabad Alonso-Castro Margherita Eufemi
Ángel Núñez Margherita Neri
Angeliki Angelidi Maria A. Bonifacio
Angeliki Katsafadou Maria Addolorata Mariggiò
Angelo Naselli Maria Agallou
Angelo Torrente Maria Angeles Rojo
Anilkumar Thaghalli Shivanna Maria Antonietta Panaro
Anisoara Cimpean Maria Botelho
Anita Kloss-Brandstätter Maria Carmela Bonaccorsi Di Patti
Anna Bilska-Wilkosz Maria Carmen Duran-Ruiz
Anna Bizoń Maria Correia
Anna Cleta Croce Maria Cristina Cangussú
Anna Drabczyk Maria Cristina Gauzzi
Anna Kabłak-Ziembicka Maria Da Glória Queiroz
Anna Kasielska-Trojan Maria Grazia Cerrito
Anna Lewinska María Jesús Costas
Anna Paradowska-Stolarz Maria Loureiro
Anna Piotrowska Maria Lucibello
Anna Shtro Maria Mascellino
Anna Spagnoletta Maria Mirabelli
Anna-Maria Barciszewska Maria Pia Ferraz
Anne Demulder Maria Rosaria De Miglio
Annette Audigé Maria Rubtsova
Anny Slama-Schwok Maria Salagianni
Anoop Rawat Maria Xilouri
Antal Csampai Mariagiovanna Cantone
Anthony William Coleman Marian Simka
Antimo Di Maro Mariana Floria
Antonella Ragnini-Wilson Mariangela Mancini
Antonia Rujia Sun Mariann Harangi
Antonino Di Pino Mariano Francesco Caratozzolo
Antonino S. Rubino Mariapaola Marino
Antonio Barbato Mariarosaria Boccellino
António Miguel Morgado Marie Černá
Antonio Nenna Marie-Louise Bang
Antonio Orlacchio Marie-Odile Soyer-Gobillard
Antonio Pontoriero Mariia Ivanova
Anusorn Cherdthong Marika Comegna
Ao Zhang Marilena Mangiardi
Apolinaras Zaborskis Marina Bobkova
Apostolos Papachristos Marina Khodanovich
Apostolos Tsolakis Marina Piscopo
Apostolos Zaravinos Marino Paroli
Arancha Llama-Palacios Mario D'Acunto
Arboix Adrià Mario Ganau
Arda Isik Mario Simirgiotis
Argyro Mavrogiorgou Mario Valenti
Ari-Pekka Koivisto Mario Valentino
Aristeidis Stavroulopoulos Marion Korach-André
Aristotle Koutsiaris Mariusz Hartman
Armando Caseiro Mariusz Klencki
Armando Patrizio Mariusz Niemczyk
Arpad Tosaki Mariusz Siemiński
Arrigo Cicero Marjorie Jones
Artem Gureev Mark Musch
Artur Ribeiro Mark Roberts
Artur Słomka Marlena Brzozowa-Zasada
Arturo Sanchez Perez Marlena Godlewska
Arulselvan Palanisamy Marloes Dekker Nitert
Arun Kumar Hanumana Gouda Patil Marta Elena Losa Iglesias
Arun Sridhar Marta Gaburjáková
Arũnas Ramanavičius Marta Letizia Hribal
Arvind Negi Marta Wysocka-Mincewicz
Asim Ali Yaqoob Martha Gallegos
Assunta Pozzuoli Martin Michel
Astrida Velena Martin Wawruch
Athanasios Kiourtis Martina Maggi
Athanasios Papadopoulos Martina Smolic
Athanasios Papakyriakou Marwan El Ghoch
Attila Frigy Marwan Osman
Audrius Dulskas Maryam Ardalan
Avisek Majumder Marzia Baldereschi
Ayaz Shahid Marzia Di Donato
Ayslan Brant Marzia Segù
Azad Bhuiyan Masahiro Yasuda
B. H. Jaswanth Gowda Masaki Nagaya
Bai-Yan Li Masaru Tanaka
Balakumar Chandrasekaran Masashi Mizuguchi
Bangfu Zhu Masayuki Nashimoto
Baoquan Liu Massimiliano Ammirabile
Barbara Giordani Massimo Broggini
Bárbara Henriques Massimo Corsalini
Barbara Kaplan Mateusz Szudzik
Barbara Lapinska Mathias Dolci
Barbara Ruaro Mats Eriksson
Barbara Strzalka-Mrozik Matteo Ramazzotti
Bartosz Małkiewicz Matteo Riccò
Basant Puri Matthew Benesch
Basveshwar Gawali Matthew Butchbach
Beata Mrozikiewicz-Rakowska Matthias Eckhardt
Beata Wodecka Matthias Müller
Beatrice Turcq Matthias Ocker
Bela Balint Mau-Ern Poh
Ben Chen Maurizio Iacobone
Ben De Lacy Costello Maurizio Mulas
Beniamin Grabarek Mauro Giacomelli
Benjamin Cull Mauro Lombardo
Benjamín Floran Garduño Mauro Montalbano
Benjamin Teply Mayank Choubey
Bennett Elzey Mayur Virarkar
Bernardo Pereira Md. Azad
Bhaswati Bhattacharya Md. Khalid Anwer
Bhaumik Pandya Md. Tanvir Rahman
Bhupendra Prajapati Mederle Ovidiu Alexandru
Bhupinder Kumar Meerambika Mishra
Bi-He Cai Mehdi Dadmehr
Bilal Kirmani Mehdi Montazer
Biljana Arsic Mehmet Gumustas
Bin Du Meijun Du
Bipradas Roy Melanie Walker
Blanca Bazán-Perkins Mengliang Zhang
Błażej Grodner Mercedes Fernandez
Blessy Suresh Mercedes Gimeno
Bogdan Gherman Mercedes Lopez-Santalla
Bogdan Iliescu Mi Chen
Bogdan Socea Mi Kyung Park
Bogdan Walkowiak Micaela Medrano
Bogna Grygiel-Górniak Michael Diamantidis
Bojana Vidović Michael Landowski
Boldeanu Virgil Michael Leitges
Boleslaw T. Karwowski Michael Petronek
Boris Kozlov Michael Schirmer
Božana Lončar-Brzak Michael Seidenstuecker
Brian D. Adams Michael Sticherling
Bruce MacIver Michael Weller
Bruno Bueno-Silva Michael West
Bruno Fonseca Michal J. Dabrowski
Burak Tüzün Michal Nowak
Camelia Gurban Michal Ordak
Cândida Teixeira Tomaz Michal Pruc
Caner Günaydın Michel Puceat
Carina Balcoş Michel Roethlisberger
Carine Arnoni Michela Mitchell
Carla Pagliari Michela Terlizzi
Carla Palma Michele Boffano
Carla Perego Michele Costanzo
Carla Zannella Michele D'Attilio
Carlo Aprile Michele Schiano Di Visconte
Carlo Diaferia Mick Welling
Carlos Cerdán Santacruz Mieszko Wieckiewicz
Carlos Del Fresno Sánchez Miguel A. Ortega
Carlos Eric Galván-Tejada Miguel Angel Alcántara Ortigoza
Carlos Gamarra-Luques Miguel García-Castro
Carlos López-De-Celis Miguel Gonzalez-Gay
Carlos Miguel Marto Miha Moškon
Carlos Torres-Torres Mihaela Adriana Ilie
Carlos Trenado Mihaela Avram
Carlos Viegas Mikaeel Young
Carly Filgueira Mikael Lindström
Carmen Llena Mikhail Akimov
Carmen Sáez Mikhail Dubinin
Carmine Izzo Mikhail Inyushin
Carol Wadham Mikhail Kostik
Carsten Carlberg Mikhail Vorob'ev
Carsten Tjell Mikołaj Maga
Cassiano Gonçalves-De-Albuquerque Milan D. Perovic
Catalin Pruncu Milan Kolar
Catana Cristina Milan Toma
Catherine Yzydorczyk Milica Pešić
Cesar Ceballos Milka Mileva
Cesar Mattei Miloš Mitić
Cesare Tosetti Mineko Terao
Céu Costa Ming Yang
Chadi Abdul Kader El Farran Ming-Chi Lu
Chandra Mishra Ming-Wei Lin
Chandrabose Selvaraj Miquéias Lopes-Pacheco
Chang Lei Mircea-Catalin Fortofoiu
Changzheng Chen Miriam Hickey
Chan-Yen Kuo Mirjana Jerkic
Chao Wang Mirko Manetti
Charles Norton Mohamad Shahgholi
Charlie Rice Mohamed Addi
Chen Xie Mohamed Al-Agamy
Cheng-Rong Yu Mohamed Jaber
Chetta Massimiliano Mohamed Khalifa
Chia-Che Chang Mohamed Rahouma
Chien-Chung Yang Mohammad Doroudian
Chih-Li Lin Mohammad Mobashir
Chis Adriana Aurelia Mohammad Qneibi
Chisato Kinoshita Mohammad Reza Jamalpour
Chitra Rawat Mohammad Zamani
Chiung-Hui Liu Mohammadreza Shalbafan
Christian Barbato Mohammed El-Magd
Christian Lehmann Mohammed Emran
Christian Saleh Mohammed Hawash
Christian Wiraja Mohammed Ramadan
Christian Wunder Mohammed Sayed
Christina Banti Mohd Imran
Christina Kostara Mohd Kausar
Christoph Faschinger Mohsin Shah
Christopher Anderson Moises Leon Juarez
Christopher Kobierzycki Mona Sadat Larijani
Christopher Plaisier Monica Gallego
Christopher William Monica Sancho
Christos Mikropoulos Monika Łopuszańska-Dawid
Christos Papaneophytou Monika Ruszala
Chrysoula Voidarou Monika Szturmowicz
Chuan Hun Ding Monika Ulamec
Chuanming Xu Moshe Davidovitch
Chuanqi Chu Motoki Fukuda
Chulhun Park Mounir M. Salem Bekhit
Chung Lin Lee Mrinal Bhattacharjee
Chung-Hsin Wu Muammel Hanon
Chung-Ming Chen Mugurel Constantin Rusu
Chun-Jung Chen Muhamad Noor Alfarizal Kamarudin
Chun-Song Yang Muhammad N. Zahid
Cíntia Helena Saraceni Muhammad Sajid Hamid Akash
Ciprian Danielescu Myron Szewczuk
Claire Jean-Quartier Nadège Kindt
Claire Stocker Nadezda Apostolova
Claudia Altamura Nadira Yuldasheva
Claudia Kowolik Nagavendra Kommineni
Claudia Riccardi Nagendran Tharmalingam
Claudio Ferrante Nahum Rosenberg
Claudiu Morgovan Naima Cortes-Perez
Claudiu N. Lungu Naji Kharouf
Clement Chung Nan Jiang
Concettina La Motta Nanako Kawaguchi
Constantin Munteanu Nancy Saad
Constantinos Pistos Napoleão Argôlo Neto
Conxita Mestres Narendar Dudhipala
Cornelia Mircea Narongchai Autsavapromporn
Cornelius Krasel Naser Alsharairi
Corrado Pelaia Natalia Belosludtseva
Cristian Baicus Natalia Ivanovna Agalakova
Cristian Mornos Natalia Shnayder
Cristian Persu Natalia Stepanova
Cristina Capatina Nataša Marčun Varda
Cristina Capusa Nathaniel Szewczyk
Cristina Casalou Nauman Khan
Cristina Gluhovschi Naveed Ahmed
Cristina Manuela Dragoi Neal Davies
Cristina Mas-Bargues Neelanjan Vishnu
Cristina Zbârcea Neeraj Thakur
Cristoforo Pomara Nejc Umek
Cyril Fersing Nemat Ali
Cyril Nicolas Neven Papić
Cyrille Blondet Nhu-Nang Vu
Cyrille Magne Nicholas Bradshaw
Dae-Wui Yoon Nicholas Rowell
Damir Fabijanić Nicola Mondanelli
Dan Tesloianu Nicola Scott
Dana Carmen Zaha Nicolae Gica
Dana Ciobanu Nicoleta Anton
Dana Copolovici Nicoletta Cera
Dan-Alexandru Szabo Nicoletta Coccaro
Dane Wolf Nicolò Brandi
Daniel Antwi-Amoabeng Nicolò Fabbri
Daniel Barbosa Nidhi Puranik
Daniel Böger Nikolaos Kadoglou
Daniel Liedtke Nikolaos Kostomitsopoulos
Daniel Meier Nikolay Barashkov
Daniel Ortuño-Sahagún Nilay Shah
Daniel Otto Nima Rafati
Daniel Piskorz Nina Anfinogenova
Daniel Potaczek Nina Filip
Daniel Pozza Nina Graffmann
Daniel Torres-Lagares Nina Pastor
Daniel Van Wamelen Nirmal Mohakud
Daniela Cabibi Nisha Arenja
Daniela Elena Serban Nitin Amdare
Daniela Iancu Nitin Saksena
Daniela Opriş-Belinski Noriko Takegahara
Daniela Regazzo Noura Dosoky
Daniele Fanale Nurbubu Moldogazieva
Daniele Maria-Ferreira Oana Almasan
Daniele Ugo Tari Oana Pop
Daniele Vergara Oana-Maria Boldura
Daniil Olennikov Octavio Galindo-Hernandez
Danijela Ristic-Medic Oleg Shichalin
Danilo Boskovic Oleg Shuvalov
Dapeng Chen Oleksii Skorokhod
Daria Chudakova Olesya Sazonova
Daria Shishkova Olga Anatskaya
Darin Zerti Olga Kopach
Dario Siniscalco Olga Pershina
Darko Kero Olga Sysoeva
Darlene Mitrano Olga Zakharova
Daryoush Shahbazi-Gahrouei Oliver Felthaus
David Aebisher Oliver Sander
David Bar-Or Olivier Rukundo
David Gewirtz Omid Mirmosayyeb
David Greenhalgh Omneya Attallah
David Kopsky Ondrej Vasicek
David Leavesley Osama Kishta
David Li-Kroeger Oscar Cabrera-Marante
David Parada Oscar Campuzano
David Ramiro-Cortijo Óscar Lorenzo González
David S. Y. Ong Óscar Rapado-González
David Sánchez-García Oskars Kalejs
Davide Bizzoca Otávio Augusto Chaves
Davide Borroni Otávio Espíndola
Davide Giuseppe Ribaldone Oumaima Ammar
Davide Romano Oyuna Kozhevnikova
Davood Rahmatabadi Pablo Martinez-Camblor
Debashis Dutta Palanisamy Ravichandiran
Deborah Verran Pallabita Chowdhury
DeGaulle Chigbu Pamela Di Giovanni
De-Li Shi Panagiotis Mallis
Demetrios Arvanitis Panayiota Petrou
Demin Cai Pantelis Zebekakis
Dengchao Cao Paola Maycotte
Denis Silachev Paolina Crocco
De-Pei Li Paolo Benna
Desislava Teneva Paolo Cavoretto
Despina A. Tata Paolo Limoli
Dhananjay Yadav Paolo Meneguzzo
Dharambir Kashyap Paolo Natale
Dhiraj Bhatia Paolo Trucillo
Diana Pinto Paolo Tucci
Dianbao Zhang Parisa Gazerani
Diego Romano Perinelli Partha Narayan Dey
Dignesh Khunt Paschalis Theotokis
Dillon Mintoff Pasquale Marrazzo
Dimitra Mitsiou Pasquale Paolisso
Dimitrios-Efthymios Vlachos Pasquale Sessa
Dimitris Tatsis Pasqualino Sirignano
Dimosthenis Lykouras Patrice X. Petit
Diwakar Guragain Patrícia Pires
Djordje Vukelic Patricia Wadowski
Dmitrii Maltsev Patrick G. Arndt
Dmitry Ryumin Patrick Martin
Dmitry Verbenko Patrick Rockenfeller
Dolores E. Lopez Patrycja Woźniak
Domenico Di Raimondo Paulo J. Palma
Domenico Ferro Pavel Solopov
Domenico Lio Pawan Raghav
Domenico Tripodi Paweł Krzyżek
Dominik Dłuski Paweł Wańkowicz
Dominik Sturm Payal Ganguly
Domiziano Tarantino Pedro Ferreira-Santos
Donatella Delle Cave Pedro Guillen
Donato Liloia Petar Ozretić
Dong Keon Yon Peter Anderson
Donghwa Kim Peter Gaengler
Dongil Shin Peter Liddle
Dongrui Ma Peter Lunt
Dong-Wook Han Peter Piko
Dorianna Sandonà Peter Scharff
Dorota Bartusik-Aebisher Péter Ujma
Dorota Formanowicz Petko Alov
Dragana Gabric Petr Masliukov
Dragana M. Stanojevic Petros Ioannou
Dragos Serban Philip Busbee
Drozdstoy Stoyanov Philip Chilibeck
Dzmitry Shcharbin Philippe Lefrançois
Eberhard Uhl Philippe Lewalle
Ebrahim Asadi Philippos Klonizakis
Edgar López López Pia Giovannelli
Edit Hermesz Pier Nicola Sergi
Edoardo Pasqui Piera Anna Martino
Eduardo Gutiérrez-Abejón Pierre Moffatt
Eduardo Rivadeneyra Domínguez Pierre Tennstedt
Edward J. Pavlik Pierre-Simon Jouk
Edward N. Harris Pieter Jj Sauer
Egor Dzyubenko Pietro Cacialli
Egor Plotnikov Pietro Geri
Ehsan Ahmadpour Pietro Hiram Guzzi
Eiichi Kumamoto Pietro Scicchitano
Eirini Christodoulou Pilar Font-Ugalde
Eishin Morita Ping K. Yip
Eitaro Kodani Ping Wang
Ekaterina Naumenko Ping-Chung Kuo
Ekaterina V. Zubareva Pingfan Hu
Ekaterina Yurchenko Piotr B. Heczko
Elaine Dunlop Piotr Dobrowolski
Elena Criscuolo Piotr Gauden
Elena Kovalenko Piotr Mamczur
Elena Salernitano Piotr Michel
Elena Tchetina Piotr Szymczyk
Elena Tchevkina Piya Temviriyanukul
Eleni Alexandratou Piyush Baindara
Eleni Mavrogonatou Piyush Gondaliya
Elenko Popov Piyush Gupta
Eleonora Alfinito Placido Bruzzaniti
Eleonora Russo Plamen Todorov
Eleonora Scarlata Polliana Mihaela Leru
Eleonore Fröhlich Ponti Donatella
Eleuterio A. Sánchez Romero Prabhanjan Giram
Elisa Belluzzi Pradeep Uchil
Elisa Cairrao Pranav Prabhakar
Elisa Camela Prasanth Puthanveetil
Elisa Ceccherini Prasenjit Mondal
Elisa Lazzari Prashant Kumar
Elisa Oltra Pravin Sehgal
Elisa Russo Prem Kushwaha
Elisa Zavattaro Premranjan Kumar
Elisabete M. S. Castanheira Priti Prasanna Maity
Elisabeth Bloemena Pui Wah Hui
Elisabeth Pinart Pushpa Joshi
Elisavet Stavropoulou Pushpa Verma
Elpiniki Papageorgiou Qi Xiang
Elrashdy Redwan Qianrong Qi
Elton Vasconcelos Qibin Geng
Elvira Orduna-Hospital Qilei Chen
Elyor Berdimurodov Qin Xiang Ng
Elżbieta Grześk Qingjun Pan
Eman Khalifa Qingsen Shang
Eman Toraih Qiuwang Zhang
Emanuela Chiarella Rabbani Syed
Emanuele Bernardinelli Rachy Abraham
Emel Baloglu Radu Chicea
Emilia Manole Radu Miftode
Emily S. J. Edwards Radu Racovita
Emma Adriana Ozon Rafael Baltiérrez-Hoyos
Emmanouil-Georgios Tzanakakis Rafael Gongora
Emmanuel Topoglidis Rafał Czepczyński
Enric I. Canela Rafał Watrowski
Enrique Berjano Raffaele Frazzi
Eric Chappel Raffaele Serra
Eric Huet Raghbendra Dutta
Erika Di Zazzo Raghuvaran Shanmugam
Erin Van Schaik Raghuveera Goel
Ernesto Cortés Castell Rahul Mannan
Ernő Zádor Raja Singh Paulraj
Erzsébet Horváth-Puhó Rajeev K. Singla
Estefania Nuñez Rajendra Rohokale
Eugene V. Radchenko Ram Sagar
Euphrosyni Koutsouraki Ramanjaneyulu Rayala
Eva Fischer-Fodor Ramaswamy Kannappan
Evangelia Antoniou Ramcés Falfán-Valencia
Evangelia Kouidi Ramendra Pandey
Evgen Multia Ramesh Kumar Paidi
Evgenia Sitnikova Rami Najjar
Evgenii Skurikhin Ramiro Guerrero-Santos
Evgeniya Kaigorodova Ramón Fuentes
Evgeniya Ostroumova Ramona Danac
Evgeny Ermakov Ranjeet Kumar
Ewa Balcerczak Ranjith Kumar Manoharan
Ewa Tomaszewska Ranko Gacesa
Fabio Zicker Ravi Sharma
Fabrice Compain Ravindra Deshpande
Fabrizio Bambini Raviraj Vankayala
Fabrizio Martora Razeghian-Jahromi Iman
Faisal Alzahrani Rebeca Busto
Fangfang Sun Rebekka Heitmar
Farah Al-Marzooq Récsán Zsuzsa
Fares Ali Remington L. Nevin
Farzad Taghizadeh-Hesary Renata Ciccarelli
Fatemeh Khatami Renato Galzio
Fatma Abdel Bar Renato Melo
Fatma Abdelhamid Rene Buchet
Fausto Fiori Revathy Nadhan
Federica Fogacci Reza Assaran Darban
Federico Marchesi Reza Nedaeinia
Fei Pan Reza Razaghi
Felicia Grasso Reza Shirazi
Felix Clanchy Ricardo Marques
Felix Sebastian Oberhoffer Ricardo Ruiz-Villaverde
Fengyuan Zhao Richard Drevet
Ferdinando Antonio Gulino Richard Frye
Fernanda Seixas Ritthideach Yorsaeng
Fernanda Tonelli Rizwan Wahab
Fernando Durães Rob McCorkle
Fernando Ferreira Robert Eibl
Fernando Sanchez Lasheras Robert Friedman
Filemon Dela Cruz Robert Kleszcz
Filippo Mariano Robert L. Meisel
Filippo Torrisi Roberta Giordano
Filippos Triposkiadis Roberta Imperatore
Filomena Salazar Roberta Moschini
Fiorella Colasuonno Roberto Cannataro
Fiorella Tonello Roberto Castiglione
Fiorenzo Moscatelli Roberto Codella
Firoz Akhter Roberto De Santis
Flávia Leão Barbosa Roberto Montalti
Flavio Milana Robin Cooper
Flaviu Moldovan Robin Kumar
Fletcher White Rodolfo Garcia
Flor H. Pujol Rodolfo Reda
Flora N. Balieva Rogerio Buchaim
Florence Carrouel Rolf Heumann
Florence Legendre Roman Lysiuk
Florin Tripon Roman Nowicki
Fortunato Iacovelli Ronan Murphy
Franc Vrečer Rosa María Giráldez-Pérez
Francesca Di Sole Rosa Suades
Francesca Felicia Operto Rosa Vona
Francesca Pacifici Rosa Zampino
Francesco Bianco Rosalba Senese
Francesco Boccalatte Rosanna Mallamaci
Francesco Cadario Rosaria Meccariello
Francesco Ciccarese Rossella Cacciola
Francesco Claps Rostyslav Bilyy
Francesco De Francesco Roua Popescu
Francesco Di Gregorio Roxana Liana Lucaciu Stan
Francesco Dondi Roxana Racoviceanu Babuta
Francesco Saverio Ludovichetti Rubén San-Segundo
Francesco Serrapica Rueinian Li
Francesco Sessa Rui Han
Francisco David Rodríguez Rui Tada
Francisco Epelde Rui Vitorino
Francisco Esteves Rumyana Simeonova
Francisco Germain Ruoxing Wang
Francisco Guillen-Grima Ruperto González-Pérez
Francisco José Nunes Antunes Rusan Catar
Frank D. Eckerdt Ruth Perez
František Trejtnar Ryo Saga
Franz Zehentmayr Saad Darwish
Furong Tian Sabina Galiniak
Gabor Halmos Sabina Sevcikova
Gábor Kökény Sabrina Bossio
Gábor Nagy Saeed Mohammadi
Gabriel Gutiérrez-Ospina Saeid Ghavami
Gabriela Dumitru Sagrario Martín-Aragón
Gabriela Popa Saikat Paul
Gabriele Grunig Sajjad Ahmad
Gabriele Toietta Sakthivel Muniyan
Gaetana Costanza Salih Durdu
Gaetano Marverti Sally Freeman
Gaetano Santulli Salvatore Feo
Gagandeep Saggu Salvatore Giordano
Galina Nikolova Salvatore Pezzino
Gamaleldin Harisa Salvatore Saccone
Gary Farkas Samar Tharwat
Gary Moore Samo Fokter
Gatikrushna Singh Samrita Dogra
Gema Navarrete Samy Sayed
Gennadi Saiko Sandeep Kumar Reddy Adena
George Imataka Sandra Donnini
George Koumantakis Sandra Pina
George Manis Sandro Glumac
George Mihai Nitulescu Sandro Massao Hirabara
George Paraskevas Sanjay Patel
Georgia Vrioni Santosh Misal
Georgios Katsaras Sara Carmo
Georgios Pampalakis Sara Gibertini
Georgios Panos Sara Manti
Gerald Lushington Sashi Debnath
Gerardo Cazzato Sathish Kumar Natarajan
Gergő Tóth Sathish Thirunavukkarasu
Gessica Sala Satish Sagar
Gheorghe Solcan Satoru Munakata
Giacinto Barresi Satyavani Kaliamurthi
Giada Amodeo Satyesh K. Sinha
Gianandrea Pasquinelli Saverio Muscoli
Giancarlo Micheletto Savvas Lampridis
Gianluca Fasciolo Sayed Sartaj Sohrab
Gianluca Nazzaro Sazan Rasul
Gilbert Lim Scott McComb
Gilles Lemaître Sebastián Castillo-Galán
Gionata Fragomeni Sebastian Glowinski
Giorgio Treglia Sebastian Werneburg
Giou-Teng Yiang Sebastian Yu
Giovanna Gambarotta Sebastiano Cicco
Giovanna Mottola Seong-Hee Ko
Giovanni Buzzaccarini Serap Özer Yaman
Giovanni Colonna Sergei Boichuk
Giovanni Levi Sergei Gaidin
Giovanni Ribaudo Sergey Dikalov
Giovanni Rosti Sergey Kolomeichuk
Girolamo Costanza Sergey Sedykh
Gisele Nai Sergey Sekatskii
Giulia Di Benedetto Sergey Tkachev
Giuliana Muzio Sergi Maicas
Giulio Mengozzi Sergii Babichev
Giulio Sancini Sergio Crespo-Garcia
Giuseppe Biagini Shabana Naz
Giuseppe Bruno Shabnam Bakhshalizadeh
Giuseppe Caminiti Shadma Wahab
Giuseppe Cirillo Shalini Dogra
Giuseppe Di Martino Shanfeng Zhang
Giuseppe Martelli Shanmuga S. Mahalingam
Giuseppe Nasso Shaohua Wang
Giuseppe Schepisi Shao-Ming Wang
Gjin Ndrepepa Sharad Purohit
Goran Augustin Shenghong He
Goran Vrgoč Sherif Fahmy
Gordana Wozniak Knopp Sherif T. S. Hassan
Grazyna Gromadzka Shifeng Xue
Grażyna Nowicka Shin-Chen Pan
Gražyna Simha Martynková Shingen Nakamura
Grzegorz Bartosz Shin-ichi Hirano
Grzegorz Grześk Shin-ichi Kawaguchi
Grzegorz Jakubiak Shining Loo
Guangbi Li Shinji Takamatsu
Guan-Jun Yang Shiv Dutt Purohit
Guendalina Zuccari Shraddha Parate
Guglielmo Duranti Shujaat Ahmad
Guglielmo Manenti Shujat Ali
Guido Gembillo Shuta Ohara
Guido Vanham Silvano Dragonieri
Guillaume E. Courtoy Silvia Visentin
Guillermo Gervasini Simona Coniac
Guillermo Tellez Simona Dedoni
Gulali Aktas Simona Ferraro
Gul-e-Saba Chaudhry Simona Iftimie Iftimie
Gundula Schulze-Tanzil Simona-Delia Nicoara
Guochun Jiang Simone Cilio
Guowei Kim Simone Porsborg
Gustavo Fernandes Simons Svirskis
Guy Hans Singh Avishek
Györgyi Műzes Sivaraman Natarajan
Hadia Almahli Sivashankar Krishnamoorthy
Haidi Ibrahim Sladjan Pavlovic
Haijun Liu Slavica Kvolik
Hailong Hu Slawomir Jakiela
Haim Breitbart Snehasis Bhakta
Haina Huang Snježana Kaštelan
Haitham Abo-Al-Ela Sohail Mumtaz
Haiyu Ji Soheil Abbaspour-Ravasjani
Halilibrahim Ciftci Soledad López-Enríquez
Hamed Barabadi Solomon Viswas Raja
Hamed Nosrati Soma Shekar Dachavaram
Hamed Saghaei Somchai Amornyotin
Hanna Szaefer Sonia Benítez
Hans Binder Sonia Ronchey
Hans Peter Lang Soochong Kim
Hans-Christian Kolberg Søren Christensen
Hany H. Arab Sotiria Vrouva
Hanying Chen Sousana Papadopoulou
Hao Wu Srijit Das
Haralampos Tzoupis Srikanth Prabhu
Harald Krentel Stanislav Naryzhny
Harald Schulze Stefan Brocke
Harikanth Venkannagari Stefan Frent
Harikumar Rajaguru Stefan Kranz
Harish Ramachandramoorthy Stefan Linsler
Haruhiko Sugimura Stefana Moisa
Haruhito A. Uchida Stefania Garzoli
Haruki Usuda Stefano Bacci
Hassan Ishqi Stefano Ciardullo
Hassan Mirzaei Stefano Fais
He Zhang Stefano Giannubilo
Héctor Mora-Montes Stefano Vendrame
Heinz Koelbl Stelian Sergiu Maier
Helder Cardoso-Cruz Stephan Schmid
Hemant Prajapati Stephen Inbaraj
Hengyi Xu Stephen Walker
Henrico Strazzi-Sahyon Stergios Boussios
Henrik Ronnberg Steven Esworthy
Henrique Silveira SubbaRao Madhunapantula
Henry Sutanto Subir Kumar Juin
Herbert Ryan Marini Sueli Fumie Yamada-Ogatta
Hervé Reychler Sugandh Kumar
Hexiao Wang Suhwan Lee
Hideji Yoshida Sukanya Saha
Hideo Kato Sulev Kõks
Hideo Wada Süleyman Cemil Oğlak
Hidetoshi Saitoh Suman Mukhopadhyay
Hipolito Nzwalo Sung-Lang Chen
Hiroaki Inaba Supandeep Hallan
Hiroaki Neki Suparerk Janjarasjitt
Hiroaki Taguchi Supriya Chakraborty
Hiroki Ide Surbhi Chouhan
Hiroki Teragawa Susana Silva
Hiroyasu Sakai Susanne Füssel
Hiroyasu Yamanaka Susanne Klaus
Hiroyuki Nojima Svetlana Ermolaeva
Hiroyuki Wakiguchi Svetlana Guryanova
Hisao Haniu Svetoslav Todorov
Hisayoshi Kawahara Swati Dahariya
Hong Shi Syed Husain Mustafa Rizvi
Hongbing Chen Syed Mohd Faisal
Honghua Hu Sylvain Bourgoin
Hongwei Cheng Sylvain Broussy
Hsiang-Ning Luk Sylvère Störmann
Hsinjung Ho Székely Andrea
Hsiu-Mei Chiang Szu-Tah Chen
Hsiuying Wang Tadahisa Sugiura
Huacheng Zhang Tadakazu Kondo
Hugo Martiniano Tae Hun Chung
Hui Hannah Xiaoyan Taif Shah
Huiwen Ren Takashi Obama
Hung-Chi Cheng Takemichi Fukasawa
Hung-Pin Tu Takuji Tanaka
Hyuck Jin Lee Takuya Tada
Hyun-Ouk Kim Talal Zari
Hyun-Woo Park Taner Tuncer
Ibrahim Sayed Tania Colasanti
Ichiro Kawahata Tanja Miličić
Ignacija Vlašić Tarek M. A. Abdel-Fatah
Ignacio Bosch Tarek Mohamed
Ignacio Díez López Tarr Tünde
Ignazio Gaspare Vetrano Tatiana Antipova
Igor Buzalewicz Tatiana Arefieva
Igor Iskusnykh Tatiana Kuznetsova
Igor Jurak Tatiana Moshonkina
Ihar Volkau Tatjana Radosavljević
Ilaria Girolami Tatsuo Kanda
Iliana Medina-Ramirez Tatyana Baltina
Ilias Mylonis Tejeshwar Rao
Ilya Klabukov Terenzio Cosio
Ilze Strumfa Teresa Bellón
Iman Karimzadeh Teresa Rubio-Tomás
Iman Tavassoly Terry Lichtor
Iman Van Den Bout Teru Kamogashira
Imran Ali Khan Tetsuro Tamaki
Ines Aguinaga-Ontoso Thach Nguyen
Ines Drenjancevic Thanavel Rajangam
Inna S. Midzyanovskaya Theocharis Koufakis
Inna Solyanikova Theodoros Androutsakos
Ioan Petean Theodoros Mavridis
Ioana Corina Bocsan Theofilos Kolettis
Ioana Ionut Theresa Whiteside
Ioannis Giantsis Thierry Cens
Ioannis Ilias Thomas Greither
Ioannis Kanakis Thomas Hieronymus
Ioannis Ntanasis-Stathopoulos Thomas Van Groen
Ioannis Petrakis Tiago Ribeiro
Ioannis Tomos Tianhua Niu
Ioannis Tsoulos Tianjie Pu
Iolanda De Marco Ting-Feng Wu
Ion Cosmin Puia Tom Broderick
Ionel Alexandru Checherita Tomasz Frączyk
Ionela-Larisa Miftode Tomasz Gębarowski
Irena Jekova Tomasz Kubrak
Irena Nalepa Tomaz Velnar
Irene Buj-Corral Tommaso Ercoli
Irene Dini Tommaso Lombardi
Irene Ottaviani Tomohiro Chiba
Irfan Khan Tomohiro Torii
Irina Georgiana Mocanu Torbjörn Ledin
Irina Pronina Torill Sauer
Irina Shipounova Toshiaki Ohara
Irmina Nahon Toshihiro Kita
Isabella Panfoli Tracy Murray Stewart
Isidora Vujcic Triantafyllos Didangelos
Ismail Fidan Trim Lajqi
Istvan Koncz Trish Berger
Istvan Zupko Tsunahiko Hirano
Ítala Marx Tsung-Cheng Tsai
Ivan Bratchenko Tuba Taslamacioglu Duman
Ivan Ivanov Tudor Lucian Pop
Iván Padrón Tudor Pop
Ivan Pavić Tulasigeri M. Totiger
Ivan Sabol Tusty-Jiuan Hsieh
Ivana Škrlec Tze-Kiong Er
Ivo Dumic-Cule Ubaldo Armato
Iwona Wertel Udi Sarig
Izabela Zakrocka Ugo Ala
Jacek Nycz Ulrich Gergs
Jacek Tabarkiewicz Ulrich Julius
Jackson Bittencourt Ulrike Baranyi
Jacopo Junio Valerio Branca Umapathi Reddicherla
Jacopo Lamanna Undurti Das
Jacqueline M. Bentel Usman Ghafoor
Jae Kyu Ryu Vadim Elagin
Jae-Hyung Park Vadim Genkel
Jakub Hadzik Vahid Jahed
Jakub Rok Vahideh Rabani
Jamel El Benna Vaitsa Giannouli
James Chow Valentin Zaharia
James Chung-Wai Cheung Valentina Giudice
Jan Bocianowski Valentina Vellecco
Janaina Sena De Souza Valeria Rachela Villella
Janja Trček Valérian Dormoy
Janusz Kluczynski Valerio Caputo
Janusz Madaj Valerio Leoni
Jared Ahrendsen Van Du Nguyen
Jarek Baran Van Thanh Tien Nguyen
Jaroslav Pejchal Van-An Duong
Javier Martinez-Useros Vangelis Karalis
Javier Parada Vanya Mantareva
Javier Rodriguez Carpena Vasile Valeriu Lupu
Javier Saenz-Medina Vasileios P. Papadopoulos
Jaya Shanker Tedla Vassiliy Tsytsarev
Jayanta Kumar Patra Velmarini Vasquez
Jean Amiral Vera Faustino
Jean Boutin Vera Panzarella
Jean Vanderpas Veronica Filetti
Jean-Christophe Jacquier Veronica Marrella
Jean-Marie Exbrayat Vibhav Gautam
Jean-Pierre Gagner Vicente Giner-Galvañ
Jeffrey Bryant Travers Victor I. Sevastianov
Jelena Ban Victor Kuz'min
Jen-Chih Tseng Victor Midlej
Jeni Prosperi Victor Seledtsov
Jennifer Pursley Vikas Kumar
Jeremy Lavine Vikas Malik
Jer-Ming Chang Vincent Van Der Velden
Jerry Malayer Vincenza Gragnaniello
Jessica Daolio Vincenzo Positano
Jesús Palomero Vincenzo Ronsivalle
Jesús Pastor Violeta Popovici
Jianfeng Xiang Virgil-Florin Duma
Jiangang Chen Vittorio Aprile
Jianing Fu Vjekoslav Peitl
Jianli Tao Vladimir Babenko
Ji-Chang Wang Vladimir Bilim
Jie Gao Vladimir Chobot
Jiekai Yin Vladimir Jurisic
Jimmy T. Efird Vladimir Kalinin
Jin-Chul Kim Vladimir Pisarev
Jinghua Wang Vladimir Yeremeev
Jinghui Wang Volkan Arısan
Jin-Ha Choi Vrinda Gote
Jinming Han Vyacheslav Dyachuk
Jitendra Kumar Sinha Wai Hang Cheng
Joachim Storsberg Wai San Cheang
Joana Barbosa Waldemar Wagner
Joana Damásio Walid Tawfik
Joanna Bartkowiak-Wieczorek Walied Abdo
Joanna Gromadzka-Ostrowska Walther Bild
João Henrique G. Lago Wansu Park
Joao Pessoa Wei Hong Lim
Joaquim Bustorff-Silva Wei-Chieh Lee
Joaquim C. G. Esteves Da Silva Wei-Chih Kan
Joaquim Carreras Wei-Hsiung Yang
Jochen D. Schipke Weihua Huang
Jochen Maurer Weiren Luo
Joel Ellwanger Weita Chen
Joel Soares Filipe Wen Yang
Johannes Hofer Wenchao Xu
John A. St. Cyr Wenji Piao
John Chisholm Wenjie Zhou
John Lalith Charles Richard Wenjing Tao
John M. Perry Wen-Jun Shen
John Nicholson Wen-Sheng Liu
John Parrish Wenyi Wang
John Triantafillidis Wesley Raup-Konsavage
Jolanta Dlugaszewska Wiesław Kaca
Jolanta E. Loster Wilhelm Mistiaen
Jonathan Rayner William Grant
Joni H. Ylostalo Wing Wong
Jordi Soriano Wojciech Jacheć
Jorge Ble-Castillo Wojciech Szlasa
Jorge Feito Wolfgang Kreisel
Jorge Gutiérrez-Cuevas Wolfram Kunz
José A. Carrión Woon‑Man Kung
Jose A. Fontenla Xavier Sastre-Garau
José A. García-Sanz Xiang Ma
José Lopes Xiao Shen
Jose M. Mendez-Arriaga Xiaoan Wu
José Pedraza-Chaverri Xiaobo Wu
Jose Tudela Xiaochun Peng
Jose Velázquez-Aragón Xiaohe Yang
Josefa Gonzalez-Santos Xiaonan Zhang
Jose-Luis Pérez-Castrillón Xin Li
Joseph Christakiran Moses Xin Liu
Joseph Kwong Xin Wang
Joseph Papamatheakis Xin Xiong
Josip A. Borovac Xing Zhang
Josko Bozic Xingchun Gao
Joy Mitra Xinxu Yuan
Jozsef Dudas Xuan Fang
Juan Antonio Rosado Xuan Li
Juan Carlos Fernandez-Lopez Xueqin Gao
Juan E. Ludert Xun Tao
Juan Guzman-Flores Yanan Liu
Juan Leon Yang Chen
Juan Mozas-Moreno Yang Zhang
Juan Pablo Rigalli Yang-Wei Lin
Juan-Carlos Galvez-Ruiz Yanira Vasquez
Juandy Jo Yan-Ming Xu
Judit Oláh Yanqiang Li
Julián Solís García Del Pozo Yanshuo Han
Julio Plaza-Diaz Yansong Qi
Julita Kulbacka Yaoxiang Li
Julius Höhne Yasemin M. Akay
Juliusz Huber Yasuhiro Nakamura
Jun Zhang Yasumasa Okazaki
Junaid Rafi Yasuo Imai
Junchao Tong Yehoshua Socol
Jun-ichi Tanuma Yekta Can
Jure Urbančič Yen-Chun Peng
Kabirullah Lutfy Yhiya Amen
Kacper Nijakowski Yichi Zhang
Kah Hui Wong Yifei Jin
Kaili Ma Yi-Lang Chen
Kamenna Vutova Yiming Huang
Kamyar Khoshnevisan Yinglei Song
Kandi Sridhar Yogendra Pratap Singh
Kangfu Chen Yong Weon Yi
Kanve N. Suvilesh Yong-Moon Lee
Kanwal Rehman Yorito Hattori
Karel Allegaert Yoshiaki Yura
Karel Kostev Yoshihiro Shidoji
Karen Kyuregyan Yoshihito Kano
Karolina A. Wojtunik-Kulesza Yoshikane Yamauchi
Karolina Stepien Yoshinobu Kariya
Katalin Sipos Younes Zaid
Katarina Baralić Youness Limami
Katarzyna Garbacz Young Zoon Kim
Katarzyna Zorena Youri Pavlov
Katerina Kotzampassi Yu Pi
Katharina Rump Yuet-Kin Leung
Katherine Sattler Yuhki Satou
Katherine Theken Yuji Nagatomo
Katsuhisa Inoue Yumeng Xi
Katsuhito Kino Yunfeng Zhao
Katsusuke Ozawa Yung-Hsiang Chen
Katsuyuki Tanabe Yunwen Tao
Kay-Dietrich Wagner Yuqing Zhang
Kazuhiko Nakadate Yuriy Vasil'ev
Kazuomi Sato Yusra Habib Khan
Kazuto Tajiri Yutian Ma
Keigi Fujiwara Yutian Zou
Keld-Erik Byg Yuyan Jiang
Kelly De Jesus Yves Combarnous
Ken Rosenthal Yves Piette
Kenji Hayashida Zbigniew Adamiak
Kenji Hirata Zdeněk Fišar
Kenneth Chat Pan Cheung Zenon Pogorelić
Kenneth N. White Zhaoxi Sun
Keun-Yeong Jeong Zhe Li
Kevin Dzobo Zheng Yuan
Kevin Ita Zhengwei Huang
Kexiao Yu Zhibin Zhou
Kezheng Li Zhichuan Zhu
Khalil Karimi Zhong Jian
Khurshid Ahmad Zhuhuang Zhou
Kielan McAlinden Zhuqiu Jin
Kinga Lis Zihao Ou
Kiran Lokhande Zoltan Banki
Kirk Stephenson Zoltan Kozinszky
Kirsten Haastert-Talini Zoltán Kukor
Kishor Pant Zoltán Pethő
Kishu Ranjan Zorana Dobrijević
Kit-Leong Cheong Zorana Golubović
Ko Miyoshi Zvonko Rumboldt
Kok Lun Pang Zygmunt Warzecha

26 January 2024
Interview with Dr. Alessandra Bettiol—Winner of the Biomedicines Young Investigator Award 2023

We had the privilege of interviewing Dr. Alessandra Bettiol, one of our distinguished winners of the 2023 Young Investigator Award, to delve into her remarkable journey and insights into biomedical research.

Dr. Alessandra Bettiol is a postdoctoral researcher at the Department of Experimental and Clinical Medicine, University of Florence, Italy. Since receiving her Ph.D. in 2018, Dr. Bettiol has worked in the field of rare autoimmune diseases, particularly systemic vasculitis, producing ground-breaking research on the biochemical and pathogenetic mechanisms sustaining these conditions, with a particular focus on the role of oxidative stress and fibrinogen structural and functional modifications in thrombo-inflammation. Also, she has made significant contributions to the field of innovative therapeutic approaches, collecting and analyzing data related to the largest European cohort of patients treated with innovative drugs for eosinophilic granulomatosis with polyangiitis (EGPA), a rare systemic vasculitis. Dr. Bettiol is a highly productive young researcher and has published >120 peer-reviewed articles in high-ranking journals. According to Scopus, her research has received > 1650 citations, and her h-index is 21.

The following is an interview with Dr. Alessandra Bettiol:

1. Could you kindly share your sentiments upon winning the Biomedicines Young Investigator Award 2023?

It has been a great surprise and honor for me to receive the Biomedicines Young Investigator Award 2023. I feel honored to see the research efforts made over these years by me and the research group I work with, awarded by this prestigious journal.

Also, I feel privileged to have the possibility, through this award, of enriching my CV and my international impact as a researcher.

2. Would you please provide a brief introduction to your main research focus? Additionally, could you share with us your motivation to pursue this particular area of research?

Since my Ph.D. was obtained in 2018, I have worked in the field of rare autoimmune diseases, particularly systemic vasculitis, at the Department of Experimental and Clinical Medicine of the University of Florence (Italy).

During this period, I had the chance to collaborate with the most important European centers working on eosinophilic granulomatosis with polyangiitis (EGPA), a rare systemic vasculitis, and I have authored relevant publications on this rare disease, collecting and analyzing data from the largest European cohorts of patients treated with innovative drugs for this condition.

The close collaboration with clinicians, biochemists, biologists and statisticians, also in the framework of National and International working groups, allowed me to become passionate about this research field, and to conduct ground-breaking research on biochemical and pathogenetic mechanisms of rare immune-mediated diseases. Specifically, I have worked on innovative observational and clinical studies assessing the contribution of oxidative stress and fibrinogen modifications in thromboinflammation associated with Behçet syndrome (BS), and on the role of gut microbiome in EGPA.

My wish is that this research will pave the way for future studies on theragnostic and prognostic markers for several immune-mediated diseases.

3. Could you elaborate on how you initially learned about the Biomedicines journal? And what inspired you to publish with us?

The Biomedicines journal is among the referral journals for investigators working in the field of translational medical research. Being particularly interested in pathogenetic, theragnostic and prognostic aspects of rare autoimmune diseases, I have always considered this journal as a potential candidate for the publication of my research works, and I had indeed the chance to publish one paper in this journal in 2022 [Niccolai E, Bettiol A et al. Biomedicines. 2022 May 24;10(6):1227.].

4. Furthermore, what inspired you to apply for the Biomedicines Young Investigator Award 2023? In what ways does this award contribute to the advancement of your professional career?

Over the last decade, I have worked with dedication and enthusiasm for identifying research needs, designing and conducting new research studies, and overcoming challenges in the field of rare autoimmune diseases. Applying for the Biomedicines Young Investigator Award 2023 has been the opportunity to have my work recognized, as well as enriching my CV and my international impact as a researcher.

5. Do you have any advice for aspiring young researchers looking to make a meaningful impact in their respective fields?

My advice for all young researchers is to be passionate about what they do. Passion, motivation and hard work are always rewarded.  

6. How do you believe your experiences, as a woman in this biomedical field, have contributed to your success and the advancements you’ve made in your research? Additionally, what advice would you offer to other aspiring female researchers in the field or facing similar challenges?

This award came to be during a very special period as a female researcher, as I was on maternity leave. Being a woman has always been a source of pride for me because I think that society forces us to learn a multi-tasking, translational way of managing things, that becomes an invaluable resource for us and our careers.

My advice for all young female researchers is to turn challenges into opportunities.

26 January 2024
Interview with Dr. Nico Sollmann—Winner of the Biomedicines Young Investigator Award 2023

Recently, we reached out to Dr. Nico Sollmann, a winner of the Biomedicines Young Investigator Award 2023, as we were eager to hear his perspectives on biomedicines and biomedical research.

Dr. Nico Sollmann graduated from the Medical School at the Technical University of Munich (TUM), Germany, in 2013. He completed the Ph.D. program “Medical Life Science and Technology” at TUM in 2017, followed by a residency at the Department of Diagnostic and Interventional Neuroradiology at Klinikum rechts der Isar (TUM). To focus on research in between his clinical rotations, Dr. Sollmann completed an internship at Harvard Medical School, Boston, USA, in 2016 and held a post-doc position at the University of California San Francisco, USA, in 2021. He currently works as a radiologist in training at the University Hospital Ulm as well as at the Klinikum rechts der Isar (TUM). He has published over 200 PubMed-listed articles and has an h-index of 37. He has been awarded several prestigious scientific awards. Dr. Sollmann continues to serve as a reviewer and editor for multiple journals and is a member of several national and international scientific societies, with a strong focus on neuroimaging and imaging of the spine.

In this interview, Dr. Sollmann offers a glimpse into the dedication and aspirations that have fueled his impactful contributions to the biomedical field.

1. Could you kindly share your sentiments upon winning the Biomedicines Young Investigator Award 2023?

I feel very honored and would like to thank all the Award Committee members for their evaluation and the Section Editor-in-Chief, Prof. Dr. Paul Rösch, for awarding me with the Biomedicines Young Investigator Award 2023. Furthermore, given that research is always a team effort, I would like to thank all my co-workers for their constant commitment, dedication, and inspiration. Working on research projects in addition to daily clinical work can sometimes be quite intense, and I consider this award a great motivator for all our upcoming projects.

2. Would you please provide a brief introduction to your main research focus? Additionally, could you highlight any compelling discoveries or unforeseen challenges encountered during your research journey?

I believe my research interests are quite broad but mostly revolve around quantitative in-vivo magnetic resonance imaging (MRI) in the field of neuroradiology, including imaging of the brain and spine. Two currently ongoing major projects focus on advanced MRI of the neck and shoulder muscles in patients with primary headaches (to elucidate the role of neck and shoulder muscles in the pathophysiology of migraine and tension-type headache) and on longitudinal MRI of the brain following a mild traumatic brain injury (to develop some kind of an individual injury profile that may help to better understand injury-related changes in the brain and to improve patient management and outcome prediction after injury).

One of the main lessons learned over recent years is that most projects take a very different direction than initially thought, and that the success of a project is oftentimes highly dependent on the attitude of the colleagues you work with (not only in terms of the actual findings but also in terms of the joy and gratitude you experience once a project has been completed). Hence, a flexible and curious mindset is key to becoming proficient in science.

3. Could you elaborate on how you initially learned about the Biomedicines journal? Furthermore, what inspired you to apply for the Biomedicines Young Investigator Award 2023?

Together with co-workers, I have published some of our work on spine imaging in the Biomedicines journal before. Hence, I have been aware of the journal and came across the award notification on the journal’s homepage. The announcement appeared to be highly interesting in light of my current career level and scientific profile, thus I wanted to take the chance and applied for this award.  

4. In what ways does this award contribute to the advancement of a young/early-career researcher's professional career, such as yours?

I think that an award like the Biomedicines Young Investigator Award can be regarded as a great motivator and a catalyst for ongoing and future projects. Sometimes research projects can be quite time-consuming and demanding, and you do not know whether your efforts will pay off in the end. Hence, such an award helps you to stay on track, and also to keep going during times when you might not see the ultimate benefit of the efforts you put into the research.

5. Do you have any advice for aspiring young researchers looking to make a meaningful impact in their respective fields?

A key piece of advice is to stay on track and make yourself aware that research is often like long-distance running rather than a sprint. Good projects can often take time and you should not get frustrated if initial plans do not exactly work out.

6. As we conclude, could you share your vision for the future of your research and the contributions you aspire to make in the field of biomedicines?

I am most grateful to my colleagues and co-workers for their enthusiasm, and I hope that I can continue relying on and working together with such a great team again in the future. My vision is that our current major projects will lead to clinically meaningful results that can improve patient care and management, and that those results will drive future ideas and collaborations in the field of biomedicines.

19 January 2024
Biomedicines | Hot Papers in the “Gene and Cell Therapy” Section

This Section of Biomedicines (ISSN: 2227-9059) aims to rapidly publish contributions on all aspects of the latest research results concerning gene and cell therapy. We encourage the submission of manuscripts that provide novel and mechanistic insights and papers that report significant advances in the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.

You’re welcome to read the following papers:

1. “Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials”
by Celia Bonilla and Mercedes Zurita
Biomedicines 2021, 9(6), 669; https://doi.org/10.3390/biomedicines9060669
Available online: https://www.mdpi.com/2227-9059/9/6/669

2. “Telomeres and Age-Related Diseases”
by Hans-Jürgen Gruber, Maria Donatella Semeraro, Wilfried Renner and Markus Herrmann
Biomedicines 2021, 9(10), 1335; https://doi.org/10.3390/biomedicines9101335
Available online: https://www.mdpi.com/2227-9059/9/10/1335

3. “C-Peptide as a Therapy for Type 1 Diabetes Mellitus”
by Rachel L. Washburn, Karl Mueller, Gurvinder Kaur, Tanir Moreno, Naima Moustaid-Moussa, Latha Ramalingam and Jannette M. Dufour
Biomedicines 2021, 9(3), 270; https://doi.org/10.3390/biomedicines9030270
Available online: https://www.mdpi.com/2227-9059/9/3/270

4. “Photobiomodulation of Human Fibroblasts and Keratinocytes with Blue Light: Implications in Wound Healing”
by Francesca Rossi, Giada Magni, Francesca Tatini, Martina Banchelli, Federica Cherchi, Michele Rossi, Elisabetta Coppi, Anna Maria Pugliese, Duccio Rossi degl’Innocenti, Domenico Alfieri et al.
Biomedicines 2021, 9(1), 41; https://doi.org/10.3390/biomedicines9010041
Available online: https://www.mdpi.com/2227-9059/9/1/41

5. “Telomerase in Brain: The New Kid on the Block and Its Role in Neurodegenerative Diseases”
by Gabriele Saretzki and Tengfei Wan
Biomedicines 2021, 9(5), 490; https://doi.org/10.3390/biomedicines9050490
Available online: https://www.mdpi.com/2227-9059/9/5/490

6. “CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications”
by Motahareh Arjomandnejad, Acadia L. Kopec and Allison M. Keeler
Biomedicines 2022, 10(2), 287; https://doi.org/10.3390/biomedicines10020287
Available online: https://www.mdpi.com/2227-9059/10/2/287

7. “Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies”
by Bart De Geest and Mudit Mishra
Biomedicines 2021, 9(11), 1645; https://doi.org/10.3390/biomedicines9111645
Available online: https://www.mdpi.com/2227-9059/9/11/1645

8. “Immunomodulation of Skin Repair: Cell-Based Therapeutic Strategies for Skin Replacement (A Comprehensive Review)”
by Shima Tavakoli, Marta A. Kisiel, Thomas Biedermann and Agnes S. Klar
Biomedicines 2022, 10(1), 118; https://doi.org/10.3390/biomedicines10010118
Available online: https://www.mdpi.com/2227-9059/10/1/118

9. “A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1”
by Anna Tamanini, Enrica Fabbri, Tiziana Jakova, Jessica Gasparello, Alex Manicardi, Roberto Corradini, Alessia Finotti, Monica Borgatti, Ilaria Lampronti, Silvia Munari et al.
Biomedicines 2021, 9(2), 117; https://doi.org/10.3390/biomedicines9020117
Available online: https://www.mdpi.com/2227-9059/9/2/117

10. “The Relationship between Telomere Length and Gestational Weight Gain: Findings from the Mamma & Bambino Cohort”
by Andrea Maugeri, Roberta Magnano San Lio, Maria Clara La Rosa, Giuliana Giunta, Marco Panella, Antonio Cianci, Maria Anna Teresa Caruso, Antonella Agodi and Martina Barchitta
Biomedicines 2022, 10(1), 67; https://doi.org/10.3390/biomedicines10010067
Available online: https://www.mdpi.com/2227-9059/10/1/67

We would appreciate it if you could circulate the link of any papers that you find appealing to your network.

Submit a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launch a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Join the Editorial Board:
We are looking for active scholars who have interests within and a passion for this Section to help with the selection of submissions; please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

19 January 2024
Biomedicines | Hot Papers in the “Biomedical Engineering in Human Health” Section

This Section of Biomedicines (ISSN: 2227-9059) aims to rapidly publish reviews and original peer-reviewed papers describing research results on the development and application principles of biomedical engineering in human health and diseases. The main topics of this Section include, but are not limited to, the following:

  • Tissue/neural/genetic/protein/antibody engineering;
  • Artificial organs;
  • 3D bioprinting;
  • Bioinformatics of diseases;
  • Micro-/nano systems;
  • Microfluidic chips;
  • 3D cell culture systems;
  • Next-generation sequencing;
  • Biomedical sensors;
  • Biomedical signal and image processing;
  • Next-generation sequencing.

Please feel free to read the following papers:

1. “Near-Infrared-Triggered Upconverting Nanoparticles for Biomedicine Applications”
by Manoj Kumar Mahata, Ranjit De and Kang Taek Lee
Biomedicines 2021, 9(7), 756; https://doi.org/10.3390/biomedicines9070756
Available online: https://www.mdpi.com/2227-9059/9/7/756

2. “Biofabrication of Gingival Fibroblast Cell-Laden Collagen/Strontium-Doped Calcium Silicate 3D-Printed Bi-Layered Scaffold for Osteoporotic Periodontal Regeneration”
by Chen-Ying Wang, Yung-Cheng Chiu, Alvin Kai-Xing Lee, Yun-An Lin, Ping-Yi Lin and Ming-You Shie
Biomedicines 2021, 9(4), 431; https://doi.org/10.3390/biomedicines9040431
Available online: https://www.mdpi.com/2227-9059/9/4/431

3. “A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences”
by Alessandro De Vita, Silvia Vanni, Giacomo Miserocchi, Valentina Fausti, Federica Pieri, Chiara Spadazzi, Claudia Cocchi, Chiara Liverani, Chiara Calabrese, Roberto Casadei et al.
Biomedicines 2022, 10(2), 372; https://doi.org/10.3390/biomedicines10020372
Available online: https://www.mdpi.com/2227-9059/10/2/372

4. “Elastomeric Cardiowrap Scaffolds Functionalized with Mesenchymal Stem Cells-Derived Exosomes Induce a Positive Modulation in the Inflammatory and Wound Healing Response of Mesenchymal Stem Cell and Macrophage”
by Juan Carlos Chachques, Chiara Gardin, Nermine Lila, Letizia Ferroni, Veronique Migonney, Celine Falentin-Daudre, Federica Zanotti, Martina Trentini, Giulia Brunello, Tiberio Rocca et al.
Biomedicines 2021, 9(7), 824; https://doi.org/10.3390/biomedicines9070824
Available online: https://www.mdpi.com/2227-9059/9/7/824

5. “Multi-Modal Biological Destruction by Cold Atmospheric Plasma: Capability and Mechanism”
by Dayun Yan, Alisa Malyavko, Qihui Wang, Kostya (Ken) Ostrikov, Jonathan H. Sherman and Michael Keidar
Biomedicines 2021, 9(9), 1259; https://doi.org/10.3390/biomedicines9091259
Available online: https://www.mdpi.com/2227-9059/9/9/1259

6. “Incorporation of Calcium Sulfate Dihydrate into a Mesoporous Calcium Silicate/Poly-ε-Caprolactone Scaffold to Regulate the Release of Bone Morphogenetic Protein-2 and Accelerate Bone Regeneration”
by Kuo-Hao Huang, Chen-Ying Wang, Cheng-Yu Chen, Tuan-Ti Hsu and Chun-Pin Lin
Biomedicines 2021, 9(2), 128; https://doi.org/10.3390/biomedicines9020128
Available online: https://www.mdpi.com/2227-9059/9/2/128

7. “Nanomaterial-Based Fluorescence Resonance Energy Transfer (FRET) and Metal-Enhanced Fluorescence (MEF) to Detect Nucleic Acid in Cancer Diagnosis”
by Jin-Ha Choi, Taehyeong Ha, Minkyu Shin, Sang-Nam Lee and Jeong-Woo Choi
Biomedicines 2021, 9(8), 928; https://doi.org/10.3390/biomedicines9080928
Available online: https://www.mdpi.com/2227-9059/9/8/928

8. “Polyphenols as Antioxidants for Extending Food Shelf-Life and in the Prevention of Health Diseases: Encapsulation and Interfacial Phenomena”
by Marlene Costa, Zerrin Sezgin-Bayindir, Sonia Losada-Barreiro, Fátima Paiva-Martins, Luciano Saso and Carlos Bravo-Díaz
Biomedicines 2021, 9(12), 1909; https://doi.org/10.3390/biomedicines9121909
Available online: https://www.mdpi.com/2227-9059/9/12/1909

9. “Penetration of the SARS-CoV-2 Spike Protein across the Blood–Brain Barrier, as Revealed by a Combination of a Human Cell Culture Model System and Optical Biosensing”
by Dániel Petrovszki, Fruzsina R. Walter, Judit P. Vigh, Anna Kocsis, Sándor Valkai, Mária A. Deli and András Dér
Biomedicines 2022, 10(1), 188; https://doi.org/10.3390/biomedicines10010188
Available online: https://www.mdpi.com/2227-9059/10/1/188

10. “Applications of Plasma-Activated Liquid in the Medical Field”
by Sungryeal Kim and Chul-Ho Kim
Biomedicines 2021, 9(11), 1700; https://doi.org/10.3390/biomedicines9111700
Available online: https://www.mdpi.com/2227-9059/9/11/1700

We would much appreciate it if you could circulate the link to any papers you find appealing within your network.

Submit a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launch a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Join the Editorial Board:
We are looking for active scholars who have interests within and a passion for this field to help with the selection of submissions; please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

9 January 2024
Meet Us at the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 18–21 March 2024, Vienna, Austria


Conference: The 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Date: 18–21 March 2024
Location: Vienna, Austria

MDPI will be attending the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology at Booth #06, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has had an ever-increasing impact among pharmaceutical scientists, and it is organized every two years, in March or April of even years.

The entire spectrum of topics ranging from engineering aspects of the manufacturing process, the portfolio of commercially available excipients enabling the formulation of a large variety of medicinal products, the underlying physico-chemical principles, cutting-edge characterization techniques as well as potential pitfalls and hurdles to be overcome during product development, manufacturing and characterisation will be addressed.

Young and experienced scientists from academia and industry will present their latest research achievements in the form of poster presentations, allowing for fruitful scientific exchanges with the authors.

The meeting is intended to bring together people working in fundamental and applied academic research, in the chemical and pharmaceutical industry and the regulatory field, offering the opportunity to initiate fruitful discussions and collaborations.

The following MDPI journals will be represented:

  • Pharmaceutics;
  • Pharmaceuticals;
  • IJMS;
  • DDC;
  • Molecules;
  • Biomedicines;
  • CIMB;
  • Applied Biosciences;
  • BioMedInformatics;
  • Medicines;
  • Cosmetics;
  • Biomolecules.
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.worldmeeting.org/home/about-world-meeting/

2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

13 December 2023
Prof. Dr. Felipe Fregni Appointed Editor-in-Chief of Biomedicines


We are pleased to announce that Prof. Dr. Felipe Fregni has been appointed Editor-in-Chief of Biomedicines (ISSN: 2227-9059).

Name: Prof. Dr. Felipe Fregni

Homepage: https://www.hsph.harvard.edu/ecpe/faculty/felipe-fregni/

Affiliation: 1.Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; 2.Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA

Interests: neuromodulation; pain perception modulation; neurophysiology; neuroplasticity

Prof. Dr. Fregni is a Professor of epidemiology at Harvard T.H. Chan School of Public Health and PM&R at Harvard Medical School. He leads a large clinical research laboratory (Spaulding Neuromodulation Center) funded by major NIH grants and is currently investigating techniques to guide and measure neuroplasticity in brain injury. He has been at the forefront of advancing neurorehabilitation science to treat conditions such as stroke, Parkinson’s disease, and chronic pain. He holds an M.D. and Ph.D. from the University of Sao Paulo, Brazil, and three master’s degrees from Harvard University. He has more than 580 peer-reviewed publications and has been leading the international training program Principles. In recognition of his outstanding contributions, he has been awarded the highest honor bestowed by the United States government to outstanding scientists and engineers in the U.S.: the Presidential Early Career Award for Scientists and Engineers (PECASE).

Currently, his research focuses on understanding neuroplastic changes associated with conditions such as chronic pain, Parkinson’s disease, and stroke, using non-invasive brain stimulation as an investigative tool for such aims.

We warmly welcome our new Editor-in-Chief and wish the journal every success in the future.

30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

28 November 2023
Editorial Board Members from Biomedicines Featured in the 2023 Highly Cited Researchers List Published by Clarivate


Recently, Clarivate™ revealed its 2023 list of Highly Cited Researchers™—individuals at universities, research institutes, and commercial organizations.

The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals, representing just 1 in 1,000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.

According to our statistics, 6 members of the Editorial Board of Biomedicines (ISSN: 2227-9059) were selected for the list of Highly Cited Researchers by ClarivateTM in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. The Biomedicines Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.

Researcher Category Affiliation
Carvalho, Andre F. Psychiatry and Psychology Deakin University, Australia
Pitt, Bertram Clinical Medicine University of Michigan, United States
Parati, Gianfranco Cross-Field IRCCS Istituto Auxologico Italiano, Italy
Serruys, Patrick W. Clinical Medicine University of Galway, Ireland
Capasso, Raffaele Cross-Field University of Naples Federico II, Italy
Davis, Thomas P. Cross-Field University of Queensland, Australia

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Mierlo, Joeri Van
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

16 November 2023
Biomedicines | Hot Papers in the “Endocrinology and Metabolism Research” Section

The Section “Endocrinology and Metabolism Research” of Biomedicines (ISSN: 2227-9059) publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of endocrinology and metabolism. Papers aiming to uncover molecular and cellular mechanisms in endocrinology and metabolism are welcome. Topics include, but are not limited to, gene regulation, cell biology, signaling, mutations, growth factors, cytokines, hormone receptors, hormone action and regulation, developmental endocrinology, genetic endocrinology, endocrine diseases (diabetes, obesity, osteoporosis, hyperthyroidism, etc.), and metabolic diseases.

Please feel free to read the following papers:

1. “Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome”
by Ana Teresa Brinca, Ana Cristina Ramalhinho, Ângela Sousa, António Hélio Oliani, Luiza Breitenfeld, Luís A. Passarinha and Eugenia Gallardo
Biomedicines 2022, 10(6), 1254; https://doi.org/10.3390/biomedicines10061254
Available online: https://www.mdpi.com/2227-9059/10/6/1254

2. “2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus”
by Luca Navarini, Marta Vomero, Stefano Di Donato, Damiano Currado, Onorina Berardicurti, Annalisa Marino, Pietro Bearzi, Alice Biaggi, Matteo Ferrito, Piero Ruscitti et al.
Biomedicines 2022, 10(7), 1675; https://doi.org/10.3390/biomedicines10071675
Available online: https://www.mdpi.com/2227-9059/10/7/1675

3. “The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review”
by Salvatore Giovanni Vitale, Anna Maria Fulghesu, Mislav Mikuš, Rafał Watrowski, Maurizio Nicola D’Alterio, Li-Te Lin, Mohsin Shah, Enrique Reyes-Muñoz, Thozhukat Sathyapalan and Stefano Angioni
Biomedicines 2022, 10(8), 1816; https://doi.org/10.3390/biomedicines10081816
Available online: https://www.mdpi.com/2227-9059/10/8/1816

4. “Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome”
by Dorte Glintborg, Naja Due Kolster, Pernille Ravn and Marianne Skovsager Andersen
Biomedicines 2022, 10(6), 1455; https://doi.org/10.3390/biomedicines10061455
Available online: https://www.mdpi.com/2227-9059/10/6/1455

5. “Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia”
by Giuseppe Mandraffino, Carmela Morace, Maria Stella Franzè, Veronica Nassisi, Davide Sinicropi, Maria Cinquegrani, Carlo Saitta, Riccardo Scoglio, Sebastiano Marino, Alessandra Belvedere et al.
Biomedicines 2022, 10(8), 1770; https://doi.org/10.3390/biomedicines10081770
Available online: https://www.mdpi.com/2227-9059/10/8/1770

6. “Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives”
by Mojca Jensterle, Rok Herman and Andrej Janež
Biomedicines 2022, 10(8), 1989; https://doi.org/10.3390/biomedicines10081989
Available online: https://www.mdpi.com/2227-9059/10/8/1989

7. “Impact of Thyroid Function on Pregnancy and Neonatal Outcome in Women with and without PCOS”
by Sarah Feigl, Barbara Obermayer-Pietsch, Philipp Klaritsch, Gudrun Pregartner, Sereina Annik Herzog, Elisabeth Lerchbaum, Christian Trummer, Stefan Pilz and Martina Kollmann
Biomedicines 2022, 10(4), 750; https://doi.org/10.3390/biomedicines10040750
Available online: https://www.mdpi.com/2227-9059/10/4/750

8. “Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease”
by Louise S. Dalbøge, Michael Christensen, Martin Rønn Madsen, Thomas Secher, Nicole Endlich, Vedran Drenic’, Alba Manresa-Arraut, Henrik H. Hansen, Ida Rune, Lisbeth N. Fink et al.
Biomedicines 2022, 10(7), 1661; https://doi.org/10.3390/biomedicines10071661
Available online: https://www.mdpi.com/2227-9059/10/7/1661

9. “Cortisol as an Independent Predictor of Unfavorable Outcomes in Hospitalized COVID-19 Patients”
by Renata Świątkowska-Stodulska, Agata Berlińska and Ewelina Puchalska-Reglińska
Biomedicines 2022, 10(7), 1527; https://doi.org/10.3390/biomedicines10071527
Available online: https://www.mdpi.com/2227-9059/10/7/1527

10. “Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial”
by Katharina Lechner, Clemens von Schacky, Johannes Scherr, Elke Lorenz, Matthias Bock, Benjamin Lechner, Bernhard Haller, Alexander Krannich, Martin Halle, Rolf Wachter et al.
Biomedicines 2022, 10(9), 2296; https://doi.org/10.3390/biomedicines10092296
Available online: https://www.mdpi.com/2227-9059/10/9/2296

We would appreciate it if you would circulate the link of any papers you find appealing throughout your network. Furthermore, the following opportunities for collaboration may be of interest:

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Proposals may be submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in and passionate about helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

1 November 2023
MDPI Insights: The CEO's Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.

Testimonial

“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit


Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.

Testimonials

“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair


Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer
MDPI AG

20 October 2023
Biomedicines | Hot Papers in the Section “Drug Discovery”

The “Drug Discovery” Section of Biomedicines (ISSN: 2227-9059) publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the biomedical use of natural compounds. Papers aim to review or report the discovery of novel natural compounds, novel medical or health uses of existing natural compounds, the bioactivities of natural compounds, pharmaceutical and nutraceutical formulations of natural compounds, new technology for natural compound extraction and purification, the pharmacology of natural compounds, combination therapy with natural compounds as supplements, and any new frontiers of natural compound research. Topics include, but are not limited to, the following: in vivo/in vitro bioactivity research, the chemical identification and characterization of bioactive natural compounds, the clinical study of natural compounds, the pharmaceutical formulation of natural compounds (including nano-formulation and prodrug formulation), targeted combination therapies (i.e., synergy between natural compounds and standard chemotherapy), preclinical and clinical pharmacology, the synthesis (chemical synthesis and biosynthesis) and modification of natural compounds, and advanced extraction as well as purification technology to improve yield, purity, and bioactivity.

You’re welcome to read the following papers:

1. “Natural Photosensitizers in Antimicrobial Photodynamic Therapy”
by Ece Polat and Kyungsu Kang
Biomedicines 2021, 9(6), 584; https://doi.org/10.3390/biomedicines9060584
Available online: https://www.mdpi.com/2227-9059/9/6/584

2. “Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs”
by Bruno Rizzuti, Fedora Grande, Filomena Conforti, Ana Jimenez-Alesanco, Laura Ceballos-Laita, David Ortega-Alarcon, Sonia Vega, Hugh T. Reyburn, Olga Abian and Adrian Velazquez-Campoy
Biomedicines 2021, 9(4), 375; https://doi.org/10.3390/biomedicines9040375
Available online: https://www.mdpi.com/2227-9059/9/4/375

3. “Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines”
by Bashir Lawal, Yen-Lin Liu, Ntlotlang Mokgautsi, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander T. H. Wu and Hsu-Shan Huang
Biomedicines 2021, 9(1), 92; https://doi.org/10.3390/biomedicines9010092
Available online: https://www.mdpi.com/2227-9059/9/1/92

4. “Antiviral Effects of Polyphenols from Marine Algae”
by Natalya N. Besednova, Boris G. Andryukov, Tatyana S. Zaporozhets, Sergey P. Kryzhanovsky, Ludmila N. Fedyanina, Tatyana A. Kuznetsova, Tatyana N. Zvyagintseva and Mikhail Yu. Shchelkanov
Biomedicines 2021, 9(2), 200; https://doi.org/10.3390/biomedicines9020200
Available online: https://www.mdpi.com/2227-9059/9/2/200

5. “Biomarkers and Utility of the Antioxidant Potential of Probiotic Lactobacilli and Bifidobacteria as Representatives of the Human Gut Microbiota”
by Olga V. Averina , Elena U. Poluektova, Mariya V. Marsova and Valery N. Danilenko
Biomedicines 2021, 9(10), 1340; https://doi.org/10.3390/biomedicines9101340
Available online: https://www.mdpi.com/2227-9059/9/10/1340

6. “Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities”
by Jolita Stabrauskiene, Dalia M. Kopustinskiene, Robertas Lazauskas and Jurga Bernatoniene
Biomedicines 2022, 10(7), 1686; https://doi.org/10.3390/biomedicines10071686
Available online: https://www.mdpi.com/2227-9059/10/7/1686

7. “Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update”
by Sonja Vukadin, Farah Khaznadar, Tomislav Kizivat, Aleksandar Vcev and Martina Smolic
Biomedicines 2021, 9(7), 835; https://doi.org/10.3390/biomedicines9070835
Available online: https://www.mdpi.com/2227-9059/9/7/835

8. “Serum Inflammatory Biomarkers in the Diagnosis of Periprosthetic Joint Infections”
by Irene K. Sigmund, Stephan E. Puchner and Reinhard Windhager
Biomedicines 2021, 9(9), 1128; https://doi.org/10.3390/biomedicines9091128
Available online: https://www.mdpi.com/2227-9059/9/9/1128

9. “Curcumin and Radiotherapy Exert Synergistic Anti-Glioma Effect In Vitro”
by Vasiliki Zoi, Vasiliki Galani, Evrysthenis Vartholomatos, Natalia Zacharopoulou, Eftichia Tsoumeleka, Georgios Gkizas, Georgios Bozios, Pericles Tsekeris, Ieremias Chousidis, Ioannis Leonardos et al.
Biomedicines 2021, 9(11), 1562; https://doi.org/10.3390/biomedicines9111562
Available online: https://www.mdpi.com/2227-9059/9/11/1562

10. “Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers”
by Vasiliki Zoi, Vasiliki Galani, Pericles Tsekeris, Athanasios P. Kyritsis and George A. Alexiou
Biomedicines 2022, 10(2), 312; https://doi.org/10.3390/biomedicines10020312
Available online: https://www.mdpi.com/2227-9059/10/2/312

We would appreciate it if you would circulate the links of any papers that you find appealing to your network.

Submitting a Manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who have an interest in and passion to help with the selection of submissions; please do not hesitate to get in touch (biomedicines@mdpi.com) if you are interested in joining the Editorial Board.

Biomedicines Editorial Office

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues


MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

18 October 2023
Meet Us at Neuroscience 2023, 11–15 November 2023, Washington, DC, USA


Neuroscience 2023 will be held from 11 to 15 November 2023 in Washington, DC, USA. The conference is organized by the Society for Neuroscience.

The conference will gather scientists, clinicians, and decision makers from around the world, creating a platform for the communication of knowledge and the sharing of groundbreaking research on the brain as well as nervous system. As stated in the introduction to the conference, you can “Present new research. Exchange ideas. Expand collaborations. Strengthen your career.”

As one of the exhibitors of Neuroscience 2022 last year, MDPI will be a part of Neuroscience 2023 this year, and looks forward to meeting our scholars as well as new friends, hoping to impress you with our open access publishing model face-to-face.

The following MDPI journals will be represented:

  • Brain Sciences.
  • JCM.
  • Cells.
  • NeuroSci.
  • J. Intell.
  • Neuroglia.
  • JPM.
  • Biomedicines.
  • Clinics and Practice.
  • Diagnostics.
  • Neurology International.
  • Pathophysiology.
  • Psych.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.sfn.org/meetings/neuroscience-2023.

13 October 2023
Biomedicines | Hot Papers in the “Neurobiology and Neurologic Disease” Section

Chronic non-communicable neurologic diseases, known to affect the central and the peripheral nervous system, represent the leading cause of disability and the second-leading cause of mortality worldwide. Topics include, but are not limited to, neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.

We invite you to read the following papers:

1. “Dopamine in Health and Disease: Much More Than a Neurotransmitter”
by Rafael Franco, Irene Reyes-Resina and Gemma Navarro
Biomedicines 2021, 9(2), 109; https://doi.org/10.3390/biomedicines9020109
Available online: https://www.mdpi.com/2227-9059/9/2/109

2. “Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions”
by Christian Ogasawara, Brandon D. Philbrick and D. Cory Adamson
Biomedicines 2021, 9(3), 319; https://doi.org/10.3390/biomedicines9030319
Available online: https://www.mdpi.com/2227-9059/9/3/319

3. “The Neurobiological Correlates of Gaze Perception in Healthy Individuals and Neurologic Patients”
by Simone Battaglia, Jasper H. Fabius, Katarina Moravkova, Alessio Fracasso and Sara Borgomaneri
Biomedicines 2022, 10(3), 627; https://doi.org/10.3390/biomedicines10030627
Available online: https://www.mdpi.com/2227-9059/10/3/627

4. “Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling”
by Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, Andras Hajnal and Mihai Covasa
Biomedicines 2022, 10(2), 436; https://doi.org/10.3390/biomedicines10020436
Available online: https://www.mdpi.com/2227-9059/10/2/436

5. “Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection”
by Maria Isabella Donegani, Alberto Miceli, Matteo Pardini, Matteo Bauckneht, Silvia Chiola Michele Pennone, Cecilia Marini, Federico Massa, Stefano Raffa, Giulia Ferrarazzo, Dario Arnaldi et al.
Biomedicines 2021, 9(3), 287; https://doi.org/10.3390/biomedicines9030287
Available online: https://www.mdpi.com/2227-9059/9/3/287

6. “Inflammation, Anxiety, and Stress in Attention-Deficit/Hyperactivity Disorder”
by Luigi F. Saccaro, Zoé Schilliger, Nader Perroud and Camille Piguet
Biomedicines 2021, 9(10), 1313; https://doi.org/10.3390/biomedicines9101313
Available online: https://www.mdpi.com/2227-9059/9/10/1313

7. “Relevance of Autophagy and Mitophagy Dynamics and Markers in Neurodegenerative Diseases”
by Carlotta Giorgi, Esmaa Bouhamida, Alberto Danese, Maurizio Previati, Paolo Pinton and Simone Patergnani
Biomedicines 2021, 9(2), 149; https://doi.org/10.3390/biomedicines9020149
Available online: https://www.mdpi.com/2227-9059/9/2/149

8. “Critical Molecular and Cellular Contributors to Tau Pathology”
by Liqing Song, Evan A. Wells and Anne Skaja Robinson
Biomedicines 2021, 9(2), 190; https://doi.org/10.3390/biomedicines9020190
Available online: https://www.mdpi.com/2227-9059/9/2/190

9. “Mind the Gap: Mitochondria and the Endoplasmic Reticulum in Neurodegenerative Diseases”
by Nuno Santos Leal and Luís Miguel Martins
Biomedicines 2021, 9(2), 227; https://doi.org/10.3390/biomedicines9020227
Available online: https://www.mdpi.com/2227-9059/9/2/227

10. “Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease”
by Victoria García-Morales, Anabel González-Acedo, Lucía Melguizo-Rodríguez, Teresa Pardo-Moreno, Víctor Javier Costela-Ruiz, María Montiel-Troya and Juan José Ramos-Rodríguez
Biomedicines 2021, 9(12), 1910; https://doi.org/10.3390/biomedicines9121910
Available online: https://www.mdpi.com/2227-9059/9/12/1910

We would appreciate it if you could circulate the link of any paper you find appealing within your network.

Submit a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launch a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field.

Join the Editorial Board:
We are looking for active scholars who are interested in and passionate about helping with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

2 October 2023
MDPI Insights: The CEO's Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.


Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award


Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)


Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan


Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer
MDPI AG

27 September 2023
Biomedicines | Hot Papers in the “Immunology and Immunotherapy” Section

The “Immunology and Immunotherapy” Section of the journal Biomedicines (ISSN: 2227-9059) publishes high-quality reviews and original peer-reviewed papers covering all aspects of immunology and oncoimmunology. The papers published in this Section aim to uncover the modulations of the immune system, active and passive immunotherapies, diagnostic testing based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to, the following: in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; the use of nanoparticles and microvesicles for developing immunotherapeutics; etc. In this context, we are pleased to feature some recently published papers on immunology and immunotherapy in Biomedicines, which provide valuable insights into this exciting field.

As Biomedicines is an open access journal, the following papers can be read for free:

1. “Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches”
by Luca Fania, Dario Didona, Francesca Romana Di Pietro, Sofia Verkhovskaia, Roberto Morese, Giovanni Paolino, Michele Donati, Francesca Ricci, Valeria Coco, Francesco Ricci et al.
Biomedicines 2021, 9(2), 171; https://doi.org/10.3390/biomedicines9020171
Available online: https://www.mdpi.com/2227-9059/9/2/171

2. “Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography”       
by Jorge González-Zamora, Valentina Bilbao-Malavé, Elsa Gándara, Anna Casablanca-Piñera, Claudia Boquera-Ventosa, Manuel F. Landecho, Javier Zarranz-Ventura and Alfredo García-Layana
Biomedicines 2021, 9(3), 247; https://doi.org/10.3390/biomedicines9030247 
Available online: https://www.mdpi.com/2227-9059/9/3/247

3. “Relationship between Vitamin D Status and Antibody Response to COVID-19 mRNA Vaccination in Healthy Adults”
by Thilo Samson Chillon, Kamil Demircan, Raban Arved Heller, Ines Maria Hirschbil-Bremer, Joachim Diegmann, Manuel Bachmann, Arash Moghaddam and Lutz Schomburg
Biomedicines 2021, 9(11), 1714; https://doi.org/10.3390/biomedicines9111714 
Available online: https://www.mdpi.com/2227-9059/9/11/1714

4. “Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?”
by Kondababu Kurakula, Valérie F. E. D. Smolders, Olga Tura-Ceide, J. Wouter Jukema, Paul H. A. Quax and Marie-José Goumans
Biomedicines 2021, 9(1), 57; https://doi.org/10.3390/biomedicines9010057 
Available online: https://www.mdpi.com/2227-9059/9/1/57

5. “Dynamic Changes of the Neutrophil-to-Lymphocyte Ratio, Systemic Inflammation Index, and Derived Neutrophil-to-Lymphocyte Ratio Independently Predict Invasive Mechanical Ventilation Need and Death in Critically Ill COVID-19 Patients”
by Emanuel Moisa, Dan Corneci, Silvius Negoita, Cristina Raluca Filimon, Andreea Serbu, Mihai Ionut Negutu and Ioana Marina Grintescu
Biomedicines 2021, 9(11), 1656; https://doi.org/10.3390/biomedicines9111656 
Available online: https://www.mdpi.com/2227-9059/9/11/1656

6. “Roles of XBP1s in Transcriptional Regulation of Target Genes”
by Sung-Min Park, Tae-Il Kang and Jae-Seon So
Biomedicines 2021, 9(7), 791; https://doi.org/10.3390/biomedicines9070791 
Available online: https://www.mdpi.com/2227-9059/9/7/791

7. “The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review”
by Claudio Brasso, Silvio Bellino, Cecilia Blua, Paola Bozzatello and Paola Rocca
Biomedicines 2022, 10(4), 772; https://doi.org/10.3390/biomedicines10040772 
Available online: https://www.mdpi.com/2227-9059/10/4/772

8. “Role of NLRP7 in Normal and Malignant Trophoblast Cells”
by Roland Abi Nahed, Maya Elkhoury Mikhael, Deborah Reynaud, Constance Collet, Nicolas Lemaitre, Thierry Michy, Pascale Hoffmann, Frederic Sergent, Christel Marquette, Padma Murthi et al.
Biomedicines 2022, 10(2), 252; https://doi.org/10.3390/biomedicines10020252 
Available online: https://www.mdpi.com/2227-9059/10/2/252

9. “Puerarin Attenuates Obesity-Induced Inflammation and Dyslipidemia by Regulating Macrophages and TNF-Alpha in Obese Mice”
by Ji-Won Noh, Hee-Kwon Yang, Min-Soo Jun and Byung-Cheol Lee
Biomedicines 2022, 10(1), 175; https://doi.org/10.3390/biomedicines10010175 
Available online: https://www.mdpi.com/2227-9059/10/1/175

10. “High Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Are Associated with a Higher Risk of Hemodialysis Vascular Access Failure”
by Edoardo Pasqui, Gianmarco de Donato, Elisa Lazzeri, Cecilia Molino, Giuseppe Galzerano, Michele Giubbolini and Giancarlo Palasciano
Biomedicines 2022, 10(9), 2218; https://doi.org/10.3390/biomedicines10092218 
Available online: https://www.mdpi.com/2227-9059/10/9/2218

We would appreciate it if you would share the papers you find interesting with your network.

Submitting a manuscript:
The “Immunology and Immunotherapy” Section is currently open for submissions. Papers may be submitted here.

 Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Special Issues can be proposed here.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions. Please do not hesitate to get in touch in case you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

25 September 2023
Meet Us at the 2023 Chinese Medicinal Chemistry Symposium & CPA-EFMC International Symposium on Medicinal Chemistry, 7–10 October 2023, Chongqing, China


MDPI will be attending the 2023 Chinese Medicinal Chemistry Symposium & CPA-EFMC International Symposium on Medicinal Chemistry, which will be held from 7 to 10 October 2023 in Chongqing, China.

The conference is held every two years and the theme for 2023 is “Original New Drug Development and New Drug Synthesis Technology”. It aims to promote the deep integration of basic research, new drug R&D, and clinical transformation and improve the overall level of innovative drug R&D and clinical transformation in China. It provides a good exchange and cooperation platform for experts, scholars, and business colleagues in the field of medicinal chemistry and related basic research and clinical transformation.

The following MDPI journals will be represented:

  • Molecules;
  • Pharmaceuticals;
  • Biomedicines;
  • Antibiotics.

If you are planning to attend this conference, please feel free to stop by our booth #68 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following website: https://www.cmcs2023.com/.

6 September 2023
Recap of Awards Granted to Scholars in 2022


MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

5 September 2023
Meet Us at the 16th China Pharmaceutical Preparations Conference, 15–17 September 2023, Changsha, China


The upcoming conference is the 16th so far, and it has become an important conference in the field of pharmaceutical research in China. The theme of this formulation conference is "New Technologies, New Opportunities, and New Challenges" which will be held in Changsha, China. Experts from various fields and directions in pharmacy at home and abroad will be invited to conduct exchanges and discussions on theoretical research, technology applications, policies, and regulations on pharmaceutical formulations. In addition to the main venue, the conference also has a basic pharmacy forum (targeted drug delivery strategy, controlled release strategy), industrial pharmacy forum, International Controlled Release Association China Branch Forum, external preparations forum, improved new drugs and clinical research forum, medicinal excipients and pharmaceutical packaging materials forum, preparation R&D services and equipment forum, young pharmaceutical workers forum, graduate student forum, and other sub-venues.

Pharmaceutics (ISSN: 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and it is published monthly online by MDPI. Pharmaceutics will participate in this event as an exhibitor together with seven other MDPI journals.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #A39. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information, please feel free to contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.

5 September 2023
Interview with Prof. Dr. Bernhard Ryffel—Section Board Member of Section “Cell Biology and Pathology” in Biomedicines

We had the pleasure of speaking with Prof. Dr. Bernhard Ryffel, Section Board Member of the “Cell Biology and Pathology” Section in Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and his research interest in the field of immunopharmacology, inflammation and infectious diseases. Prof. Dr. Ryffel is currently research director at CNRS in the laboratory of Molecular Immunology and Embryology in Orleans, France, and Professor and Head of Department of Immunology, University of Cape Town, RSA. We hope you enjoy the interview.

1 September 2023
Meet Us at the Tissue Engineering and Regenerative Medicine International Society (TERMIS–AP) Conference, 16–19 October 2023, Hong Kong, China


MDPI will attend the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AP) conference, which will be held from 16 to 19 October 2023 at the Hong Kong Science Park, Hong Kong, China. The mission of TERMIS–AP is to provide a platform for the generation and dissemination of knowledge and interactions across a range of expertise for the advancement of basic, translational, and clinical research.

The conference will comprise various topics that provide comprehensive coverage of diverse issues in current tissue engineering and regenerative medicine under the main theme of “New Chapter of Future Regenerative Medicine”.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth #09 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ap2023.termis.org/.

30 August 2023
MDPI Insights: The CEO's Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer
MDPI AG

28 August 2023
Biomedicines | Hot Papers from the Section “Cancer Biology and Therapeutics”

The “Cancer Biology and Therapeutics” Section of Biomedicines (ISSN: 2227-9059) publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumors and microenvironments, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.

“Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance”
by Maria V. Babak and Dohyun Ahn
Biomedicines 2021, 9(8), 852; https://doi.org/10.3390/biomedicines9080852
Available online: https://www.mdpi.com/2227-9059/9/8/852

“Advances and Limitations of Antibody Drug Conjugates for Cancer”
by Candice Maria Mckertish and Veysel Kayser
Biomedicines 2021, 9(8), 872; https://doi.org/10.3390/biomedicines9080872
Available online: https://www.mdpi.com/2227-9059/9/8/872

“Trifarotene: A Current Review and Perspectives in Dermatology”
by Terenzio Cosio, Monia Di Prete, Roberta Gaziano, Caterina Lanna, Augusto Orlandi, Paolo Di Francesco, Luca Bianchi and Elena Campione
Biomedicines 2021, 9(3), 237; https://doi.org/10.3390/biomedicines9030237
Available online: https://www.mdpi.com/2227-9059/9/3/237

“Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies”
by Hyunkoo Kang, Haksoo Lee, Dahye Kim, Byeongsoo Kim, JiHoon Kang, Hae Yu Kim, HyeSook Youn and BuHyun Youn
Biomedicines 2022, 10(6), 1308; https://doi.org/10.3390/biomedicines10061308
Available online: https://www.mdpi.com/2227-9059/10/6/1308

“The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression”
by Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, Anna M. Pavone, Lucia Longhitano, Sebastiano Giallongo, Daniele Tibullo, Michelino Di Rosa, Agata Zappalà, Francesco P. Cammarata et al.
Biomedicines 2022, 10(4), 806; https://doi.org/10.3390/biomedicines10040806
Available online: https://www.mdpi.com/2227-9059/10/4/806

“MiR-7 in Cancer Development”
by Petra Korać, Mariastefania Antica and Maja Matulić
Biomedicines 2021, 9(3), 325; https://doi.org/10.3390/biomedicines9030325
Available online: https://www.mdpi.com/2227-9059/9/3/325

“Targeting STAT3 Signaling Pathway in Colorectal Cancer”
by Antonios N. Gargalionis, Kostas A. Papavassiliou and Athanasios G. Papavassiliou
Biomedicines 2021, 9(8), 1016; https://doi.org/10.3390/biomedicines9081016
Available online: https://www.mdpi.com/2227-9059/9/8/1016

“Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis”
by Jerry Xiao, Paula R. Pohlmann, Claudine Isaacs, Benjamin A. Weinberg, Aiwu R. He, Richard Schlegel and Seema Agarwal
Biomedicines 2021, 9(9), 1111; https://doi.org/10.3390/biomedicines9091111
Available online: https://www.mdpi.com/2227-9059/9/9/1111

“CK2 Regulation: Perspectives in 2021”
by Scott E. Roffey and David W. Litchfield
Biomedicines 2021, 9(10), 1361; https://doi.org/10.3390/biomedicines9101361
Available online: https://www.mdpi.com/2227-9059/9/10/1361

“Glycobiology of the Epithelial to Mesenchymal Transition”
by Michela Pucci, Nadia Malagolini and Fabio Dall’Olio
Biomedicines 2021, 9(7), 770; https://doi.org/10.3390/biomedicines9070770
Available online: https://www.mdpi.com/2227-9059/9/7/770

We would appreciate it if you would circulate the link of any of the papers you find appealing into your network.

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Special Issue proposals can be submitted at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions and please do not hesitate to get in touch in case you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

24 August 2023
Meet Us at the ASHG Annual Meeting 2023, 1–5 November 2023, Washington D.C., USA


MDPI will attend the ASHG Annual Meeting 2023, held in Washington, D.C., USA, from 1 to 5 November 2023.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

  • Genes;
  • JPM;
  • Biomolecules;
  • Medicina;
  • Diagnostics;
  • Cancers;
  • Biomedicines;
  • Humans;
  • Applied Biosciences;
  • DNA;
  • IJMS;
  • Brain Sciences;
  • Cardiogenetics;
  • Vaccines;
  • Life;
  • Epigenomes;
  • BioTech;
  • Biology;
  • CIMB;
  • Biomedinformatics.

If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.ashg.org/meetings/.

18 August 2023
Meet Us at the 2023 China Biomaterials Conference, 12–15 October 2023, Chongqing, China


Conference: 2023 China Biomaterials Conference (CSBM2023)
Date: 12–15 October 2023
Booth: #B4

MDPI journals will be attending the 2023 China Biomaterials Conference (CSBM2023) as an exhibitor. This meeting will be held in Chongqing, China, from 12 to 15 October 2023.

The theme of the conference is “Innovative Biomaterials to Protect People's Health”, focusing on the frontiers of biomaterials science, technological innovation, achievement transformation, regulatory science, etc., to discuss and share the latest developments in the current field of biomaterials.

The following MDPI journals will be represented:

  • IJMS;
  • JFB;
  • Bioengineering;
  • Biomimetics;
  • Marine Drugs;
  • Polymers;
  • Nanomaterials;
  • Biomedicines;
  • Micromachines;
  • Pharmaceutics;
  • Electrochem.

If you plan on attending this conference, please feel free to stop by our booth (#B4) and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit http://2023.csbm.org.cn/index.php/index/index/index.html.

18 August 2023
MDPI’s 2022 Young Investigator Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.

We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

  • Yuyan Jiang, Stanford University, USA
  • Billy Wai-Lung Ng, Chinese University of Hong Kong, China

Cancers:

  • Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
  • Miranda Fidler-Benaoudia, University of Calgary, Canada

Current Oncology:

  • Bishal Gyawali, Queen’s University, Canada

Healthcare:

  • Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong

JCM:

  • Jan Bednarsch, Universitätsmedizin Berlin, Germany

JPM:

  • Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
  • Jerome Lechien, University of Mons, Belgium

Pharmaceuticals:

  • Daniele Bertoglio, University of Antwerp, Belgium

Pharmaceutics:

  • Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

TropicalMed:

  • Haley Adcox, Virginia Commonwealth University, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Travel Awards in Medicine and Pharmacology—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.

MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Antibiotics:

  • Filip Jansåker, Lund University, Lund, Sweden
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Cancers:

  • Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
  • Luigi Russo, Italian Institute of Technology (IIT), Italy

Current Oncology:

  • Sneha Sethi, University of Adelaide, Australia
  • Xiyin Wang, Indiana University School of Medicine, USA

Dentistry Journal:

  • Sonia Nath, University of Adelaide, Australia
  • Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania

Diagnostics:

  • Adrien Holzgreve, The University Hospital of Munich, Germany

Hemato:

  • Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy

JCDD:

  • Susanna Cooper, St. George’s University of London, UK
  • Renée Tillie, Maastricht University Medical Center, the Netherlands

JCM:

  • Max Lennart Eckstein, University of Bayreuth, Germany
  • Lorenzo Bertani, University of Pisa, Italy

Pharmaceutics:

  • Yuxue Cao, University of Queensland, Australia
  • Flávia Sousa, Italian Institute of Technology, Italy

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Medicine and Pharmacology—Winners Announced


In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

  • Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
  • Violeta Popovici, Ovidius University of Constanta, Romania
  • Yosra A. Helmy, University of Kentucky, USA

Cancers:

  • Antonio G. Solimando, Aldo Moro University of Bari, Italy
  • Linlin Guo, The Ohio State University Medical Center, USA
  • Ravindra Deshpande, Wake Forest School of Medicine, USA
  • Songli Zhu, Fred Hutchinson Cancer Research Center, USA
  • Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
  • Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
  • Chenghui Li, University of Arkansas for Medical Sciences, USA
  • Laurentiu Pop, University of Texas Southwestern Medical Center, USA
  • Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
  • Rafał Watrowski, University of Freiburg, Germany
  • Ruben C. Petreaca, The Ohio State University, USA
  • Ruchi Roy, Rush University Medical Center, USA
  • Salvatore Cocuzza, University of Catania, Italy
  • Santosh Kumar Singh, Morehouse School of Medicine, USA
  • Sergei Boichuk, Kazan State Medical University, Russia
  • Simon John Christoph Soerensen, Stanford University, USA
  • Takuya Koie, Gifu University, Japan
  • Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
  • Teruki Nii, Kyushu University, Japan
  • Tomasz Marjanski, Medical University of Gdansk, Poland

Current Oncology:

  • Kristen Haase, The University of British Columbia, Canada
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Makoto Endo, Kyushu University, Japan

Healthcare:

  • Tefera Tadesse, Addis Ababa University, Ethiopia
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Ryuichi Ohta, Unnan City Hospital, Japan

JCM:

  • Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
  • José-María Sánchez-González, University of Seville, Spain
  • Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece

JPM:

  • Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
  • Rodolfo Reda, Sapienza University of Rome, Italy
  • Giulio Francesco Romiti, Sapienza University of Rome, Italy
  • Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
  • James Walter, 1Hines VA Hospital, USA; 2 Loyola Medical Center, USA

Medical Sciences:

  • Vasiliki Tsigkou, Sotiria Hospital, Greece

Pharmaceutics:

  • Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
  • Bhupendra Prajapati, Ganpat University, India
  • Van-An Duong, Gachon University, Republic of Korea
  • Ashish Agrawal, Indian Institute of Technology (BHU), India

Tomography:

  • Aydin Eresen, University of California Irvine, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Cancers:

  • “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”

by João Pedro da Silva Machado Lobo, University of Porto, Portugal

  • “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”

by Adrià Cañellas Socias, University of Barcelona, Spain

Healthcare:

  • “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”

by Shireen Mentor, University of Cape Town, South Africa

JPM:

  • “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”

by Roberta Magnano San Lio, University of Catania, Italy

Pharmaceutics:

  • “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”

by Shirin Tavakoli, University of Helsinki, Finland

TropicalMed:

  • “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”

by Quinten Ducarmon, Leiden University Medical Center, the Netherlands

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.

We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

Dentistry Journal:

Healthcare:

JCM:

JPM:

Pharmaceutics:

Pharmacy:

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

17 August 2023
Interview with Dr. Alireza Dolatshahi-Pirouz—Section Board Member of Section “Biomedical Engineering in Human Health” in Biomedicines

We had the pleasure of speaking with Dr. Alireza Dolatshahi-Pirouz, Section Board Member of the “Biomedical Engineering in Human Health” Section in Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and his research interest in the field of biomechanics and tissue engineering. Dr. Dolatshahi-Pirouz is currently an associate professor at the Department of Health Technology, Technical University of Denmark, Denmark. We hope you enjoy the interview!

10 August 2023
Interview with Prof. Dr. Swee Hin Teoh—Editorial Board Member of Biomedicines

We had the pleasure of speaking with Prof. Dr. Swee Hin Teoh, Editorial Board Member of Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and the recent research trends in the field.

Prof. Dr. Swee Hin Teoh

Prof. Dr. Swee-Hin Teoh graduated with a BEng and Ph.D. from Monash University, Australia, in 1978 and 1981, respectively. He then worked at the National University of Singapore from 1982 to 2022. He is presently an Emeritus Professor at Nanyang Technological University (NTU). He is a Fellow of the Academy of Engineers Singapore. Prof. Dr. Teoh is one of a few scientists who has brought research from the lab to the clinic and to public listing. He was at the Nanyang Technological University Singapore (NTU) from 2012 to 2022 and was honored with the President’s Chair School of Chemical and Biomedical Engineering, and was jointly appointed Professor of bioengineering at Lee Kong Chian School of Medicine, NTU Singapore. Recently, he was listed among the World’s Top 2% Scientists by scholars from Stanford University. The Stanford rankings reflect the significant influence and research excellence of Prof. Dr. Teoh, who is committed to furthering knowledge for the benefit of society.

Prof. Dr. Teoh is known for the clinical translation of 3D-printed bioresorbable scaffolds for bone tissue engineering. This device has FDA approval and has been implanted in more than 60,000 patients globally, and the company Osteopore successfully went public in Australia in 2019. His pioneering work in fracture and wear of biomaterials is well recognized and highly cited. He has won a number of major awards, such as the Golden Innovation Award from Far East Economic Review, and the Institute of Engineers Singapore’s Prestigious Engineering Achievement Award in 2004. Majoring in materials engineering at Monash University, Melbourne, Australia, his research journey focused on translating materials research to biomedical benefits. He has over 260 research publications and 22 patents. He was the Founding Chief Engineer of the Skin Research Institute of Singapore, a unique entity that is highly interdisciplinary and involves NTU, A*Star and Singapore Hospital (TTSH). He undertook pioneering work to develop a unique bioreactor with electromagnetic energy to study bone growth and organ biocompatibility in chick embryos. His Web of Science citation record is 11,382, and he has an h-index of 51. His Google Scholar citations equal 91334, and his h-index is 136. He has also won numerous Excellent Teaching Awards. Presently he is the Designate Director at the Centre for Advanced Materials Engineering in Medicine (CAMEM) and Distinguished Cheung Kong Professor at the School of Materials and Engineering, Hunan University, People’s Republic of China.

We hope you enjoy the interview.

1. Why did you decide to work for Biomedicines? Tell us about the journal and your role there.
Biomedicines reminds me of the great scientist Louis Pasteur, a chemist-turned-microbiologist who became the father of modern medicine; a legendary man who inspired me. The multidisciplinary nature of Biomedicines, the focus on disease research to benefit and impact society and the rapid speed of publication of original work and the assistance of able editorial managers are some of the reasons why I chose the journal. I started as a Guest Editor in the Special Issue “Scaffolds for Bone Tissue Engineering”, a topic I have researched for more than 20 years. Bone diseases are important problems to solve, especially for the aging population experienced worldwide.

2. Why should scientists submit their manuscripts in Biomedicines? And how do you think open access impacts authors?
A survey where Nobel Laureates published their works will show that it is not just the numerical high impact factor of a journal based on citation but on other factors such as the impact on society, commonly measured by Alternative (A) index in social media, news, web, YouTube, and also the Composite (C) index based on an interdisciplinary team, resilience in pursuing details, especially in experimentation, as opposed to just discovering something novel which sometimes depends on serendipity. I think Biomedicines has some of these qualities that attract scientists who are seeking a mature audience, especially in translational medicine with good science. This is also of interest to industries. Open access is attractive as it allows a larger audience to quickly read the published works.

3. Tell us more about your first publishing experience. How do you begin the process of writing a paper?
I always begin by asking why anyone would be interested in reading my paper if it does not address a compelling issue in medicine. After identifying the issue, I would ask myself whether I have assembled a credible multidisciplinary team to look at the solution and whether we have demonstrated a repeatable science-based experimental technique. One also needs to ask are the results based on a sound statistical analysis and are the conclusions moderated, which otherwise may seem overenthusiastic, blind to other shortcomings.

4. What are some current challenges in this field?
Some current challenges in bone tissue engineering are the cocktail of stem cells that need to be packed in the 3D printed scaffolds to address long-term viability in vascularization and tissue remodeling, which is dependent on the biomechanics and electromagnetic stimulation of the new bone construct from the surrounding environment.

5. Finally, do you have any advice for young researchers?
Before embarking on a Ph.D. topic please do a detailed problem-based study with a team of interdisciplinary researchers. Do as much content learning via the internet and seek experts’ opinions on various issues, especially if you are pursuing biomedical research. Formulating the right questions is an important first step. It would be great if a young researcher would meditate on the words of wisdom of the great scientist Louis Pasteur—“Chance favors a prepared mind”—and spend time studying his autobiography and capture his passion for standing up for truths in science through experimentation and prove skeptics wrong no matter where they are placed in the hierarchy of their profession.

We are thankful for Prof. Dr. Teoh’s time and his support for Biomedicines.

Prof. Dr. Swee Hin Teoh’s contact information:
E-mail: teohsh@ntu.edu.sg

9 August 2023
Interview with Prof. Dr. Ali Nokhodchi—Editorial Board Member of Biomedicines

We had the pleasure of speaking with Prof. Dr. Ali Nokhodchi, Editorial Board Member of Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and the recent research trends in the field.

Prof. Dr. Ali Nokhodchi

Prof. Dr. Ali Nokhodchi is a pharmacist by training (since 1989) and he obtained his Ph.D. in pharmaceutical technology at John Moores University, Liverpool, UK in 1996. He is an Emeritus Professor at the University of Sussex, UK and a Fellow at Lupin Research Center, Florida, USA. His main research interest is formulation science spanning particle engineering of excipients and actives for pulmonary and oral delivery, dissolution enhancement, 3D printing in drug delivery, nanomedicine, controlled release formulation and transdermal delivery. Prof. Dr. Nokhodchi has published over 350 research articles including 10 book chapters and a book on pulmonary drug delivery. His h-index is 65 with 13783 citations (dated 7 March 2023). Prof. Dr. Nokhodchi is listed among the top 1% of scientists worldwide by the ESI-WoS. He is on the editorial board of over 10 international pharmacy journals published by Elsevier, Springer Nature and Taylor & Francis.

We hope you enjoy the interview.

1. How would you recommend picking the right journal to submit your research to?
For me, two factors are important; quick review and the impact factor of the journal.

2. What is the priority for a good scientific article: great research with high scientific value or a well-thought-out composition and good writing?
I think both of the mentioned parameters are equally important. If great research with a scientific value fails to be translated into good writing, it will lose its value.

3. What excites you the most about the fields of drug delivery and nanotechnology?
When you see how drug delivery systems can help patients to treat various diseases and reduce pain and stress, it is really rewarding and makes researchers happy. It is really exciting to see how changing the size of drug particles (nanomedicines) can change the behavior of medicines. The application of drug delivery in health care is very exciting.

4. Could you describe the difficulties and breakthrough innovations encountered in this research?
In my opinion, one of the big challenges is the safety of nanoparticles to normal cells in the long term. It seems it is extremely challenging to make all nanoparticles without any toxicity in their long-term use. There is no doubt more research in the field could address the challenges facing nanoparticle delivery and toxicity. Innovations in drug delivery are needed to meet the challenges that are imposed by regulatory bodies. For innovations, the collaboration of different disciplines such as pharmaceutics, biology, biochemistry, physiology, chemistry and engineering are needed. Designing new drug delivery systems, exploring new applications of nanoparticles and implementing 3D printing in drug delivery are innovations in the field. A close collaboration between academics and industry is also needed for scale-up purposes.

5. What are some current challenges in this field?
Although extensive progress has been made by researchers on the drug delivery side of pharmaceutics, there are still many challenges. The first challenge is the delivery of poorly water-soluble drugs to the target site. Medicinal chemists discover many potential drugs but most of them cannot find their way to the market due to poor solubility, hence poor bioavailability. The second biggest challenge is the biocompatibility and acceptability of the new synthetic materials for drug delivery purposes, as most of them interact with human body cells which can cause serious side effects. Designing a cost-effective drug delivery system is another challenge.

We are thankful for Prof. Dr. Nokhodchi’s time and his support for Biomedicines.

Prof. Dr. Ali Nokhodchi’s contact information:
E-mail: A.Nokhodchi@sussex.ac.uk

2 August 2023
Biomedicines | Hot Papers in the “Cell Biology and Pathology” Section

The “Cell Biology and Pathology” Section of Biomedicines (ISSN: 2227-9059) covers all aspects of this general field, from molecular machines that enable or adversely modify cell function to the pathology of complete organisms. Both review articles and original research contributions are welcome, as long as they conform to the highest scientific standards. Contributions that explore the origin of diseases at the molecular level, such as structural, biochemical, and genetic studies of receptors, oncogenes, tumor suppressor and regulatory proteins, signal pathways, RNA/DNA, as well as articles that propose new routes for the cure and prevention of diseases, are of particular interest. Cutting-edge diagnostic tools ranging from PCR to magnetic resonance, as applied to the detection of cellular or organismic pathological dysfunctions on all levels, will be accepted.

Feel free to read the following papers:

“Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme”
by Carlos M. González-Casimiro, Beatriz Merino, Elena Casanueva-Álvarez, Tamara Postigo-Casado, Patricia Cámara-Torres, Cristina M. Fernández-Díaz, Malcolm A. Leissring, Irene Cózar-Castellano and Germán Perdomo
Biomedicines 2021, 9(1), 86; https://doi.org/10.3390/biomedicines9010086
Available online: https://www.mdpi.com/2227-9059/9/1/86

“Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis”
by Andrei Mihai Surdu, Oana Pinzariu, Dana-Mihaela Ciobanu, Alina-Gabriela Negru, Simona-Sorana Cainap, Cecilia Lazea, Daniela Iacob, George Saraci, Dacian Tirinescu, Monica Borda et al.
Biomedicines 2021, 9(2), 172; https://doi.org/10.3390/biomedicines9020172
Available online: https://www.mdpi.com/2227-9059/9/2/172

“Obesity Affects HDL Metabolism, Composition and Subclass Distribution”
by Julia T. Stadler, Sonja Lackner, Sabrina Mörkl, Athina Trakaki, Hubert Scharnagl, Andrea Borenich, Willibald Wonisch, Harald Mangge, Sieglinde Zelzer, Nathalie Meier-Allard et al.
Biomedicines 2021, 9(3), 242; https://doi.org/10.3390/biomedicines9030242
Available online: https://www.mdpi.com/2227-9059/9/3/242

“Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease”
by Julia T. Stadler, Christian Wadsack and Gunther Marsche
Biomedicines 2021, 9(4), 349; https://doi.org/10.3390/biomedicines9040349
Available online: https://www.mdpi.com/2227-9059/9/4/349

“Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy”
by Hsiang-Hao Chuang, Yen-Yi Zhen, Yu-Chen Tsai, Cheng-Hao Chuang, Ming-Shyan Huang, Michael Hsiao and Chih-Jen Yang
Biomedicines 2021, 9(4), 359; https://doi.org/10.3390/biomedicines9040359
Available online: https://www.mdpi.com/2227-9059/9/4/359

“MicroRNA Expression in Extracellular Vesicles from Nasal Lavage Fluid in Chronic Rhinosinusitis”
by Seungbin Cha, Eun-Hye Seo, Seung Hyun Lee, Kyung Soo Kim, Chung-Sik Oh, Jong-Seok Moon and Jin Kook Kim
Biomedicines 2021, 9(5), 471; https://doi.org/10.3390/biomedicines9050471
Available online: https://www.mdpi.com/2227-9059/9/5/471

“Gender Specific Differences in Disease Susceptibility: The Role of Epigenetics”
by Lucia Migliore, Vanessa Nicolì and Andrea Stoccoro
Biomedicines 2021, 9(6), 652; https://doi.org/10.3390/biomedicines9060652
Available online: https://www.mdpi.com/2227-9059/9/6/652

“Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein”
by Hiroyuki Itabe, Naoko Sawada, Tomohiko Makiyama and Takashi Obama
Biomedicines 2021, 9(6), 655; https://doi.org/10.3390/biomedicines9060655
Available online: https://www.mdpi.com/2227-9059/9/6/655

“The Importance of Lipoprotein Lipase Regulation in Atherosclerosis”
by Anni Kumari, Kristian K. Kristensen, Michael Ploug and Anne-Marie Lund Winther
Biomedicines 2021, 9(7), 782; https://doi.org/10.3390/biomedicines9070782
Available online: https://www.mdpi.com/2227-9059/9/7/782

“The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions”
by Annachiara Tesoriere, Alberto Dinarello and Francesco Argenton
Biomedicines 2021, 9(8), 956; https://doi.org/10.3390/biomedicines9080956
Available online: https://www.mdpi.com/2227-9059/9/8/956

We would appreciate it if you could circulate the link of any paper you find appealing in your network.

Submit a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launch a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Join the Editorial Board:
We are looking for active scholars to help with the selection of submissions. Please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

27 July 2023
MDPI Insights: The CEO's Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

26 July 2023
Meet Us at the 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023), 5–8 September 2023, Zaragoza, Spain


Conference:
The 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023)
Date: 5–8 September 2023
Place: University of Zaragoza Faculty of Medicine, Zaragoza, Spain
Booth: #30

MDPI journals will be attending the 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023) as an exhibitor. This meeting will be held in Zaragoza, Spain, from 5 to 8 September 2023.

SEBBM contributed significantly to the creation of the Federation of European Biochemical Societies (FEBS) in 1964, represents Spain in the International Union of Biochemistry and Molecular Biology (IUBMB), is one of the founding members of the Confederation of Spanish Scientific Societies (COSCE) and belongs to the Spanish Association of Biocompanies (ASEBIO), which develops activities in the field of biotechnology in Spain.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.acs.org/meetings/acs-meetings/fall-2023.html.

25 July 2023
Biomedicines | Invitation to Read 2021–2022 Highly Cited Papers in Web of Science

We are delighted to present the highly cited papers in Web of Science from 2021 and 2022, a curated list of high-quality articles from Biomedicines (ISSN: 2227-9059), as shown below.

“Current FDA-Approved Therapies for High-Grade Malignant Gliomas”
by Jacob P. Fisher and David C. Adamson
Biomedicines 2021, 9(3), 324; https://doi.org/10.3390/biomedicines9030324
Available online: https://www.mdpi.com/2227-9059/9/3/324
Cited by 85 | Viewed by 6038

“Intestinal Barrier and Permeability in Health, Obesity and NAFLD”
by Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q. -H. Wang and Agostino Di Ciaula
Biomedicines 2022, 10(1), 83; https://doi.org/10.3390/biomedicines10010083
Available online: https://www.mdpi.com/2227-9059/10/1/83
Cited by 47 | Viewed by 8195

“The Cardiovascular System in Space: Focus on In Vivo and In Vitro Studies”
by Ronni Baran, Shannon Marchal, Sebastian Garcia Campos, Emil Rehnberg, Kevin Tabury, Bjorn Baselet, Markus Wehland, Daniela Grimm and Sarah Baatout
Biomedicines 2022, 10(1), 59; https://doi.org/10.3390/biomedicines10010059
Available online: https://www.mdpi.com/2227-9059/10/1/59
Cited by 23 | Viewed by 4192

“The Selenoprotein Glutathione Peroxidase 4: From Molecular Mechanisms to Novel Therapeutic Opportunities”
by Kamari Weaver and Rachid Skouta
Biomedicines 2022, 10(4), 891; https://doi.org/10.3390/biomedicines10040891
Available online: https://www.mdpi.com/2227-9059/10/4/891
Cited by 19 | Viewed by 4037

“Advances in Nanomaterial-Mediated Photothermal Cancer Therapies: Toward Clinical Applications”
by Hwa Seung Han and Ki Young Choi
Biomedicines 2021, 9(3), 305; https://doi.org/10.3390/biomedicines9030305
Available online: https://www.mdpi.com/2227-9059/9/3/305
Cited by 115 | Viewed by 6659

“Natural Photosensitizers in Antimicrobial Photodynamic Therapy”
by Ece Polat and Kyungsu Kang
Biomedicines 2021, 9(6), 584; https://doi.org/10.3390/biomedicines9060584
Available online: https://www.mdpi.com/2227-9059/9/6/584
Cited by 55 | Viewed by 7951

“Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics”
by Dixit V Bhalani, Bhingaradiya Nutan, Avinash Kumar and Arvind K. Singh Chandel
Biomedicines 2022, 10(9), 2055; https://doi.org/10.3390/biomedicines10092055
Available online: https://www.mdpi.com/2227-9059/10/9/2055
Cited by 25 | Viewed by 6026

“Inflammatory Mechanisms Contributing to Endothelial Dysfunction”
by Panagiotis Theofilis, Marios Sagris, Evangelos Oikonomou, Alexios S. Antonopoulos, Gerasimos Siasos, Costas Tsioufis and Dimitris Tousoulis
Biomedicines 2021, 9(7), 781; https://doi.org/10.3390/biomedicines9070781
Available online: https://www.mdpi.com/2227-9059/9/7/781
Cited by 121 | Viewed by 8508

“Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway”
by Masaru Tanaka, Fanni Toth, Helga Polyak, Agnes Szabo, Yvette Mandi and Laszlo Vecsei
Biomedicines 2021, 9(7), 734; https://doi.org/10.3390/biomedicines9070734
Available online: https://www.mdpi.com/2227-9059/9/7/734
Cited by 111 | Viewed by 8414

“Neuroinflammation in Alzheimer’s Disease”
by Isaac G. Onyango, Gretsen V. Jauregui, Maria Carna, James P. Bennett and Gorazd B. Stokin
Biomedicines 2021, 9(5), 524; https://doi.org/10.3390/biomedicines9050524
Available online: https://www.mdpi.com/2227-9059/9/5/524
Cited by 72 | Viewed by 10519

“Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches”
by Luca Fania, Dario Didona, Francesca Romana Di Pietro, Sofia Verkhovskaia, Roberto Morese, Giovanni Paolino, Michele Donati, Francesca Ricci, Valeria Coco, Francesco Ricci et al.
Biomedicines 2021, 9(2), 171; https://doi.org/10.3390/biomedicines9020171
Available online: https://www.mdpi.com/2227-9059/9/2/171
Cited by 56 | Viewed by 8303

“Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?”
by Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Alfredo Caturano, Erica Vetrano, Concetta Aprea, Gaetana Albanese, Anna Di Martino, Carmen Ricozzi et al.
Biomedicines 2021, 9(1), 3; https://doi.org/10.3390/biomedicines9010003
Available online: https://www.mdpi.com/2227-9059/9/1/3
Cited by 55 | Viewed by 4202

“Dopamine in Health and Disease: Much More Than a Neurotransmitter”
by Rafael Franco, Irene Reyes-Resina and Gemma Navarro
Biomedicines 2021, 9(2), 109; https://doi.org/10.3390/biomedicines9020109
Available online: https://www.mdpi.com/2227-9059/9/2/109
Cited by 47 | Viewed by 7569

“Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission”
by Diana Martos, Bernadett Tuka, Masaru Tanaka, Laszlo Vecsei and Gyula Telegdy
Biomedicines 2022, 10(4), 849; https://doi.org/10.3390/biomedicines10040849
Available online: https://www.mdpi.com/2227-9059/10/4/849
Cited by 42 | Viewed by 3191

“Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research”
by Eleonora Spekker, Masaru Tanaka, Agnes Szabo and Laszlo Vecsei
Biomedicines 2022, 10(1), 76; https://doi.org/10.3390/biomedicines10010076
Available online: https://www.mdpi.com/2227-9059/10/1/76
Cited by 41 | Viewed by 8003

“The Neurobiological Correlates of Gaze Perception in Healthy Individuals and Neurologic Patients”
by Simone Battaglia, Jasper H. Fabius, Katarina Moravkova, Alessio Fracasso and Sara Borgomaneri
Biomedicines 2022, 10(3), 627; https://doi.org/10.3390/biomedicines10030627
Available online: https://www.mdpi.com/2227-9059/10/3/627
Cited by 39 | Viewed by 4223

“Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases”
by Carmine Stolfi, Claudia Maresca, Giovanni Monteleone and Federica Laudisi
Biomedicines 2022, 10(2), 289; https://doi.org/10.3390/biomedicines10020289
Available online: https://www.mdpi.com/2227-9059/10/2/289
Cited by 32 | Viewed by 5820

“Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling”
by Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, Andras Hajnal and Mihai Covasa
Biomedicines 2022, 10(2), 436; https://doi.org/10.3390/biomedicines10020436
Available online: https://www.mdpi.com/2227-9059/10/2/436
Cited by 30 | Viewed by 7602

“The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression”
by Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, Anna M. Pavone, Lucia Longhitano, Sebastiano Giallongo, Daniele Tibullo, Michelino Di Rosa, Agata Zappala, Francesco P. Cammarata et al.
Biomedicines 2022, 10(4), 806; https://doi.org/10.3390/biomedicines10040806
Available online: https://www.mdpi.com/2227-9059/10/4/806
Cited by 28 | Viewed by 3964

“Oxidative Stress in Ischemia/Reperfusion Injuries following Acute Ischemic Stroke”
by Anamaria Jurcau and Adriana Ioana Ardelean
Biomedicines 2022, 10(3), 574; https://doi.org/10.3390/biomedicines10030574
Available online: https://www.mdpi.com/2227-9059/10/3/574
Cited by 27 | Viewed by 3332

19 July 2023
Biomedicines | Hot Papers in the “Molecular and Translational Medicine” Section

The “Molecular and Translational Medicine” Section of Biomedicines (ISSN: 2227-9059) aims to cover the studies concerning disease pathogenesis at the molecular or physiological level, as well as basic preclinical, clinical, and translational aspects. We encourage scientists to submit results that have potential for application in human disease, as well as research obtained from human experimentation or animal models of human disease with the potential to shed light on the underlying causes of human diseases and cancer, to develop future human medicines, medical devices, and diagnostics.

Feel free to read the following papers:

“Inflammatory Mediators and Pain in Endometriosis: A Systematic Review”
by Nikolaos Machairiotis, Sofia Vasilakaki and Nikolaos Thomakos
Biomedicines 2021, 9(1), 54; https://doi.org/10.3390/biomedicines9010054  
Available online: https://www.mdpi.com/2227-9059/9/1/54

“The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell Fate”
by Natalia Siwecka, Wioletta Rozpędek-Kamińska, Adam Wawrzynkiewicz, Dariusz Pytel, J. Alan Diehl and Ireneusz Majsterek
Biomedicines 2021, 9(2), 156; https://doi.org/10.3390/biomedicines9020156  
Available online: https://www.mdpi.com/2227-9059/9/2/156

“Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?”
by Alexandra Zisser, David H. Ipsen and Pernille Tveden-Nyborg
Biomedicines 2021, 9(4), 365; https://doi.org/10.3390/biomedicines9040365  
Available online: https://www.mdpi.com/2227-9059/9/4/365

“Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety”
by Irena Vlatkovic
Biomedicines 2021, 9(5), 530; https://doi.org/10.3390/biomedicines9050530
Available online: https://www.mdpi.com/2227-9059/9/5/530

“The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases”
by Daniela Gabbia, Luana Cannella and Sara De Martin
Biomedicines 2021, 9(6), 687; https://doi.org/10.3390/biomedicines9060687  
Available online: https://www.mdpi.com/2227-9059/9/6/687

“Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges”
by Mohammad Shafi Kuchay, José Ignacio Martínez-Montoro, Narendra Singh Choudhary, José Carlos Fernández-García and Bruno Ramos-Molina
Biomedicines 2021, 9(10), 1346; https://doi.org/10.3390/biomedicines9101346  
Available online: https://www.mdpi.com/2227-9059/9/10/1346

“Viability Assessment in Liver Transplantation—What Is the Impact of Dynamic Organ Preservation?”
by Rebecca Panconesi, Mauricio Flores Carvalho, Matteo Mueller, David Meierhofer, Philipp Dutkowski, Paolo Muiesan and Andrea Schlegel
Biomedicines 2021, 9(2), 161; https://doi.org/10.3390/biomedicines9020161  
Available online: https://www.mdpi.com/2227-9059/9/2/161

“Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success”
by Gabriella Racchetti and Jacopo Meldolesi
Biomedicines 2021, 9(6), 667; https://doi.org/10.3390/biomedicines9060667  
Available online: https://www.mdpi.com/2227-9059/9/6/667

“Towards Clinical Application of Artificial Intelligence in Ultrasound Imaging”
by Masaaki Komatsu, Akira Sakai, Ai Dozen, Kanto Shozu, Suguru Yasutomi, Hidenori Machino, Ken Asada, Syuzo Kaneko and Ryuji Hamamoto
Biomedicines 2021, 9(7), 720; https://doi.org/10.3390/biomedicines9070720  
Available online: https://www.mdpi.com/2227-9059/9/7/720

“Zinc: Multidimensional Effects on Living Organisms”
by Math P. Cuajungco, Maria Soledad Ramirez and Marcelo E. Tolmasky
Biomedicines 2021, 9(2), 208; https://doi.org/10.3390/biomedicines9020208  
Available online: https://www.mdpi.com/2227-9059/9/2/208

We would appreciate it if you could circulate the link of any paper you find appealing in your network.

Submit a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launch a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Join the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions; please do not hesitate to get in touch if you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

14 July 2023
Meet Us at 2023 BMES Annual Meeting, 11–14 October 2023, Seattle, USA


A range of MDPI journals will be attending the 2023 BMES Annual Meeting as exhibitors. This meeting will be held in Seattle, USA, from 11 to 14 October 2023.

The BMES Annual Meeting will gather participants for networking, education, and continued growth in the biomedical engineering field. It is a premiere event centered around topics and discussions specific to our community. The theme of this year’s meeting is focused on the convergence of three pillars essential to our field’s success: science, technology, and social transformation.

The conference's vision is to center the perspective that the future of biomedical engineering requires and the curious evaluation of complex scientific challenges, while candidly considering intersectionality and social factors. Through creative programming, it will ensure that these three pillars are interwoven into all aspects of the meeting.

The following MDPI journals will be represented:

  • Bioengineering;
  • Biomedicines;
  • Biomimetics;
  • Cancers;
  • CIMB;
  • Diseases;
  • Micromachines;
  • Biosensors.

If you are attending this conference, please feel free to start a conversation with us at our booth at #931. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.bmes.org/annualmeeting.

13 July 2023
Biomedicines Webinar | Pathogenesis, Diagnosis, and Therapeutics of Infectious Diseases, 19 July 2023


Dear Colleagues,

As a Guest Editor for a Special Issue of Biomedicines (ISSN: 2227-9059), I am inviting you to participate on 19 June 2023, starting with a webinar at 9 a.m. CET with the purpose of:

  • Facilitating networking between scientists involved in the mentioned topics;
  • Informing professionals regarding new research that has been conducted or is ongoing in the specific topics;
  • Presenting the articles already published in the relevant Special Issue;
  • Discovering the scientific publishing possibilities for scientists working in the specified topics;
  • Sharing experience.

We kindly invite all researchers interested in the relevant discussions.

Dr. Adriana Pistol
Associate Professor

Date: 19 July 2023 at 9:00 a.m. CEST | 3:00 a.m. EDT | 3:00 p.m. CST Asia
Webinar ID: 878 0458 8326

Register now for free!

Program:

Speaker/Presentation

Time in CEST

Time in EDT

Prof. Dr. Adriana Pistol
Chair Introduction

9:00–9:10 a.m.

3:00–3:10 a.m.

Prof. Dr. Camelia Sultana
HIV-HBV Co-Infection–Current Challenges

9:10–9:30 a.m.

3:10–3:30 a.m.

Prof. Dr. Florentina Ligia Furtunescu
The Screening Registry for B and C Viral Hepatitis in Romania–Exploratory Data and Lessons Learned

9:30–9:50 a.m.

3:30–3:50 a.m.

Q&A Session

9:50–10:10 a.m.

3:50–4:10 a.m.

Prof. Dr. Adriana Pistol
Closing of Webinar

10:10–10:15 a.m.

4:10–4:15 a.m.

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.

Webinar Chair and Keynote Speakers:

  • Prof. Dr. Adriana Pistol, Public Health Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania;
  • Prof. Dr. Camelia Sultana, Virology Discipline, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania;
  • Prof. Dr. Florentina Ligia Furtunescu, Department of Public Health, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Relevant Special Issue:
Pathogenesis, Diagnosis, and Therapeutics of Infectious Diseases
Edited by: Dr. Adriana Pistol
Deadline: 30 September 2023

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

4 July 2023
Meet Us at the CRS 2023 Annual Meeting, 24–28 July 2023, Las Vegas, USA


The conference is the 50th annual conference of the Controlled Release Society. The annual CRS conference is the most important conference in the pharmaceutics field. The main topics of the conference include drug delivery and controlled release, nanomedicine and nanotechnology, and biopharmaceutics. The conference organizer has a full program for the duration of the conference with highly prominent plenary talks, technical sessions covering a wide scope of topics, industry-led workshops, and technical forums.

Pharmaceutics (ISSN: 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and is published monthly online by MDPI. Pharmaceutics will participate in this event as an exhibitor together with eleven other MDPI journals.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #409. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.eventscribe.net/2023/CRSAnnualMeeting or contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.

3 July 2023
Biomedicines Receives an Updated Impact Factor of 4.7 and an Improved Category Ranking


We are pleased to inform you that Biomedicines (ISSN: 2227-9059) received an updated Impact Factor of 4.7. Biomedicines now ranks in the top 25% in the “Pharmacology & Pharmacy” category. Our journal is continuing to build momentum in biomedicines.

Biomedicines ranks as follows:

  • Q1 (69 out of 277 journals) in the "Pharmacology & Pharmacy" category;
  • Q2 (54 out of 136 journals) in the "Medicine, Research & Experimental" category;
  • Q2 (92 out of 285 journals) in the "Biochemistry & Molecular Biology"

For more journal statistics, please visit https://www.mdpi.com/journal/biomedicines/stats.

The Biomedicines Editorial Office would like to thank all authors, reviewers, and editors who have contributed to the journal.

3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI

Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.

Testimonials

If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer
MDPI AG

29 June 2023
Meet Us at the ESMO Congress 2023, 20–24 October 2023, Madrid, Spain


MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.esmo.org/meeting-calendar/esmo-congress-2023.

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Microbiology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Electrochemistry
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Parasitology
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Fisheries
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging


Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)

 

14 June 2023
Meet Us at the 2023 Chinese Biophysics Congress, 19–23 July 2023, Changsha, China
 


Conference:
2023 Chinese Biophysics Congress
Date: 19–23 July 2023
Place: Changsha, China

MDPI will be attending the 2023 Chinese Biophysics Congress, which will be held from 19 to 23 July 2023 in Changsha, China.

The Chinese Biophysics Congress is the largest and most developed academic event in the field of biophysics in China. Prof. Tao Xu, the chairman of the Chinese Society of Biophysics, will be the chair of the organizing committee. The main theme is Biophysics and Human Health, focusing on the latest research progress and development trend of biophysics and related research fields.

The following MDPI journals will be represented:

  • IJMS;
  • Biophysica;
  • Biomedicines;
  • Physics;
  • CIMB;
  • Bioengineering;
  • Biomolecules.

Please do not hesitate to reach out (ijms@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have. For more information about the conference, please visit the following website: https://www.bsc.org.cn/2023/.

7 June 2023
Meet Us at the WASOG 2023 Conference, 19–21 June 2023, Stockholm, Sweden

Conference: WASOG 2023

Organization: The World Association of Sarcoidosis and Other Granulomatous Disorders

Date: 19–21 June 2023

Place: Aula Medica, Karolinska Institutet, Stockholm, Sweden

Booth: #7

MDPI will be attending the WASOG 2023 conference, which will be held from 19 to 21 June 2023 at Aula Medica, Karolinska Institutet, Stockholm, Sweden.

WASOG 2023 will offer a creative meeting ground for investigating how novel experimental, theoretical and computational approaches in Sarcoidosis and Interstitial Lung Diseases (ILDs) can improve our understanding of their underlying disease mechanisms. It aims to build an even stronger scientific bridge between different sectors, ultimately closing the knowledge gap and accelerating the development and spread of precision medicine in ILDs.

The following MDPI journals will be represented:

Please reach out (diagnostics@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://mkon.nu/wasog2023.

5 June 2023
Meet Us at the 42nd Annual Meeting of the American Society for Virology, 24–28 June 2023, Athens, Georgia, USA


MDPI journals will be attending the 42nd annual meeting of the American Society for Virology as an exhibitor. This meeting will be held in Athens, Georgia, USA from 24 to 28 June 2023.

The American Society for Virology (ASV) is a wonderful community that brings together virologists from all areas of the field. As a result, the annual meetings are rich in diverse scientific offerings and they can be quite large (sometimes over 1600 attendees). This conference is hosted by the University of Georgia and held at the Classic Center; the scientific program will include symposia, concurrent workshops, poster sessions, exhibits, and special events. Professional development activities and social events will be interspersed throughout the meeting.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and our booth, please visit: https://asv.org/asv2023/.

23 May 2023
Biomedicines Webinar | Antimicrobial Peptides Aka Host Defense Peptides, 31 May 2023


Today, we have clear evidence that HDPs have far more than broad-spectrum antimicrobial activity, including immunomodulatory effects, wound healing, LPS neutralization, chemotaxis, or anti-cancer effects. Moreover, the multifunctionality of HDPs has resulted in a lot of interest in the development of new therapeutic strategies against infectious diseases.

The “Antimicrobial Peptides AKA Host Defense Peptides” webinar will present the latest research on multifunctional host defense molecules. The webinar will cover a wide range of topics, such as structure/function studies, regulation of expression, mechanisms of action, and development of antimicrobial peptides as therapeutics. Invited speakers will represent cross-disciplinary research, including biochemistry, microbiology, structural biology, medicine, innate immunity, signaling, and drug development.

Date: 31 May 2023 at 10:00 a.m. CEST | 4:00 a.m. EDT | 4:00 p.m. CST Asia
Webinar ID: 893 2420 8525

Register now for free!

Program

Speaker/Presentation

Time in CEST

Time in EDT

Dr. Jitka Petrlova
Chair Introduction

10:00–10:10 a.m.

4:00–4:10 a.m.

Dr. Parveen Papareddy
Coagulation system derived antimicrobial peptides in host defense

10:10–10:30 a.m.

4:10–4:30 a.m.

Prof. Dr. Ester Boix
Moonlight RNases, a source of antimicrobial peptides

10:30–10:50 a.m.

4:30–4:50 a.m.

Q&A Session

10:50–11:10 a.m.

4:50–5:10 a.m.

Dr. Jitka Petrlova
Closing of Webinar

11:10–11:15 a.m.

5:10–5:15 a.m.

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.

Webinar Chair and Keynote Speakers:

  • Jitka Petrlova, Department of Clinical Sciences, Division of Dermatology and Venereology, Lund University, Lund, Sweden;
  • Parveen Papareddy, Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden;
  • Dr. Ester Boix, Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.

Relevant Special Issues:
Antimicrobial Peptides Aka Host Defense Peptides – from Basic Research to Therapy
Guest Editor: Dr. Jitka Petrlova 

Antimicrobial Peptides Aka Host Defense Peptides – from Basic Research to Therapy 2.0
Guest Editor: Dr. Jitka Petrlova

31 March 2023
Meet Us at the 8th European Congress of Virology 2023, 4–7 May 2023, Gdańsk, Poland


Conference: 8th European Congress of Virology 2023
Date: 4–7 May 2023
Location: Gdańsk, Poland

MDPI will be attending the 8th European Congress of Virology 2023 (ECV 2023) as an exhibitor, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is organized by the European Society for Virology. ECV 2023 will be a great opportunity for European virologists representing various fields of research to meet, present their results, and discuss all the developments in virology that have taken place during this unusual time. It will also be a great opportunity to meet friends, renew old acquaintances, and establish new collaborations. Although coronavirus studies will undoubtedly be one of the leading subjects at ECV 2023, it is important to have all research areas represented, including basic, clinical, veterinary, and plant virology. 

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.eusv-congress.eu/.

29 March 2023
Meet Us at the 19th World Congress of Basic & Clinical Pharmacology 2023, 2–7 July 2023, Glasgow, Scotland

This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.

Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at pharmaceuticals@mdpi.com.

16 March 2023
Meet Us at the Chinese Academic Conference on Tumor Biomarker, 7–9 April 2023, Shanghai, China


MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

  • Biomedicines;
  • Cancers;
  • Cells;
  • Diagnostics;
  • Current Oncology;
  • JPM;
  • JCM;
  • Onco;
  • CIMB;
  • BioMedInformatics.

If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.

15 March 2023
Interview with Prof. Dr. M. R. Mozafari—Editorial Board Member of Biomedicines

We had the pleasure of speaking with Prof. Dr. M. R. Mozafari, Editorial Board Member of Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and the recent research trends in the field.

Prof. Dr. M. R. Mozafari is an expert in nano-biotechnology, encapsulation and targeting of bioactive agents with a substantial number of publications, 12 patents, five books and several book chapters. He is the author of the first book on nanoliposomes, he completed many industrial research projects, and developed methods (e.g., “Mozafari Method”) for the large-scale manufacture of controlled release systems without using toxic agents. Recently, he introduced a novel technology for the encapsulation and delivery of a bioactive material called "Tocosome".

We hope you enjoy the interview.

1. Why did you decide to work with Biomedicines?
The main important characteristics of MDPI in general, and Biomedicines in particular, are being well organized, user-friendly, fast process of publication, fast responses to emails, increasing citations and impact factor. Therefore, being associated with Biomedicines is prestigious for me and any scientist.

2. Could you tell us more about the journal and your role there?
Biomedicines is an internationally recognized, scientific, peer-reviewed, open access journal in the broad field of biomedicines, and allied disciplines, published monthly by MDPI. I am a Section Board Member of Biomedicines and currently act as a Guest Editor for two Special Issues. I have already compiled a Special Issue for this journal in which eight high-quality papers were published.

3. Why should scientists submit their manuscripts in Biomedicines?
Researchers and scientists want to see their articles attract a good number of readers and attain high citation numbers. These parameters are important in increasing the h-index of authors. Biomedicines journal is committed to assuring the quality and maximum visibility of the published manuscripts.

4. How would you recommend picking the right journal to submit your research in?
I recommend scientists to publish in prestigious and well-organized journals with high impact factor, high quartiles, reliable user-friendly websites, accessible editors and staff, and efficient promotional policy.

5. What makes a great research paper?
When I was an M.Sc. student, I remember how desperate I was to find a useful paper that can help me with my laboratory research and later on with the preparation of my thesis. A great research paper and a good review article can help scientists and researchers to find easy answers to their questions.

6. What excites you the most about the nano-delivery systems’ field?
Nano-biotechnology in general and nano-delivery systems in particular show a great promise to find solutions for challenging illnesses (e.g., cancer and viral infections) with no or minimal side-effects. The field requires ingenuity, creativity, and an inventive mindset.

We are thankful for Prof. Dr. Mozafari’s time and his support of Biomedicines.

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

8 March 2023
Biomedicines | Celebrating International Women's Day 2023—Interview with Dr. Letizia Polito

In a fair social community, women should have equal opportunities and be respected and included in diverse choices. Today is the 113th International Women's Day and the world of science is seeing more female scientists emerge to lead their fellow researchers. We had the pleasure of speaking with Dr. Letizia Polito, Guest Editor of the Special Issue “Women’s Special Issue Series: Biomedicines”, published by Biomedicines (ISSN: 2227-9059).

1. What has led you to the fields of cancer therapy and drug delivery?

During my training at the University of Bologna, I had been particularly fascinated by the concept of the magic bullet created by Paul Ehrlich: being able to deliver toxic molecules in a specific (almost magical) way toward targets present on cells, eliminating them as they are responsible for a pathological state. I have never stopped working on this topic.

2. The spirit of research seems to be quite important to you. What was your main inspiration for pursuing a scientific career? Did you pick it up from your family or school?

My parents would have initially preferred a more traditional career for me, but they taught me to always follow my dreams and goals. At school, I was certainly impressed by my science teacher, his great knowledge and his ability to disseminate it. I think he was an important part of making my future choices.

3. You have had an impressive and productive career. Which of your accomplishments do you consider to be the most impactful ones? Of which are you most proud?

It is difficult to decide between my career achievements. I remember the hard work behind each of them, the personal relationships created in the research groups, the commitment, the effort, the study, the tiredness, but also the laughter during the breaks. Each example of research that I conducted represents a piece of my life, I cannot choose between one or the other. I can, however, say that I am quite proud of all my achievements, no matter how big or small they are.

4. Does being a woman pose particular challenges in the fields you research? How could the scientific community address these challenges?

When I started my career about thirty years ago, being a woman and a researcher often meant having to face important personal choices; first of all, it meant giving up (or postponing) the idea of having kids and starting a family. Today, in several countries, this is no longer a problem, but there are still many (too many) countries where being a woman means being forced to make life choices, where being a woman means limiting one's personal freedom. For the women living in those countries, the international scientific community should act as soon as possible to break down any cultural barriers.

5. Do you feel that scientific opportunities for women have increased during your career?

As I said above, important results have been achieved in many countries, but the road ahead is still very long and arduous. It is our duty to continue to keep the attention high and to raise awareness on this subject.

6. Can you tell us something about you that people would be surprised to learn?

When I was little, I dreamed of becoming a novel writer, but now, I only write scientific papers (I am sort of a cellular and molecular novel writer).

7. Given your long career in research and development, what would you say has been the highlight of your career?

I hope to be able to continue working and achieving results for many more years on plant toxins, immunoconjugates and drug targeting, improving the techniques currently available and continuing to put together many small pieces of the great puzzle of knowledge on these topics.

8. Please describe the most difficult challenge you have faced in your research work and how you overcame it.

Certainly, my most difficult challenge was to continue researching in Italy, even when it seemed that there could be economic and career obstacles that would be difficult to overcome. I have always had the support of my family who encouraged me not to give up and to continue on my path, even if it was an uphill one.

9. What are your aims for the future?

I hope that in the future it will be possible for our research group to perfect some immunoconjugates, possibly containing plant toxins, to be utilized for clinical use.

10. Do you have any advice for young researchers, especially young women, who might be interested in doing research in cancer therapy and drug delivery?

I have only one piece of advice for young researchers: always be curious, believe in your potential and never give up.

Dr. Letizia Polito’s contact information:
Email: letizia.polito@unibo.it

Relevant Special Issue:

"Women’s Special Issue Series: Biomedicines"
Submission Deadline: 30 April 2023

Special Issue information:

Dear colleagues,

We are pleased to announce a Special Issue entitled “Women’s Special Issue Series: Biomedicines” to celebrate and highlight the achievements of women in the development of new molecules and therapies for the cancer research area.

For this Special Issue, we are seeking the submission of original research articles and comprehensive review papers from oncology-related fields, in particular regarding new therapeutic targets, therapeutic strategies and research of biomedicines and biopharmaceutical products.

The series advocates the advancement of women in science. We invite contributions to the Special Issue whose lead authors identify as women. The submission of articles with all-women authorship is especially encouraged. However, we do welcome articles from all authors, irrespective of gender.

Dr. Letizia Polito
Dr. Nadia Alfaidy
Guest Editors

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

21 February 2023
Meet Us at the 143rd Annual Meeting of the Pharmaceutical Society of Japan, 25–28 March 2023, Sapporo, Japan


Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan

MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

14 February 2023
Meet Us at the 11th National Conference on Bioinformatics and Systems Biology, 25–27 February 2023, Guangzhou, China


Conference
: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.

14 February 2023
Biomedicines 2022 Early-Career Women Award—Winner Announced


We are pleased to announce that the winner of the Biomedicines 2022 Early-Career Women Award is Dr. Roberta Giuffrida.

Dr. Roberta Giuffrida is a dermatologist and a researcher at the Department of Clinical and Experimental Medicine at the University of Messina (Italy). Dr. Giuffrida’s research interests are in new and existing non-invasive tools useful for the diagnosis and treatment of skin cancers, and her main focus is on dermoscopy. Dr. Giuffrida received her Ph.D. in 2020 and has an outstanding publication record, comprising 94 publications in peer-reviewed international journals, and her Hirsch index is 15. She is a rising star in the field of biomedicines. Please join us in congratulating Dr. Roberta Giuffrida on her outstanding achievements.

As the awardee, Dr. Roberta Giuffrida will receive an honorarium of CHF 1000, an offer to publish a paper free of charge in Biomedicines in 2023 after peer-review, and a certificate.

We would like to thank all the nominators from various fields of study for their participation and all the Award Committee members for their evaluation of many excellent nominees.

Prof. Dr. Shaker A. Mousa
Editor-in-Chief of Biomedicines

18 January 2023
Interview with Dr. Simone Patergnani—Editorial Board Member of Biomedicines

We had the pleasure of speaking with Dr. Simone Patergnani, Editorial Board Member of Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and the recent research trends in the field.

Dr. Fernando Rubiera González

Name: Dr. Simone Patergnani
Email: simone.patergnani@unife.it

Dr. Patergnani received his Ph.D. in biochemistry, molecular biology and biotechnology at the University of Ferrara, Italy. To date, he works at the University of Ferrara, Italy (Department of Medical Sciences, Experimental Medicine section) and the University Hospital of Ferrara, Italy, as a post-doctoral researcher.

Dr. Patergnani’s research is mainly focused on investigating the contribution of different intracellular organelles to regulating different cell signaling pathways, actively collaborating with several international research groups. In parallel, his work also involves testing and verifying whether new next-generation molecules or drugs already used in the clinical field have beneficial effects in the transmission of various intracellular signals, in regulating cellular metabolism, and in activating/silencing various proteins responsible for specific cell functions. In particular, his research in recent years has focused on analyzing the contribution of these cellular mechanisms in cancer, neurodegeneration, mitochondrial diseases, genetic diseases and cardiovascular diseases.

We hope you enjoy the interview.

1. Could you tell us about Biomedicines and your role in the journal?

Biomedicines is a journal that reports original investigations and reviews in the field of cell biology. I serve the journal as an Editorial Board Member, as well as a Guest Editor.

2. What makes a great research paper?

I think that there is no good answer to this question. It is something individual. It is not certain that if an investigation enthuses me, it would have the same effect on another researcher. Everybody has personal preferences and can have a different opinion than me. However, undoubtedly, good research must have great scientific value, be performed with a series of convincing experiments and be well-conceived and developed.

3. What excites you the most about the field of autophagy?

Autophagy represents “the first love” of my research career. I started to investigate this molecular mechanism when I was a student. Since then, research in the field has reached great improvements and is constantly evolving. It is incredible how different molecular pathways that are fundamental for different molecular mechanisms are always related to the autophagy process!

4. Could you describe the difficulties and breakthrough innovations encountered in this research?

I think that the most difficult aspect of my research topic is that all the world studies it. However, at the same time, this represents a fundamental aspect of my research. Since I’m aware of the existence of this high competition, I always try to do my best to be at the top. I think that the identification of specific autophagy-related genes that have been then used as specific markers for the identification of autophagy levels represents one of the most important breakthrough innovations. Another important aspect in the field of autophagy is unveiling the existence of different and selective forms of autophagy.

5. What are some current challenges in this field?

The main challenge in the field of autophagy is to demonstrate that by manipulating this process it is possible to fight several human diseases. However, before this, it is important to improve our knowledge of autophagy in such diseases. Autophagy can have a dual role according to the stage of the pathology and a pharmacological treatment aimed to modify its levels must be appropriate for the actual autophagy activity present in the cell.

6. Do you have any advice for young researchers?

The only thing that I can say to a young researcher is to never give up when an experiment fails. In research, this often happens. The young researcher must be ready to repeat it. Of course, before repeating it, it is important to understand why the previous experiment failed, they must understand whether the failure is due to a technical problem or because the starting hypothesis of the work is not totally correct. In the latter case, the young researcher must be ready to change the experimental design. If the young researcher is able to switch their ideas and improve themselves, they switch from a “young researcher” to a “researcher”.

We are thankful for Dr. Patergnani’s time and his support for Biomedicines.

5 January 2023
Interview with Dr. Kenneth Lundstrom—Editorial Board Member of Biomedicines

We had the pleasure of speaking with Dr. Kenneth Lundstrom, Editorial Board Member of Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and the recent research trends in the field.

Dr. Fernando Rubiera González

Name: Dr. Kenneth Lundstrom
Email: lundstromkenneth@gmail.com

Dr. Lundstrom received his Ph.D. in molecular genetics at the University of Helsinki, Finland. He has spent most of his career in big pharma and biotech start-ups in cancer therapy and vaccine development. Dr. Lundstrom has published more than 300 scientific articles. He is currently involved in vaccine development against SARS-CoV-2 and cancer immunotherapy.

We hope you enjoy the interview.

1. Why did you decide to work for Biomedicines?

I was attracted by the new set-up of MDPI and also by its presence in Switzerland. It seemed like a good opportunity to build something of value for the scientific community. Let me point out that I have engaged with other journals as a reviewer but also as an Editorial Board Member and even Editor-in-Chief.

2. Why should scientists submit their manuscripts in Biomedicines?

Biomedicines has a good impact factor, it is reliable, the reviewing process is fair and straightforward (most of the time!), the reviewing process is professional and rapid, and the turnover time from acceptance to online publication is impressively fast.

3. How would you recommend picking the right journal to submit your research in?

The reputation and impact factor of the journal are important. Reliable and fast procedure from submission, through reviewing, revision, proof corrections, and publication also affects the decision of which journal to choose. Obviously, when you publish frequently, it is great if you can receive waivers to limit the publication costs.

4. What do you look for most to determine if a paper will be published in the journal?

The scientific soundness of the data and the novelty are the most important things. However, the style of presentation, to ensure the manuscript is understandable for not only the experts, and also the language issue should not be forgotten. As quite a few manuscripts today are submitted by non-English speakers (i.e., native English speakers or persons with good knowledge of English), it is important to make sure that the text does not contain typos and grammatical errors and that the text does not sound like a direct use of Google Translate!

5. What is the priority for a good scientific article: great research with high scientific value or a well-thought-out composition and good writing?

As I already said above, high-quality science is most important, but the composition and writing standard are also important. Moreover, novelty and timely presentations should be highly valued.

6. What makes a great research paper?

Novelty, good science, good presentation, and good writing!

7. What excites you the most about the field of alphavirus-based gene therapy and vaccine development?

The field is relatively new, although alphavirus vectors have been around since the early 1990s. It seems that some sort of renaissance is going on, partly because of substantial progress in cancer immunotherapy and, not least, the development of nucleic acid vaccines against COVID-19. Perhaps the most attractive feature of alphaviruses is their flexibility as they can be used as recombinant and oncolytic viral particles, naked or nanoparticle-encapsulated RNA, or replicon DNA molecules. I could go on, but that would be another review!

8. Could you describe the difficulties and breakthrough innovations encountered in this research?

One difficulty has been to convince the scientific community of the safety of using alphavirus vectors and also demonstrating efficacy in clinical trials. Perhaps the most impressive breakthrough has been the demonstration of the efficacy of the current COVID-19 mRNA vaccines, which has had a direct impact on using alphavirus-based RNA delivery.

9. What are some current challenges in this field?

The main current challenges are to transfer the successful proof-of-concept findings from preclinical animal models to humans in clinical trials. Moreover, today, plenty of suspicion of the safe use of viral vectors has been encountered, especially due to so much misinformation/disinformation mainly related to the development of recent COVID-19 vaccines based on nucleic acids but also viral particles.

10. Do you have any advice for young researchers?

Conduct good research and ensure that you will be able to publish the results in good journals.

We are thankful for Dr. Lundstrom's time and his support for Biomedicines.

 

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

8 December 2022
Biomedicines | Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the Biomedicines Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience and cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars that may be interested in the issue and personally emailing the invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Overseeing editorial control of the Special issue and quality control of the publications in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Making and submitting decisions for the submissions with the assistance of mentees.

Certificates and awards:

After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and mentees.

If you are interested in this opportunity, please send your Special Issue proposal to the Biomedicines Editorial Office via the link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

Drones news

In addition to the new Special Issue Mentor Program, Biomedicines (ISSN: 2227-9059) continues to welcome all Special Issue proposals focusing on hot research topics.

1 December 2022
Editorial Board Members from Biomedicines Featured among the World’s Top 2% Scientists


Scientists at Stanford University have recently published an update of the list of the top 2% most widely cited scientists. The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 81 Editorial Board Members from MDPI’s journal Biomedicines (ISSN: 2227-9059) were featured in the World’s Top 2% Scientists list in 2022.

Name Affiliation
Prof. Dr. Ali Nokhodchi University of Sussex, UK
Prof. Dr. Alireza Dolatshahi-Pirouz Technical University of Denmark, Denmark
Dr. Anand Rotte Arcellx Inc, USA
Dr. Andrea M.P. Romani Case Western Reserve University, USA
Dr. Andrea Padoan Azienda Ospedale Università Padova, Italy
Dr. Andrei Surguchov University of Kansas Medical Center, USA
Prof. Dr. Artur Cavaco-Paulo Universidade do Minho, Portugal
Prof. Dr. Baoxue Yang Peking University Health Science Center, China
Dr. Bernhard Ryffel INEM/CNRS andUniversite d'Orleans, France
Dr. Carlo Colosimo Santa Maria University Hospital, Italy
Prof. Dr. Carmen Jerónimo Instituto Portugues de Oncologia de Francisco Gentil Porto, Portugal
Prof. Dr. Catherine Thieblemont Hôpital Saint-Louis, France
Dr. Celestino Sardu Università degli Studi della Campania Luigi Vanvitelli, Italy
Dr. Christian Dani Université Côte d'Azur, France
Dr. Christina M. Lill Universität zu Lübeck, Germany
Prof. Dr. Chul Ahn UT Southwestern Medical Center, USA
Dr. Chun Ming Wong The University of Hong Kong, Hong Kong, China
Prof. Dr. Dimiter S. Dimitrov University of Pittsburgh School of Medicine, USA
Dr. Dimitrios Kapogiannis National Institute on Aging (NIA), USA
Dr. Dongryeol Ryu SKKU School of Medicine, Korea
Dr. Elisa Rumi Università degli Studi di Pavia, Italy
Dr. Felicetto Ferrara Azienda Ospedaliera Di Rilievo Nazionale Antonio Cardarelli, Italy
Prof. Dr. Francesco Blasi Istituto Europeo di Oncologia, Italy
Dr. François R. Jornayvaz Hôpitaux Universitaires de Genève, Switzerland
Dr. Germana Bancone University of Oxford, UK
Prof. Dr. Gianluca Gambarini Sapienza Università di Roma, Italy
Prof. Dr. Gianluigi Mazzoccoli IRCCS Casa Sollievo della Sofferenza, Italy
Dr. Giuseppina Basta Istituto di Fisiologia Clinica del CNR, Italy
Prof. Dr. Heping Xu Queen's University Belfast, UK
Prof. Dr. Jan B. Vermorken Universitair Ziekenhuis Antwerpen, Belgium
Dr. Jean A. Boutin Institut de Recherches Servier, Croissy-sur-Seine, France
Prof. Dr. Jeanine Walenga Loyola University of Chicago, USA
Dr. Jenni Harvey University of Dundee, UK
Dr. Jiake Xu The University of Western Australia, Australia
Prof. Dr. José García Solé Universidad Autónoma de Madrid, Spain
Prof. Dr. Juan Sahuquillo Hospital Universitari Vall d'Hebron, Spain
Prof. Dr. Juergen Schrezenmeir Kiel Center of Innovation and Technology, Germany
Dr. Kenichi Suda Kindai University School of Medicine, Japan
Dr. Kenneth Lundstrom PanTherapeutics, Switzerland
Dr. Khalid Iqbal New York State Institute for Basic Research in Developmental Disabilities, USA
Dr. Kiichi Hirota Kansai Medical University, Japan
Dr. L. Eric Huang University of Utah Health, USA
Dr. Lennart Hardell The Environment and Cancer Research Foundation, Sweden
Prof. Dr. Lia Ginaldi Università degli Studi dell'Aquila, Italy
Dr. Lia Rimondini Università del Piemonte Orientale, Italy
Prof. Dr. M. R. Mozafari Monash University LPO, Australia
Prof. Dr. Maria Luisa Torre Università degli Studi di Pavia, Italy
Dr. Makoto C. Nagano McGill University, Canada
Dr. Manlio Vinciguerra Fakultní Nemocnice u Sv. Anny v Brně, Czech Republic
Prof. Dr. Mario Dell'Agli Università degli Studi di Milano, Italy
Dr. Meiwan Chen University of Macau, Macao, China
Dr. Mike Barbeck BerlinAnalytix GmbH, Germany
Prof. Dr. Natalia V. Gulyaeva Institute of Higher Nervous Activity and Neurophysiology of RAS, Russia
Dr. Natasha Irrera Università degli Studi di Messina, Italy
Prof. Dr. Nathalie Lassau Universite Paris-Saclay, France
Dr. Navid Rabiee Macquarie University, Australia
Prof. Dr. Nicola Silvestris IRCCS Istituto Tumori Giovanni Paolo II, Italy
Dr. Nicoletta Galeotti Università degli Studi di Firenze, Italy
Dr. Olivier Micheau Université Bourgogne Franche-Comté, France
Prof. Dr. Rakesh Kumar Swami Rama Himalayan University, India
Dr. Raphael Mechoulam Hebrew University, Israel
Prof. Dr. Ricardo Pérez-Tomás Universitat de Barcelona, Spain
Dr. Seema Singh University of South Alabama College of Medicine, USA
Dr. Sergio Cortelazzo Humanitas Gavazzeni Hospital, Italy
Prof. Dr. Silvia Di Agostino Università degli studi Magna Graecia di Catanzaro, Italy
Dr. Simone Patergnani University of Ferrara, Italy
Prof. Dr. Solomon Habtemariam University of Greenwich, UK
Prof. Dr. Stefano Angioni Università degli Studi di Cagliari, Italy
Dr. Steven E. Mutsaers The University of Western Australia, Australia
Prof. Dr. Swee Hin Teoh Nanyang Technological University, Singapore
Dr. Takenobu Katagiri Saitama Medical University, Japan
Dr. Thanigaimalai Pillaiyar Eberhard Karls Universität Tübingen, Germany
Dr. Thiruganesh Ramasamy University of Pittsburgh School of Medicine, USA
Prof. Dr. Thomas Kietzmann University of Oulu, Finland
Prof. Dr. Tracey Pirali Università degli Studi del Piemonte Orientale Amedeo Avogadro, Italy
Dr. Valentina Citi Università di Pisa, Italy
Dr. Valeria Barresi Università degli Studi di Verona, Italy
Prof. Dr. Verinder Sharma Western University, Canada
Dr. Vinay Tergaonkar ASTAR, Singapore
Dr. Xi Yao City University of Hong Kong, Hong Kong, China
Prof. Dr. Zaal Kokaia Lund University, Sweden

The latest rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Biomedicines.

21 November 2022
Meet Us at the 15th Annual Meeting of Chinese Society for Immunology, 27–30 December 2022, Chongqing, China


A range of MDPI journals will be attending the 15th Annual Meeting of Chinese Society for Immunology. This meeting will be held in Chongqing, China, from 27 to 30 December 2022.

The conference focuses on the following areas:

  • Recognition and regulation of innate immune responses;
  • Adaptive immune response;
  • Immune metabolism and immune regulation;
  • Immunity to COVID-19 infection;
  • Tumor immunity and tumor immunotherapy;
  • Autoimmune diseases and other topics.

The following MDPI journals will be represented:

  • IJMS (leading journal);
  • Vaccines;
  • Metabolites;
  • Cells;
  • Cancers;
  • Biomedicines;
  • CIMB;
  • Pathogens;
  • Immuno.

If you plan on attending this conference, feel free to stop by our booth #B13. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://csimeeting2022.sciconf.cn/cn/web/index/13562.  

21 October 2022
Biomedicines 2022 Young Investigator Award—Winners Announced


We are pleased to announce that the winners of the Biomedicines 2022 Young Investigator Award are Dr. Yuyan Jiang and Prof. Billy Wai-Lung Ng.

Dr. Yuyan Jiang is a postdoctoral researcher at the Department of Radiation Oncology at Stanford University, USA. Dr. Jiang is a highly productive young researcher with special interests in developing next-generation radio-sensitizer, bio-responsive cancer nanomedicine and photoactive ultrasensitive molecular probes for deep-tissue diagnosis. Since the beginning of her scientific career in 2016, she has published 39 peer-review articles in high-ranking journals including Nature Biomedical Engineering, Nature Communications, Chemical Reviews, Accounts of Chemical Research, etc. According to Google Scholar, her research has received > 5,500 citations and her h-index is 36. Dr. Jiang is an Editorial Board Member of Materials and Collagen and Leather. She is also the Guest Editor of two Materials Special Issues, including “Advanced Biomaterials Design and Sensing Application” and “Advanced Biomaterials for Cancer Sonodynamic Therapy”.

Prof. Billy Wai-Lung Ng leads the Ng Lab of Chemical Biology and Drug Discovery at the School of Pharmacy, Chinese University of Hong Kong (CUHK). His research interests are chemical biology, drug discovery, and medicinal chemistry. Prof. Ng completed his postdoctoral training at Harvard Medical School/Dana-Farber Cancer Institute. Prior to Harvard, he was a research fellow at the University of Oxford, with funding support from the Croucher Foundation and Marie Curie Fellowship. He was a Fulbright Scholar at Massachusetts Institute of Technology (MIT) during his graduate study. He obtained his Ph.D. and B.Sc. (1st Class Hons.) in chemistry from CUHK. He has co-authored more than 20 papers in prestigious journals such as Science, Nature Chemical Biology, Molecular Cell, J. Am. Chem. Soc., Angew. Chem. Int. Ed., and ACS Central Science and he also serves as a reviewer for more than 20 journals including Science Translational Medicine, Nature Chemical Biology, and Nature Biotechnology. Prof. Ng was honored as a Young Global Leader (YGL) by the World Economic Forum in 2022. For further details, please visit his lab webpage: https://www.ngwailung.com.

As the awardees, Dr. Yuyan Jiang and Prof. Billy Wai-Lung Ng will each receive an honorarium of CHF 1000 and an electronic certificate.

We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.

On behalf of Biomedicines 2022 Young Investigator Evaluation Committee,

Prof. Dr. Shaker A. Mousa
Editor-in-Chief

29 September 2022
Meet Us at the 2022 BMES Annual Meeting, 12–15 October 2022, San Antonio, Texas, USA


Conference: 2022 BMES Annual Meeting
Date: 12–15 October 2022
Place: San Antonio, Texas, USA
Booth: #346

MDPI will be attending the 2022 BMES Annual Meeting as an exhibitor from 12 to 15 October 2022 in San Antonio, Texas, USA.

BMES holds an annual meeting where they have hosted up to 5,500 biomedical engineers who attend more than 2,500 scientific presentations on cancer treatment, heart disease, women’s health, global health disparities, and more. The meeting allows members to advocate for their innovative solutions, demonstrating their commitment to the society’s core value of health equity for all individuals. In addition, BMES shares scientific information to inspire the up-and-coming generation through four scientific journals, three special interest groups, and collaborations with other scientific societies to elevate the visibility and significant impact that the biomedical engineering community has worldwide as the thought leaders behind the future of human health.

From 12 to 15 October 2022, in the vibrant multicultural city of San Antonio, we will celebrate the tremendous contributions made by BMES members in research, teaching, education, and the workforce that directly impact many sectors of our society. We also aim to highlight equity issues in healthcare and education, stemming from racial and socioeconomic diversity, gender and sexual orientation, and disabilities.

The following MDPI journals will be represented:

Please do not hesitate to reach out if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.bmes.org/annualmeeting.

28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

26 September 2022
Meet Us Online at the 2nd International Electronic Conference on Biomedicines (ECB 2023), 1–31 March 2023


Conference: ECB 2023: The 2nd International Electronic Conference on Biomedicines
Date: 1–31 March 2023

Biomedicines (ISSN: 2227-9059) is pleased to announce this call for participation in the 2nd International Electronic Conference on Biomedicines. ECB 2023 seeks to fulfill the need of academics to gather to share results and ideas by offering a completely digital (online) method of running this scientific conference. Researchers currently working on biomedicines are encouraged to join this event and share their findings with colleagues from all over the world.

The conference will cover but not be limited to the following general and related themes:

  1. Frontiers of biomedicine in SARS-CoV-2;
  2. RNA processing and human diseases;
  3. Extracellular vesicles for biomarker discovery;
  4. Medicinally active plants and phytochemicals;
  5. Molecular mechanisms of neurodegeneration;
  6. Immune system, tumor immunology, and autoimmune disease;
  7. Obesity and metabolic diseases;
  8. Nutraceuticals as adjuvant therapeutics;
  9. Musculoskeletal tissue regeneration;
  10. Wound healing;
  11. Peptide-based piezoelectric materials;
  12. Nanomedicine, combination cancer therapy, and immunotherapy.

All submitted abstracts will be evaluated by the conference peer review committee. Upon acceptance, authors will contribute an extended abstract for the conference proceedings and a slide presentation of their work. The authors with outstanding contributions will be invited to submit full manuscripts for potential publication in Biomedicines (https://www.mdpi.com/journal/biomedicines).

Important Dates:

Abstract Submission: 5 January 2023;
Acceptance Notification: 16 January 2023;
Full Paper Submission: 6 February 2023;
Final Paper Notification: 17 February 2023.

The Scientific Committee looks forward to receiving contributions in response to this call and will be happy to provide any further information to interested parties. Any questions may be addressed to the conference secretariat (ecb@mdpi.com).

We thank you in advance for attending this conference, and we look forward to a stimulating exchange.

To find out more about the conference, please visit the following link: https://ecb2023.sciforum.net.

22 September 2022
Recruiting Volunteer Reviewers for Biomedicines

Biomedicines (ISSN: 2227-9059) is recruiting volunteer reviewers. Reviewers are responsible for regularly providing timely, high-quality reports on manuscripts submitted to the journal. More information about the role is available at: https://www.mdpi.com/reviewers

Peer review constitutes an essential part of the publication process, ensuring that papers published in Biomedicines maintain its high standards. We are looking to recruit expert reviewers to help uphold the journal’s quality and efficiency expectations.

To apply, please visit the following link: https://susy.mdpi.com/volunteer/journals/review.

7 September 2022
Meet Us at the ASHG Annual Meeting 2022 (ASHG 2022), 25–29 October 2022, Los Angeles, USA


MDPI will be attending ASHG 2022, held in Los Angeles, USA, from 25 to 29 October 2022.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth: #1844. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link:

https://www.ashg.org/meetings/2022-annual-meeting/.

6 July 2022
Recruiting Topical Advisory Panel Members for Biomedicines

We are currently recruiting Topical Advisory Panel Members for the journal Biomedicines (ISSN: 2227-9059). The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors and Editorial Board Members. More information on the responsibilities of the Topical Advisory Panel is available at the following link: https://www.mdpi.com/editors#Supporting_Editor_Responsibilities.

Biomedicines is an international, scientific, peer-reviewed, open access journal on biomedicines published monthly online by MDPI. The aims and scope of the journal can be found on the following website: https://www.mdpi.com/journal/biomedicines/about.

The benefits of Topical Advisory Panel Members include the following:

  • The opportunity to publish one paper per year with a discount in Biomedicines, as well as potential discounts for additional papers you invite;
  • A certificate of recognition of your position;
  • Additional sponsorships for conferences organized by Topical Advisory Panel Members of Biomedicines;
  • Travel grants for conferences that you attend or organize.

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have experience in a field related to the journal;
  • Have completed their Ph.D. within approximately the last 10 years;
  • Have at least 6 papers published in the last 5 years, as a first author or corresponding author;
  • Currently hold an independent research position in academia or a government institute.

If you are interested in this position, please apply via the following link: https://www.mdpi.com/journal/biomedicines/topical_advisory_panel_application, or send an email to biomedicines@mdpi.com with your academic CV. We look forward to hearing from you!

Biomedicines Editorial Office

6 July 2022
Welcoming New Editorial Board Members of Biomedicines

We are delighted to welcome the following nine recognized researchers who recently joined the Editorial Board of Biomedicines (ISSN: 2227-9059).

Editorial Board Members:

Affiliations:

Prof. Dr. Zhi Shi

Jinan University, China

Prof. Dr. Chuan Li

National Yang Ming Chiao Tung University, Taiwan

Dr. Christos K. Kontos

National and Kapodistrian University of Athens, Greece

Prof. Dr. Swee Hin Teoh

Nanyang Technological University, Singapore

Dr. Mihaela Gherghiceanu

Victor Babes National Institute of Pathology, Romania

Dr. Xi Yao

City University of Hong Kong, Tat Chee Avenue, Hong Kong

Prof. Dr. Dafang Chen

Peking University, China

Dr. Ryota Niikura

Tokyo Medical University, Japan

Dr. Barbara Rath

Vienna Vaccine Safety Initiative, Germany

We look forward to their every success, both in their research and in the development of the journal.

Further details concerning the Editorial Board can be found at the following link: https://www.mdpi.com/journal/biomedicines/editors.

28 June 2022
2021 Impact Factors - Released

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

Journal Impact Factor Rank Category
Antioxidants 7.675 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 7.666 Q2 Cell Biology
Nutrients 6.706 Q1 Nutrition & Dietetics
Cancers 6.575 Q1 Oncology
Pharmaceutics 6.525 Q1 Pharmacology & Pharmacy
International Journal of Molecular Sciences 6.208 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Marine Drugs 6.085 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Biomolecules 6.064 Q2 Biochemistry & Molecular Biology
Batteries * 5.938 Q2 Electrochemistry
Energy & Fuels
Materials Science, Multidisciplinary
Viruses 5.818 Q2 Virology
Biosensors 5.743 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Journal of Fungi 5.724 Q1 Mycology
Q2 Microbiology
Nanomaterials 5.719 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Metabolites 5.581 Q2 Biochemistry & Molecular Biology
Foods 5.561 Q1 Food Science & Technology
Drones * 5.532 Q2 Remote Sensing
Remote Sensing 5.349 Q1 Geosciences, Multidisciplinary
Imaging Science & Photographic Technology
Q2 Remote Sensing
Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 5.318 Q2 Business
Antibiotics 5.222 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Pharmaceuticals 5.215 Q1 Pharmacology & Pharmacy
Q2 Chemistry, Medicinal
Biology 5.168 Q1 Biology
Fermentation 5.123 Q2 Biotechnology & Applied Microbiology
Toxins 5.075 Q1 Toxicology
Q2 Food Science & Technology
Bioengineering * 5.046 Q2 Engineering, Biomedical
Polymers 4.967 Q1 Polymer Science
Journal of Clinical Medicine 4.964 Q2 Medicine, General & Internal
Vaccines 4.961 Q2 Immunology
Medicine, Research & Experimental
Molecules 4.927 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Microorganisms 4.926 Q2 Microbiology
Journal of Functional Biomaterials * 4.901 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.757 Q2 Medicine, Research & Experimental
Pharmacology & Pharmacy
Biochemistry & Molecular Biology
Plants 4.658 Q1 Plant Sciences
International Journal of Environmental Research and Public Health 4.614 Q1 Public, Environmental & Occupational Health (SSCI)
Q2 Public, Environmental & Occupational Health (SCIE)
Environmental Sciences (SCIE)
Membranes 4.562 Q1 Polymer Science
Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Pathogens 4.531 Q2 Microbiology
Catalysts 4.501 Q2 Chemistry, Physical
Toxics 4.472 Q2 Toxicology
Environmental Sciences
Gels 4.432 Q1 Polymer Science
Journal of Cardiovascular Development and Disease 4.415 Q2 Cardiac & Cardiovascular Systems
Chemosensors 4.229 Q1 Instruments & Instrumentation
Q2 Chemistry, Analytical
Q3 Electrochemistry
Genes 4.141 Q2 Genetics & Heredity
Diagnostics 3.992 Q2 Medicine, General & Internal
Agronomy 3.949 Q1 Agronomy
Plant Sciences
Land 3.905 Q2 Environmental Studies
Sustainability 3.889 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Q4 Green & Sustainable Science & Technology (SSCI)
Sensors 3.847 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Materials 3.748 Q1 Metallurgy & Metallurgical Engineering
Q2 Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Biomimetics * 3.743 Q2 Engineering, Multidisciplinary
Q3 Materials Science, Biomaterials
Tropical Medicine and Infectious Disease * 3.711 Q1 Tropical Medicine
Q2 Parasitology
Q3 Infectious Diseases
Lubricants * 3.584 Q2 Engineering, Mechanical
Fractal and Fractional 3.577 Q1 Mathematics, Interdisciplinary Applications
Water 3.530 Q2 Water Resources
Q3 Environmental Sciences
Micromachines 3.523 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Journal of Personalized Medicine 3.508 Q2 Medicine, General & Internal
Health Care Sciences & Services
Agriculture 3.408 Q1 Agronomy
Processes 3.352 Q2 Engineering, Chemical
Separations 3.344 Q2 Chemistry, Analytical
Magnetochemistry 3.336 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Brain Sciences 3.333 Q3 Neurosciences
Buildings 3.324 Q2 Construction & Building Technology
Engineering, Civil
Forests 3.282 Q1 Forestry
Energies 3.252 Q3 Energy & Fuels
Life 3.251 Q2 Biology
Coatings 3.236 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
Animals 3.231 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Journal of Intelligence * 3.176 Q2 Psychology, Multidisciplinary
Fishes 3.170 Q1 Marine & Freshwater Biology
Q2 Fisheries
Healthcare 3.160 Q2 Health Policy & Services (SSCI)
Health Care Sciences & Services (SCIE)
Inorganics * 3.149 Q2 Chemistry, Inorganic & Nuclear
Insects 3.139 Q1 Entomology
Atmosphere 3.110 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Current Oncology 3.109 Q3 Oncology
ISPRS International Journal of Geo-Information 3.099 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Diversity 3.029 Q2 Biodiversity Conservation
Ecology
Tomography 3.000 Q3 Radiology, Nuclear Medicine & Medical Imaging
Current Issues in Molecular Biology 2.976 Q3 Biochemistry & Molecular Biology
Medicina 2.948 Q3 Medicine, General & Internal
Symmetry 2.940 Q2 Multidisciplinary Sciences
Horticulturae 2.923 Q1 Horticulture
Machines 2.899 Q2 Engineering, Mechanical
Engineering, Electrical & Electronic
Systems * 2.895 Q2 Social Sciences, Interdisciplinary
Applied Sciences 2.838 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Children 2.835 Q2 Pediatrics
Minerals 2.818 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Universe 2.813 Q2 Astronomy & Astrophysics
Q3 Physics, Particles & Fields
Journal of Marine Science and Engineering 2.744 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Entropy 2.738 Q2 Physics, Multidisciplinary
Fire * 2.726 Q2 Forestry
Q3 Ecology
Metals 2.695 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Electronics 2.690 Q3 Engineering, Electrical & Electronic
Computer Science, Information Systems
Physics, Applied
Crystals 2.670 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Aerospace 2.660 Q1 Engineering, Aerospace
Mathematics 2.592 Q1 Mathematics
Photonics 2.536 Q3 Optics
Actuators 2.523 Q2 Instruments & Instrumentation
Q3 Engineering, Mechanical
Veterinary Sciences 2.518 Q2 Veterinary Sciences
Behavioral Sciences * 2.286 Q3 Psychology, Multidisciplinary
Axioms * 1.824 Q2 Mathematics, Applied

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

 

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)

 

20 June 2022
MDPI’s 2021 Young Investigator Awards in “Medicine & Pharmacology”—Winners Announced

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

  • Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
  • Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

  • Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

  • Helen Rogers, Newcastle University, UK

Healthcare:

  • Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

  • Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

  • Simone Di Franco, University of Palermo, Italy
  • Catriona Hippman, University of Calgary, Canada

Medicina:

  • Veeru Kasivisvanathan, University College London, UK
  • Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

  • Qi Zhou, Purdue University, USA

20 June 2022
MDPI’s 2021 Travel Awards in “Medicine & Pharmacology”—Winners Announced

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

  • Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

  • Shawn Alexander Hallett, University of Michigan, USA

Medicines:

  • Claire Albert, Yale University, USA

Pharmaceuticals:

  • Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
  • Patrick Jim Küppers, University Hospital Bonn, Germany

20 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Medicine & Pharmacology”—Winners Announced

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

  • Antonio G. Solimando, University of Bari Aldo Moro, Italy
  • Chenghui Li, University of Arkansas for Medical Sciences, USA
  • Joaquim Carreras, Tokai University, Japan
  • Pierfrancesco Franco, University of Turin School of Medicine, Italy
  • Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

  • Margaret Fitch, University of Toronto, Canada
  • Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

  • Naser Alsharairi, Griffith University, Australia
  • Peter W. Choate, Mount Royal University, Canada
  • Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

  • Giulio Francesco, Sapienza University of Rome, Italy
  • Sebastian Schnaubelt, Medical University of Vienna, Austria
  • Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

  • Onofrio Laselva, University of Foggia, Italy
  • Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
  • Vladimir Vladimirov, Virginia Commonwealth University, USA
  • Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

  • Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

  • Anjul Khadria, California Institute of Technology, Pasadena, USA

20 June 2022
MDPI’s 2021 Best Paper Awards in “Medicine & Pharmacology”—Winners Announced

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140

9 June 2022
2021 CiteScores - Released


The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Journal

CiteScore

Quartile

Category

Non-coding RNA

10.1

Q1

Genetics

Journal of Functional Biomaterials

10.0

Q1

Biomedical Engineering

Marine Drugs

8.1

Q1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Batteries

7.9

Q1

Electrical and Electronic Engineering

Nutrients

7.9

Q1

Nutrition and Dietetics

Remote Sensing

7.4

Q1

General Earth and Planetary Sciences

Drones

7.2

Q1

Computer Science Applications

International Journal of Molecular Sciences

6.9

Q1

Inorganic Chemistry

Journal of Sensor and Actuator Networks

6.9

Q1

Computer Networks and Communications

Cells

6.7

Q1

General Biochemistry, Genetics and Molecular Biology

Nanomaterials

6.6

Q1

General Chemical Engineering

Toxins

6.6

Q1

Health, Toxicology and Mutagenesis

Viruses

6.6

Q1

Infectious Diseases

Antioxidants

6.5

Q1

Food Science

Fibers

6.5

Q1

Civil and Structural Engineering

Resources

6.4

Q1

Nature and Landscape Conservation

Sensors

6.4

Q1

Instrumentation

Big Data and Cognitive Computing

6.1

Q1

Management Information Systems

Molecules

5.9

Q1

Chemistry (miscellaneous)

Polymers

5.7

Q1

Polymers and Plastics

Biosensors

5.6

Q1

Engineering (miscellaneous)

Catalysts

5.5

Q1

General Environmental Science

Smart Cities

5.5

Q1

Urban Studies

Future Internet

5.4

Q2

Computer Networks and Communications

Beverages

5.3

Q1

Food Science

Fermentation

5.3

Q1

Plant Science

Environments

5.2

Q1

Ecology, Evolution, Behavior and Systematics

Inventions

5.2

Q1

General Engineering

Journal of Open Innovation: Technology, Market, and Complexity

5.1

Q1

Development

Colloids and Interfaces

5.0

Q1

Chemistry (miscellaneous)

Energies

5.0

Q1

Control and Optimization

ISPRS International Journal of Geo-Information

5.0

Q1

Geography, Planning and Development

Sustainability

5.0

Q1

Geography, Planning and Development

Fire

4.9

Q1

Forestry

Robotics

4.9

Q1

Control and Optimization

Soil Systems

4.9

Q1

Soil Science

Geosciences

4.8

Q1

General Earth and Planetary Sciences

Journal of Manufacturing and Materials Processing

4.8

Q1

Mechanical Engineering

Tropical Medicine and Infectious Disease

4.8

Q1

Public Health, Environmental and Occupational Health

Water

4.8

Q1

Geography, Planning and Development

International Journal of Environmental Research and Public Health

4.5

Q1

Public Health, Environmental and Occupational Health

Sports

4.5

Q1

Physical Therapy, Sports Therapy and Rehabilitation

Entropy

4.4

Q1

Mathematical Physics

Journal of Clinical Medicine

4.4

Q1

General Medicine

Symmetry

4.3

Q1

General Mathematics

Cosmetics

4.2

Q1

Surgery

Foods

4.1

Q1

Health Professions (miscellaneous)

Journal of Fungi

4.1

Q1

Plant Science

ChemEngineering

4.0

Q1

General Engineering

Forests

4.0

Q1

Forestry

Journal of Intelligence

4.0

Q1

Education

Antibiotics

3.9

Q1

General Pharmacology, Toxicology and Pharmaceutics

Cryptography

3.9

Q1

Applied Mathematics

Behavioral Sciences

3.8

Q1

Development

Buildings

3.8

Q1

Architecture

Metals

3.8

Q1

Metals and Alloys

Publications

3.5

Q1

Communication

Social Sciences

3.4

Q1

General Social Sciences

Mathematics

2.9

Q1

General Mathematics

Fractal and Fractional

2.8

Q1

Analysis

Animals

2.7

Q1

General Veterinary

Axioms

2.6

Q1

Algebra and Number Theory

Heritage

1.8

Q1

Conservation

Religions

1.0

Q1

Religious Studies

Philosophies

0.9

Q1

Philosophy

Source: 2021 CiteScores™ (Elsevier)

29 March 2022
Welcoming New Section Editors-in-Chief of Biomedicines

We are pleased to announce that Prof. Dr. Robert Passier has been appointed Editor-in-Chief of Section “Biomedical Engineering in Human Health” and Prof. Dr. Manfredi Tesauro has been appointed Editor-in-Chief of Section “Endocrinology and Metabolism Research”. We look forward to their contributions to Biomedicines (ISSN: 2227-9059).

Name: Prof. Dr. Robert Passier
Affiliation: Department of Applied Stem Cell Technologies, University of Twente, 7500 AE Enschede, The Netherlands
Interests: human pluripotent stem cells; iPSCs; disease modelling; cardiovascular disease; cardiomyocytes; organ-on-chip; tissue engineering; regeneration; genetic modifications; cardiovascular differentiation and maturation; drug screening and discovery

Name: Prof. Dr. Manfredi Tesauro
Affiliation: U.O.C. of Internal Medicine—Center of Hypertension and Nephrology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Interests: endothelial dysfunction; obesity; insulin resistance; diabetic nephropathy; metabolic syndrome; adipokines

9 December 2021
Biomedicines | 10th Anniversary


The year 2022 marks the 10th anniversary of Biomedicines (ISSN: 2227-9059, IF: 6.081), a peer-reviewed, open access journal based on research in the field of biomedicine. Thus far, more than 2800 papers from more than 17,000 authors have been published in Biomedicines. As well as this, more than 6300 reviewers have submitted at least one review report to this journal. We value the contributions made by authors and reviewers. To celebrate the 10th anniversary of Biomedicines, we are arranging events and the release of special content. We hope that you will be able to join us to celebrate this milestone of our journal.

If you have any questions, suggestions, or recommendations, please do not hesitate to contact biomedicines@mdpi.com.

Biomedicines Editorial Office

22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Abate, Antonio
Abatzoglou, John T.
Abbaszadeh, Mostafa
Acharya, U. Rajendra
Acharya, Viral V.
Agarwal, Ravi P.
Ahn, Myung-Ju
Airoldi, Laura
Ali, Imran
Allakhverdiev, Suleyman I.
Aluko, Rotimi E.
Anasori, Babak
Andersson, Dan I.
Andes, David
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Arqub, Omar Abu
Aschner, Michael
Assaraf, Yehuda G.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Atangana, Abdon
Bahram, Mohammad
Bakris, George L.
Balandin, Alexander A.
Baleanu, Dumitru
Balsamo, Gianpaolo
Bando, Yoshio
Banks, William A.
Bansal-Travers, Maansi
Barba, Francisco J.
Barros, Lillian
Basit, Abdul W.
Baskonus, Haci Mehmet
Bassetti, Matteo
Battino, Maurizio
Bell, Jordana T.
Bellomo, Nicola
Benediktsson, Jon Atli
Benelli, Giovanni
Benjakul, Soottawat
Bhatnagar, Amit
Biddle, Stuart J. H.
Biondi, Antonio
Biondi-Zoccai, Giuseppe
Bjarnsholt, Thomas
Blaabjerg, Frede
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boffetta, Paolo
Bogers, Marcel
Bonomo, Robert A.
Bowman, David M.J.S.
Boyer, Cyrille
Brestic, Marian
Brevik, Eric C.
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cai, Jianchao
Calhoun, Vince D.
Calin, George
Cao, Jinde
Cao, Guozhong
Carvalho, Andre F.
Castellanos-Gomez, Andres
Cerqueira, Miguel Ângelo Parente Ribeiro
Chang, Jo-Shu
Chang, Chih-Hao
Chastin, Sebastien
Chau, Kwok-wing
Chemat, Farid
Chen, Xiaobo
Chen, YangQuan
Chen, Jianmin
Chen, Chaoji
Chen, Min
Chen, Qi
Chen, Jun
Chen, Xi
Chen, Peng
Chen, Yulin
Chen, Bo
Chen, Chen
Chen, Zhi-Gang
Chen, Wei-Hsin
Chen, Gang
Chen, Yongsheng
Chen, Xiang
Chen, Yimin
Chen, Runsheng
Chen, Lidong
Chen, Shaowei
Chen, Qian
Chen, Yu
Chen, Shuangming
Chiclana, Francisco
Cho, Sun Young
Choi, Wonyong
Chowdhary, Anuradha
Choyke, Peter L.
Cichocki, Andrzej
Corella, Dolores
Corma, Avelino
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Crommie, Michael F.
Cui, Yi
Cui, Haiying
Cui, Qinghua
Cummings, Kenneth Michael
Dai, Shifeng
Dai, Sheng
Daiber, Andreas
Davis, Steven J.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Decker, Eric Andrew
Dekel, Avishai
Demaria, Marco
Deng, Yong
Deng, Xiangzheng
DePinho, Ronald A.
Desneux, Nicolas
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Dionysiou, Dionysios D.
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Fan
Dou, Shi Xue
Dou, Letian
Du, Qian
Du, Bo
Dube, Shanta Rishi
Dufresne, Alain
Dummer, Reinhard
Dupont, Didier
Edwards, David
Elaissari, Abdelhamid
Elhoseny, Mohamed
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estévez, Mario
Fabbro, Doriano
Facchetti, Antonio
Fan, Zhanxi
Fang, Chuanglin
Fasano, Alessio
Fečkan, Michal
Felser, Claudia
Feng, Liangzhu
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Ferreira, Isabel C. F. R.
Filippi, Massimo
Fisher, Helen
Fortino, Giancarlo
Fosso Wamba, Samuel
Franceschi, Claudio
Fujita, Hamido
Fujita, Masayuki
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gan, Lihua
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Minrui
Gao, Huijun
Gao, Wei
Gao, Huile
Garbe, Claus
Garcia, Hermenegildo
Gasbarrini, Antonio
Gasco, Laura
Gautret, Philippe
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghadimi, Noradin
Ghaffari, Roozbeh
Ghamisi, Pedram
Giampieri, Francesca
Glick, Bernard R.
Gnant, Michael
Goel, Ajay
Gogotsi, Yury
Goldewijk, Kees Klein
Gong, Jinlong
Gong, Yongji
Govindan, Kannan
Granato, Daniel
Grancini, Giulia
Green, Douglas R.
Grosso, Giuseppe
Gu, Ke
Guan, Cao
Guastella, Adam J.
Guerrero, Josep M.
Gui, Guan
Guizani, Mohsen
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Habibi-Yangjeh, Aziz
Hagemann, Stefan
Hagger, Martin
Hamblin, Michael R.
Hammoudeh, Shawkat
Han, Heesup
Hanes, Justin
Harrison, Roy M.
Hartung, Hans-Peter
Hasanuzzaman, Mirza
He, Jr-Hau
He, Hongwen
He, Jiaqing
He, Debiao
Henseler, Jörg
Herrera, Francisco
Herrera-Viedma, Enrique
Hetz, Claudio
Ho Kim, Jung
Holmes, Elaine
Hossain, Ekram
Hsueh, Po-Ren
Hu, Xiaosong
Hu, Wenbin
Huang, Jianping
Huang, Hongwei
Huang, Yu
Huang, Jianying
Huang, Peng
Huang, Baibiao
Huang, Shaoming
Hubacek, Klaus

Iqbal, Hafiz M. N.
Ismail, Ahmad Fauzi
Izzo, Angelo A.
Jacobson, Kenneth A.
Jain, Atul
Jankovic, Joseph
Jelezko, Fedor
Ji, Xiaobo
Ji, Guangbin
Jiang, Hai-Long
Jiang, Lei
Jiang, Junjun
Jiang, Qing
Jiang, Shibo
Jin, Shi
Jones, Peter A.
Kalantar-zadeh, Kourosh
Kaner, Richard B.
Kannan, Kurunthachalam
Kappos, Ludwig
Karagiannidis, George K.
Karimi, Hamid Reza
Karimi-Maleh, Hassan
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Keesstra, Saskia
Kepp, Oliver
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kim, Ki-Hyun
Kim, Haegyeom
Kim, Jeonghun
Kim, Jong Seung
Kirkwood, John M.
Kisi, Ozgur
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Konopleva, Marina Y.
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kou, Gang
Krausmann, Fridolin
Krebs, Frederik C.
Kroemer, Guido
Kuca, Kamil
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Devendra
Kumar, Alan Prem
Kumar, Sudhir
Kumar Sangaiah, Arun
Kurths, Juergen
Kuznetsov, Nikolay V.
Kuzyakov, Yakov
Kwan, Mei-Po
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lammers, Twan
Lamuela-Raventos, Rosa M.
Lancellotti, Patrizio
Landi, Francesco
Laurent, Sophie
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Sang Soo
Lee, Jin-Wook
Lee, Pooi See
Lehmann, Johannes
Lei, Yaguo
Lei, Ting
Leng, Lijian
Leung, Dennis Y. C.
Leung, Victor C. M.
Levine, Ross
Li, Wei
Li, Jie
Li, Jinghong
Li, Jun
Li, Heng
Li, Gang
Li, Yat
Li, Peng
Li, Hailong
Li, Changpin
Li, Yan
Li, Yurui
Li, Xiaodi
Li, Hong
Li, Shutao
Li, Hongyi
Li, Zhijun
Li, Peiyue
Lin, Yuehe
Lin, Hongjun
Lin, Lin
Lip, Gregory Y. H.
Liu, Jian
Liu, Meng
Liu, Hong
Liu, Tao
Liu, Lei
Liu, Jianxing
Liu, Wei
Liu, Gang
Liu, Yang
Liu, Peide
Lockhart, Shawn R.
Long, Hualou
Löscher, Wolfgang
Lu, Jun
Lu, Jianquan
Lu, Nanshu
Lucey, Brian
Lund, Henrik
Luo, Jun
Luo, Yi
Luo, Jingshan
Luo, Yangchao
Lupton, Deborah
Luque, Rafael
Lv, Wei
Lvov, Yuri M.
Lyons, Timothy W.
Ma, Tianyi
Ma, Jun
Ma, Jiayi
Ma, Wen-Xiu
Ma, Yanming
Maggioni, Aldo Pietro
Mahmood, Nasir
Mahmoudi, Morteza
Mai, Liqiang
Mallavarapu, Megharaj
Mandala, Mario
Mardani, Abbas
Marengo, Jose
Maria Rossolini, Gian
Martinoia, Enrico
Mathiesen, Brian Vad
Mathivanan, Suresh
Mattick, John S.
Matyjaszewski, Krzysztof
McCabe, Matthew E.
McCauley, Darren
McClements, David Julian
Melcher, Karsten
Melenhorst, Jan Joseph
Melero, Ignacio
Mezzetti, Bruno
Mirjalili, Seyedali
Mishchenko, Artem
Mittler, Ron
Moreau, Philippe
Motohashi, Hozumi
Mousavi Khaneghah, Amin
Mu, Shichun
Mueller, Lukas A.
Mueller-Roeber, Bernd
Muenzel, Thomas
Muhammad, Khan
Munger, J. William
Nauen, Ralf
Naushad, Mu.
Negri, Eva
Nemeroff, Charles B.
Newman, David J.
Niaura, Raymond S.
Nie, Feiping
Nieto, Juan J.
Novara, Agata
Nunkoo, Robin
Ogino, Shuji
Olabi, Abdul-Ghani
Ong, Hwai Chyuan
O'Regan, Donal
Orsini, Nicola
Ouyang, Minggao
Ozcan, Aydogan
Pacher, Pal
Pan, Xiaoqing
Pan, Likun
Pan, Quan-Ke
Pang, Huan
Pavela, Roman
Pedrycz, Witold
Pei, Yanzhong
Peng, Shushi
Peng, Qing
Peng, Mugen
Perc, Matjaz
Perez-Alvarez, Jose Angel
Perlin, David S.
Piquero, Alex R.
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Postolache, Mihai
Potenza, Marc N.
Poulter, Benjamin
Preat, Veronique
Prinsep, Michele R.
Pu, Hong-Bin
Putnik, Predrag
Qiu, Jieshan
Qu, Xiaogang
Quiles, José L.
Rabczuk, Timon
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Recio, Isidra
Reiter, Russel J.
Remuzzi, Giuseppe
Ren, Jinsong
Ren, Jun
Riahi, Keywan
Richardson, Paul G.
Rignot, Eric
Rimm, David
Rinn, John L.
Robert, Caroline
Rodriguez, Rosa M.
Rojo, Teofilo
Ros, Emilio
Rosen, Marc A.
Roubaud, David
Russo, Alessandro
Russo, Gian Luigi

Saad, Fred
Saad, Walid
Sadorsky, Perry
Sander, Chris
Santamouris, Mattheos
Santoro, Gabriele
Saraiva, Jorge A.
Sarchiapone, Marco
Scalbert, Augustin
Schloter, Michael
Schneider, Gisbert
Schubert, Ulrich S.
Schulz, Rainer
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scorrano, Luca
Scott, David
Scott, Stuart A.
Scott, Daniel
Serra-Majem, Lluis
Sethi, Gautam
Shabala, Sergey
Shaheen, Sabry M.
Shao, Zongping
Sharma, Gaurav
Shen, Guozhen
Shen, Hao
Sheremet, Mikhail A.
Shi, Peng
Shi, Yumeng
Shoenfeld, Yehuda
Siano, Pierluigi
Sillanpaa, Mika
Simões, Manuel
Simpson, Richard J.
Singh, Bhupinder Pal
Singh, Vijay P.
Smagghe, Guy
Song, Yu
Song, Houbing
Sood, Anil K.
Srivastava, Hari M.
Stadler, Marc
Stadler, Peter F.
Stanley, H. Eugene
Stoumpos, Constantinos C.
Strano, Michael S.
Stunnenberg, Hendrik G.
Su, shiliangsu@whu.edu.cn
Su, Chun-Yi
Subramanian, S. V.
Sun, Zhipei
Sun, Fengchun
Sun, Hongqi
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Szabo, Csaba
Szallasi, Arpad
Szolnoki, Attila
Tacke, Frank
Tan, Weihong
Tan, Chaoliang
Tang, Hua
Tang, Chuyang
Tang, Chuan-He
Tanzi, Rudolph E.
Teichmann, Sarah
Telenti, Amalio
Thakur, Vijay Kumar
Thiele, Holger
Tian, Jie
Tohge, Takayuki
Tran, Lam-Son Phan
Truhlar, Donald G.
Tsao, Rong
Tsuda, Kenichi
Tukker, Arnold
Tung, Chen-Ho
Turskis, Zenonas
Urquhart, Andrew
Valko, Marian
Van Breusegem, Frank
Van de Wiele, Tom
van der Werf, Guido
van Wesemael, Bas
Vangronsveld, Jaco
Varma, Rajender S.
Varsani, Arvind
Varshney, Rajeev K.
Vasilakis, Nikos
Vasilakos, Athanasios V.
Vasquez, Juan C.
Vatanen, Tommi
Ventura, Marco
Vermote, Eric
Veronese, Nicola
Verpoorte, Robert
Vethaak, A. Dick
Vieta, Eduard
Vincent, Jean-Louis
Wagner, Wolfgang
Walton, Vaughn M.
Wan, Jiafu
Wan, Shaohua
Wang, Qi
Wang, Joseph
Wang, Meng
Wang, Tao
Wang, Yuan
Wang, Xin
Wang, Chao
Wang, Yong
Wang, Jun
Wang, Erkang
Wang, Sibo
Wang, Jian
Wang, Ning
Wang, John
Wang, Qin
Wang, Shaojian
Wang, Guoxiu
Wang, Huanting
Wang, Chunsheng
Wang, Gongming
Wang, Zhong Lin
Wang, Lianzhou
Wang, Shaobin
Wang, Yang
Wang, Zifa
Wei, Zhixiang
Wei, Leyi
Weissleder, Ralph
Wen, Guanghui
Wiens, John J.
Wigneron, Jean-Pierre
Willerslev, Eske
Wishart, David S.
Witlox, Frank
Wu, Jun
Wu, Tom
Wu, Hao Bin
Wu, Hui
Wu, Haijun
Wu, Zhongbiao
Wu, Zhong-Shuai
Wu, Zheng-Guang
Xia, Meimei
Xia, Xinhui
Xiang, Quanjun
Xiao, Jianbo
Xiao, Jie
Xie, Jian-Hua
Xin, Sen
Xing, Baoshan
Xiong, Rui
Xu, Bin
Xu, Li Da
Xu, Yi-Jun
Xu, Hui
Xu, Zeshui
Yamauchi, Yusuke
Yan, Huaicheng
Yan, Kai
Yang, Chenguang
Yang, Xiao-Jun
Yang, Bing
Yang, Yun-Gui
Yang, Jie
Yang, Jian
Yang, Xinsong
Yang, Shihe
Yang, Yi
Yang, Yang
Yao, Jen-Chih
Yao, Yonggang
Yazyev, Oleg
Yin, Yulong
Yin, Zongyou
Yin, Shen
Yin, Ya-xia
Yin, Shou-Wei
Ying, Guang-Guo
Young, Allan H.
Yu, Shu-Hong
Yu, Jun
Yu, Guihua
Yu, Wenwu
Yu, Guocan
Yu, Minghao
Zarco-Tejada, Pablo J.
Zavadskas, Edmundas Kazimieras
Zeadally, Sherali
Zhai, Tianyou
Zhang, Wei
Zhang, Binlin
Zhang, Shujun
Zhang, Guoping
Zhang, Zengqiang
Zhang, Yu Shrike
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Guowen
Zhang, Min
Zhang, Yue-Jun
Zhang, Shaoqing
Zhang, Fan
Zhang, Weili
Zhang, Xiaodong
Zhang, Zhien
Zhang, Tierui
Zhang, Hongjie
Zhang, Dengsong
Zhang, Liangpei
Zhang, Dan
Zhang, Yu-Dong
Zhang, Fusuo
Zhao, Yi
Zhao, Guochun
Zhao, Li-Dong
Zheng, Hao
Zheng, Gengfeng
Zhong, Cheng
Zhou, Weiqi
Zhou, Qi
Zhou, Jizhong
Zhu, Hongwei
Zhu, Chengzhou
Zhu, Junfa
Zhu, Zhe
Zhu, Quanxin
Zhuang, Xiaodong
Zhuang, Xiaoying
Zou, Quan

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

16 November 2021
Topical Advisory Panel Established to Support Editorial Board

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have expertise and experience in the field related to the journal;
  • Have received a Ph.D. in the last 10 years, approximately;
  • Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
  • Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

  • 25 October 2021
    Energies journal and Institute of Mechanics, Chinese Academy of Sciences
  • 28 October 2021
    Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
  • 29 October 2021
    Processes journal and Beijing Institute of Technology
  • 29 October 2021
    Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced


Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

  • Adriana Burlea-Schiopoiu;
  • Alban Kuriqi;
  • Álvaro González-Vila;
  • Alessandro Alaimo;
  • Alexey Beskopylny;
  • Alexander Yu Churyumov;
  • Alberto Fernández-Isabel;
  • Andrea Mastinu;
  • Antonios N. Papadopoulos;
  • Anton Rassõlkin;
  • Antonio Humberto Hamad Minervino;
  • Arkadiusz Matwijczuk;
  • Artur Słomka;
  • Baojie He;
  • Bartłomiej Potaniec;
  • Bojan Đurin;
  • Camilo Arturo Rodriguez Diaz;
  • Carmelo Maria Musarella;
  • Chiachung Chen;
  • Chiman Kwan;
  • Cristian Busu;
  • Danil Pimenov;
  • Dan-Cristian Dabija;
  • Delfín Ortega-Sánchez;
  • Demetrio Antonio Zema;
  • Denis Butusov;
  • Elena Lucchi;
  • Gaurab Dutta;
  • Livia Anastasiu;
  • M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

22 September 2021
MDPI Joins SDG Publishers Compact

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com

22 September 2021
Welcoming Dr. Kimon Stamatelopoulos to the Editorial Board of Biomedicines

It is our pleasure to announce the appointment of Dr. Kimon Stamatelopoulos as an Editorial Board Member of the “Cancer Biology and Therapeutics” Section. We look forward to his contributions to the journal.

3 August 2021
Announcement on Japanese Consumption Tax (JCT)

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

30 June 2021
2020 Impact Factors - Released

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

  • 10 journals received their first impact factor
  • 96% of journals increased their impact factor from 2019
  • 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal Impact Factor Rank Category
Cancers 6.639 Q1 • Oncology
Cells 6.600 Q2 • Cell Biology
Pharmaceutics 6.321 Q1 • Pharmacology & Pharmacy
Antioxidants 6.313 Q1 • Food Science & Technology 
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Biomedicines 6.081 Q1 • Medicine, Research & Experimental
• Pharmacology & Pharmacy 
• Biochemistry & Molecular Biology
International Journal of Molecular Sciences 5.924 Q1 • Biochemistry & Molecular Biology
Q2 • Chemistry, Multidisciplinary
Pharmaceuticals 5.863 Q1 • Pharmacology & Pharmacy
• Chemistry, Medicinal
Journal of Fungi 5.816 Q1 • Mycology
• Microbiology
Nutrients 5.719 Q1 • Nutrition & Dietetics
Biosensors 5.519 Q1 • Chemistry, Analytical
• Instruments & Instrumentation
Q2 • Nanoscience & Nanotechnology
Marine Drugs 5.118 Q1 • Chemistry, Medicinal
• Pharmacology & Pharmacy
Biology 5.079 Q1 • Biology
Nanomaterials 5.076 Q1 • Physics, Applied
Q2 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary 
• Nanoscience & Nanotechnology
Viruses 5.048 Q2 • Virology
Journal of Personalized Medicine 4.945 Q1 • Medicine, General & Internal
• Health Care Sciences & Services
Metabolites 4.932 Q2 • Biochemistry & Molecular Biology
Biomolecules 4.879 Q2 • Biochemistry & Molecular Biology
Remote Sensing 4.848 Q1 • Geosciences, Multidisciplinary
Q2 • Remote Sensing
• Imaging Science & Photographic Technology 
• Environmental Sciences
Gels * 4.702 Q1 • Polymer Science
Antibiotics 4.639 Q2 • Infectious Diseases
• Pharmacology & Pharmacy
Toxins 4.546 Q1 • Toxicology
• Food Science & Technology
Vaccines 4.422 Q2 • Immunology
• Medicine, Research & Experimental
Molecules 4.412 Q2 • Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Foods 4.350 Q2 • Food Science & Technology
Polymers 4.329 Q1 • Polymer Science
Journal of Clinical Medicine 4.242 Q1 • Medicine, General & Internal
Toxics 4.146 Q2 • Toxicology
• Environmental Sciences
Catalysts 4.146 Q2 • Chemistry, Physical
Microorganisms 4.128 Q2 • Microbiology
Membranes 4.106 Q1 • Polymer Science
Q2 • Engineering, Chemical
• Materials Science, Multidisciplinary 
• Chemistry, Physical
Genes 4.096 Q2 • Genetics & Heredity
Fermentation * 3.975 Q2 • Biotechnology & Applied Microbiology
Journal of Cardiovascular Development and Disease * 3.948 Q2 • Cardiac & Cardiovascular Systems
Plants 3.935 Q1 • Plant Sciences
Life 3.817 Q2 • Biology
Diagnostics 3.706 Q2 • Medicine, General & Internal
Current Oncology 3.677 Q3 • Oncology
Materials 3.623 Q1 • Metallurgy & Metallurgical Engineering
Q2 • Materials Science, Multidisciplinary
• Chemistry, Physical 
• Physics, Applied 
• Physics, Condensed Matter
Sensors 3.576 Q1 • Instruments & Instrumentation
Q2 • Chemistry, Analytical
• Engineering, Electrical & Electronic
Pathogens 3.492 Q2 • Microbiology
Agronomy 3.417 Q1 • Agronomy
• Plant Sciences
Chemosensors 3.398 Q2 • Instruments & Instrumentation
• Chemistry, Analytical
Q3 • Electrochemistry
Land 3.398 Q2 • Environmental Studies
Brain Sciences 3.394 Q3 • Neurosciences
International Journal of Environmental Research and Public Health 3.390 Q1 • Public, Environmental & Occupational Health (SSCI)
Q2 • Public, Environmental & Occupational Health (SCIE)
• Environmental Sciences (SCIE)
Tomography 3.358 Q2 • Radiology, Nuclear Medicine & Medical Imaging
Fractal and Fractional * 3.313 Q1 • Mathematics, Interdisciplinary Applications
Sustainability 3.251 Q2 • Environmental Sciences (SCIE)
• Environmental Studies (SSCI)
Q3 • Green & Sustainable Science & Technology (SCIE)
• Green & Sustainable Science & Technology (SSCI)
Water 3.103 Q2 • Water Resources
• Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 3.049 Q3 • Business
Energies 3.004 Q3 • Energy & Fuels
Agriculture 2.925 Q1 • Agronomy
ISPRS International Journal of Geo-Information 2.899 Q2 • Geography, Physical
• Computer Science, Information Systems
Q3 • Remote Sensing
Micromachines 2.891 Q2 • Instruments & Instrumentation
• Physics, Applied
Q3 • Chemistry, Analytical
• Nanoscience & Nanotechnology
Coatings 2.881 Q2 • Materials Science, Coatings & Films
• Physics, Applied
Q3 • Materials Science, Multidisciplinary
Children 2.863 Q2 • Pediatrics
Processes 2.847 Q3 • Engineering, Chemical
Separations 2.777 Q3 • Chemistry, Analytical
Insects 2.769 Q1 • Entomology
Animals 2.752 Q1 • Agriculture, Dairy & Animal Science
• Veterinary Sciences
Symmetry 2.713 Q2 • Multidisciplinary Sciences
Atmosphere 2.686 Q3 • Meteorology & Atmospheric Sciences
• Environmental Sciences
Applied Sciences 2.679 Q2 • Engineering, Multidisciplinary
• Physics, Applied
Q3 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary
Photonics 2.676 Q2 • Optics
Buildings * 2.648 Q2 • Construction & Building Technology
• Engineering, Civil
Healthcare 2.645 Q2 • Health Policy & Services (SSCI)
Q3 • Health Care Sciences & Services (SCIE)
Minerals 2.644 Q2 • Mining & Mineral Processing
• Mineralogy
• Geochemistry & Geophysics
Forests 2.634 Q1 • Forestry
Crystals 2.589 Q2 • Crystallography
Q3 • Materials Science, Multidisciplinary
Entropy 2.524 Q2 • Physics, Multidisciplinary
Diversity 2.465 Q2 • Biodiversity Conservation
Q3 • Ecology
Journal of Marine Science and Engineering 2.458 Q2 • Oceanography
• Engineering, Marine 
• Engineering, Ocean
Medicina 2.430 Q2 • Medicine, General & Internal
Machines * 2.428 Q2 • Engineering, Mechanical
Q3 • Engineering, Electrical & Electronic
Electronics 2.397 Q3 • Engineering, Electrical & Electronic
• Computer Science, Information Systems 
• Physics, Applied
Fishes * 2.385 Q2 • Fisheries
• Marine & Freshwater Biology
Metals 2.351 Q2 • Metallurgy & Metallurgical Engineering
Q3 • Materials Science, Multidisciplinary
Horticulturae * 2.331 Q1 • Horticulture
Veterinary Sciences * 2.304 Q1 • Veterinary Sciences
Universe 2.278 Q3 • Physics, Particles & Fields
• Astronomy & Astrophysics
Mathematics 2.258 Q1 • Mathematics
Magnetochemistry 2.193 Q3 • Chemistry, Inorganic & Nuclear
• Chemistry, Physical 
• Materials Science, Multidisciplinary
Current Issues in Molecular Biology 2.081 Q4 • Biochemistry & Molecular Biology
Actuators 1.994 Q3 • Instruments & Instrumentation
• Engineering, Mechanical
Aerospace * 1.659 Q2 • Engineering, Aerospace

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

28 April 2021
Book BuilderCompile a Customized E-Book from Your Favorite MDPI Open Access Content

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

 

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

 



Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"


In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.

Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.

MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.

10 March 2021
Journal Selector: Helping to Find the Right MDPI Journal for Your Article


At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.

As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.

We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.

The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.

We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.

The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.

Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)

25 December 2020
Biomedicines Reaches 1000 Article Milestone


Biomedicines
(ISSN 1999-4915; ODEN: BIOMID) is a peer-reviewed open access journal on biomedicines, published monthly online by MDPI. Biomedicines has passed another milestone by publishing its 1000th article since the journal inception in 2013. On behalf of the editorial team, we would like to express our gratitude to the Editor-in-Chief of Biomedicines, Prof. Dr. Shaker A. Mousa, all Section Editors-in-Chief and Editorial Board Members, as well as to the Guest Editors of Special Issues, Topics Board Members, and Reviewer Board Members who have ensured the continued success of the journal through their hard work and diligence.

Biomedicines is now covered in the Science Citation Index Expanded (Web of Science) with Impact Factor of 4.717 for 2020 and ranked 41/197 (Q1) in “General Biochemistry, Genetics and Molecular Biology” and 48/219 (Q1) in “Medicine”.

15 December 2020
MDPI adopts C4DISC principles to improve diversity and inclusion in scholarly communications

MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.

The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.

MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.

Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.

The Coalition is committed to:

  • eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
  • creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
  • promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
  • raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
  • supporting our members in achieving diversity and inclusion within their organizations.

14 December 2020
Article Layout and Templates Revised for Future Volumes

At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.

The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.

The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:

1) Information is displayed in the left information bar.


2) In the main text, there is a blank column on the left.


3) Small tables/figures are aligned on the left, large tables/figures are centered.

11 December 2020
2020 "Highly Cited Researchers" on MDPI Journal's Editorial Boards

We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.

Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.


Adams, Dave
Agarwal, Ravi P.
Ahn, Choon Ki
Ahn, Myung-Ju
Albrecht, Randy A.
Andersson, Dan I.
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Artaxo, Paulo
Balsamo, Gianpaolo
Barba, Francisco J.
Benediktsson, Jon Atli
Benelli, Giovanni
Bhatnagar, Amit
Bialystok, Ellen
Blaabjerg, Frede
Blay, Jean-Yves
Bogers, Marcel
Bolton, Declan J.
Boyer, Cyrille
Brocca, Luca
Bruix, Jordi
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cabrerizo-Lorite, Francisco Javier
Cai, Jianchao
Calhoun, Vince D.
Cantu, Robert C.
Cerqueira, Miguel
Chang, Jo-Shu
Chau, Kwok-wing
Chemat, Farid
Chen, Jianmin
Chen, Jun
Chen, Min
Chen, Shaowei
Chen, Wei
Chen, Wei-Hsin
Chen, Xiaofeng
Chen, Yangkang
Chen, Zhi-Gang
Chiclana, Francisco
Corella, Dolores
Cortes, Javier
Cortes, Jorge
Cummings, Kenneth Michael
Dai, Shifeng
Decker, Eric A.
DePinho, Ronald A.
Dimopoulos, Meletios-Athanasios
Dincer, Ibrahim
Du, Yihong
Dupont, Didier
Edwards, David
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estruch, Ramón
Fang, Chuanglin
Fasano, Alessio
Fernandez-Lafuente, Roberto
Ferreira, Isabel
Fortino, Giancarlo
Galluzzi, Lorenzo
Galvano, Fabio
Gandomi, Amir H.
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Wei
Garbe, Claus
García, Hermenegildo
Geschwind, Daniel H.
Giampieri, Francesca
Giralt, Sergio A.
Glanz, Karen
Goldewijk, Kees Klein
Gössling, Stefan
Govindan, Kannan
Granato, Daniel
Grosso, Giuseppe
Grosso, Giuseppe
Guerrero, Josep M.
Haase, Dagmar
Hagger, Martin S.
Hamblin, Michael R.
Han, Heesup
Jankovic, Joseph
Janotti, Anderson

Jiang, Hai-Long
Kalaji, Hazem M.
Kalantar-Zadeh, Kourosh
Kaner, Richard B.
Karimi, Hamid Reza
Kataoka, Kazunori
Keesstra, Saskia
Kepp, Oliver
Kerminen, Veli-Matti
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kim, Ki-Hyun
Klemeš, Jiří Jaromír
Klenk, Hans-Peter
Konopleva, Marina Y.
Krammer, Florian
Krebs, Frederik C.
Kroemer, Guido
Kudo, Masatoshi
Kurths, Juergen
Kurzrock, Razelle
Kuznetsov, Nikolay V.
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lancellotti, Patrizio
Lee, Sangmoon
Leung, Victor C. M.
Li, Jinghong
Li, Yurui
Lindahl, José M. Merigó
Lip, Gregory Y. H.
Loh, Xian Jun
Long, Hualou
Lund, Henrik
Luo, Jingshan
Luque, Rafael
Lyons, Timothy W.
Ma, Jun
Ma, Wen-Xiu
Ma, Yanming
Maeda, Keisuke
Makarova, Kira
Mantovani, Alberto
Martín-Belloso, Olga
Martinoia, Enrico
Marzband, Mousa
Masclaux-Daubresse, Celine
Masson, Patrick
Mateos, María Victoria
Mathiesen, Brian Vad
Matyjaszewski, Krzysztof
McArthur, Grant A.
McCauley, Darren
Medlock, Jolyon M.
Melero, Ignacio
Mezzetti, Bruno
Miroshnichenko, Andrey E.
Moran, Daniel
Mueller, Lukas A.
Mueller-Roeber, Bernd
Naushad, Mu
Nemeroff, Charles B.
Nieto, Juan J.
O'Donnell, Colm
Ogino, Shuji
Olabi, Abdul-Ghani
O'Regan, Donal
Orsini, Nicola
Oswald, Isabelle P.
Ozcan, Aydogan
Pahl-Wostl, Claudia
Pang, Huan
Payne, James E.
Peng, Shushi
Perc, Matjaz
Perez-Alvarez, Jose Angel
Piquero, Alex R.
Ploss, Alexander
Postolache, Mihai
Pradhan, Biswajeet
Prinsep, Michele R.
Qian, Dong
Qu, Xiaogang
Reiter, Russel J.
Riahi, Keywan
Richter, Andreas
Rignot, Eric
Robert, Caroline
Ros, Emilio
Rosell, Rafael

Rosen, Marc A.
Rossolini, Gian Maria
Saad, Fred
Saad, Walid
Sadorsky, Perry
Sakthivel, Rathinasamy
Schwab, Matthias
Scolyer, Richard A.
Serra-Majem, Lluis
Sethi, Gautam
Seto, Karen C.
Settele, Josef
Seymour, John F.
Shi, Peng
Siano, Pierluigi
Sillanpää, Mika
Simal-Gandara, Jesus
Smagghe, Guy
Srivastava, Hari M.
Stadler, Peter F.
Sun, Fengchun
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Tan, Weihong
Teixeira, José António
Thakur, Vijay Kumar
Tong, Shilu
Tornabene, Francesco
Tsao, Rong
Tukker, Arnold
Turskis, Zenonas
Uversky, Vladimir N.
van Wesemael, Bas
Van Zwieten, Lukas
Vangronsveld, Jaco
Varma, Rajender S.
Varshney, Rajeev K.
Vasquez, Juan C.
Velicogna, Isabella
Vieta, Eduard
Wade, Timothy J.
Wagner, Wolfgang
Wamba, Samuel Fosso
Wang, Chunsheng
Wang, Guoxiu
Wang, Joseph
Wang, Qi
Wang, Tao
Wang, Yuan
Wiens, John J.
Wu, Hao Bin
Wu, Hui
Wu, Tom
Wu, Zhongbiao
Xia, Xinhui
Xiao, Wenjiao
Xin, Sen
Xiong, Rui
Xu, Bin
Xu, Zeshui
Yan, Huaicheng
Yang, Bing
Yang, Hongxing
Yang, Jie
Yang, Xiao-Jun
Yin, Shen
Ying, Guang-Guo
Young, Allan H.
Yu, Guihua
Zarco-Tejada, Pablo J.
Zavadskas, EdmundasKazimieras
Zeadally, Sherali
Zhang, Fan
Zhang, Liangpei
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Yue-Jun
Zhao, Guochun
Zhao, Li-Dong
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan

The full list of 2020 Highly Cited Researchers  can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/

--- Highly Cited Researchers (HCR) is a Clarivate product.

10 July 2020
Meet Us at the Society for Neurosciences’ 50th Annual Meeting (Neuroscience 2020), Washington, USA, 24–28 October 2020


MDPI will be attending the conference Neuroscience 2020, which will be hosted in Washington, USA, 24–28 October 2020.

SfN’s 50th annual meeting is the premier venue for the presentation of emerging science in the field of neurosciences, where one can learn from experts, forge collaborations with peers, explore new tools and technologies, and advance their career.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to stop by our booth (Booth #208). Our delegates look forward to meeting you in person, to answer any questions you may have. For more information about the conference, please visit:

https://www.sfn.org/meetings/neuroscience-2020

9 July 2020
Open Access Agreement Between Jisc Collections and MDPI

We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.

All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.

Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.

Jisc logo

About Jisc

Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection.  Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.

For more information, contact helen.dobson@jisc.ac.uk.

About MDPI

MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).

For any questions about this agreement, please contact the MDPI IOAP team at ioap@mdpi.com.

29 June 2020
Updated Impact Factors Released in the Journal Citation Reports (Clarivate)

The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.

  • Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
  • 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
  • Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).

First Impact Factors

Journal Impact Factor Rank Category Details
Actuators 1.957 31/64 (Q2) • Instruments & Instrumentation Link
Agriculture 2.072 25/91 (Q2) • Agronomy Link
Biology 3.796 19/93 (Q1) • Biology Link
Biomedicines  4.717 30/138 (Q1)
36/270 (Q1)
• Medicine, Research & Experimental
• Pharmacology & Pharmacy
Link
Biosensors 3.240 24/86 (Q2) • Chemistry, Analytical Link
Chemosensors 3.108 16/64 (Q1)
27/86 (Q2)
13/27 (Q2)
• Instruments & Instrumentation
• Chemistry, Analytical
• Electrochemistry
Link
Children 2.078 50/128 (Q2) • Pediatrics Link
Healthcare 1.916 62/102 (Q3)
45/87 (Q3)
• Health Care Sciences & Services (SCIE)
• Health Policy & Services (SSCI)
Link
Journal of Fungi 4.621 5/29 (Q1)
31/135 (Q1)
• Mycology
• Microbiology
Link
Journal of Personalized Medicine 4.433 24/165 (Q1)
10/102 (Q1)
• Medicine, General & Internal
• Health Care Sciences & Services
Link
Land 2.429 58/123 (Q2) • Environmental Studies (SSCI) Link
Life 2.991 26/93 (Q2)
109/267 (Q2)
• Biology
• Microbiology
Link
Magnetochemistry 1.947 22/45 (Q2)
109/159 (Q3)
201/314 (Q3)
• Chemistry, Inorganic & Nuclear
• Chemistry, Physical
• Materials Science, Multidisciplinary
Link
Membranes 3.094 53/143 (Q2)
129/314 (Q2)
23/89 (Q2)
• Engineering, Chemical
• Materials Science, Multidisciplinary
• Polymer Science
Link
Pharmaceuticals 4.286 49/270 (Q1) • Pharmacology & Pharmacy Link
Photonics 2.140 48/97 (Q2) • Optics Link
Separations 1.900 53/86 (Q3) • Chemistry, Analytical Link
Toxics 3.271 32/92 (Q2)
92/265 (Q2)
• Toxicology
• Environmental Sciences
Link

Updated Impact Factors

Journal Impact Factor Rank Category Details
Agronomy 2.603 18/91 (Q1)
65/234 (Q2)
• Agronomy
• Plant Sciences
Link
Animals 2.323 10/63 (Q1)
14/142 (Q1)
• Agriculture, Dairy & Animal Science
• Veterinary Sciences
Link
Antibiotics 3.893 23/93 (Q1)
64/270 (Q1)
• Infectious Diseases
• Pharmacology & Pharmacy
Link
Antioxidants 5.014 10/139 (Q1)
56/297 (Q1)
7/61 (Q1)
• Food Science & Technology
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Link
Applied Sciences 2.474 161/314 (Q3)
32/91 (Q2)
88/177 (Q2)
62/154 (Q2)
• Materials Science, Multidisciplinary
• Engineering, Multidisciplinary
• Chemistry, Multidisciplinary
• Physics, Applied
Link
Atmosphere 2.397 48/93 (Q3) • Meteorology & Atmospheric Sciences Link
Biomolecules 4.082 98/297 (Q2) • Biochemistry & Molecular Biology Link
Brain Sciences 3.332 113/271 (Q2) • Neurosciences Link
Cancers 6.126 37/244 (Q1) • Oncology Link
Catalysts 3.520 65/159 (Q2) • Chemistry, Physical Link
Cells 4.366 70/195 (Q2) • Cell Biology Link
Coatings 2.436 10/21 (Q2) • Materials Science, Coatings & Films Link
Crystals 2.404 10/26 (Q2)
165/314 (Q3)
• Crystallography
• Materials Science, Multidisciplinary
Link
Diagnostics 3.110 39/165 (Q1) • Medicine, General & Internal Link
Diversity 1.402 119/168 (Q3) • Ecology Link
Electronics 2.412 125/266 (Q2) • Engineering, Electrical & Electronic Link
Energies 2.702 63/112 (Q3) • Energy & Fuels Link
Entropy 2.494 33/85 (Q2) • Physics, Multidisciplinary Link
Foods 4.092 27/139 (Q1) • Food Science & Technology Link
Forests 2.221 17/68 (Q1) • Forestry Link
Genes 3.759 53/177 (Q2) • Genetics & Heredity Link
Insects 2.220 18/101 (Q1) • Entomology Link
International Journal of Environmental Research and Public Health (IJERPH) 2.849 58/193 (Q2)

32/170 (Q1)

105/265 (Q2)
• Public, Environmental & Occupational Health (SCIE)
• Public, Environmental & Occupational Health (SSCI)
• Environmental Sciences (SCIE)
Link
International Journal of Molecular Sciences (IJMS) 4.556 74/297 (Q1)
48/177 (Q2)
• Biochemistry & Molecular Biology
• Chemistry, Multidisciplinary
Link
ISPRS International Journal of Geo-Information (IJGI) 2.239 31/50 (Q3)
18/30 (Q3)
• Geography, Physical
• Remote Sensing
Link
Journal of Clinical Medicine 3.303 36/165 (Q1) • Medicine, General & Internal Link
Journal of Marine Science and Engineering 2.033 31/66 (Q2) • Oceanography Link
Marine Drugs 4.073 16/61 (Q2) • Chemistry, Medicinal Link
Materials 3.057 132/314 (Q2) • Materials Science, Multidisciplinary Link
Mathematics 1.747 28/324 (Q1) • Mathematics Link
Medicina 1.205 107/165 (Q3) • Medicine, General & Internal Link
Metabolites 4.097 95/297 (Q2) • Biochemistry & Molecular Biology Link
Metals 2.117 18/79 (Q1)
185/314 (Q3)
• Metallurgy & Metallurgical Engineering
• Materials Science, Multidisciplinary
Link
Micromachines 2.523 56/92 (Q3)
23/64 (Q2)
• Nanoscience & Nanotechnology
• Instruments & Instrumentation
Link
Microorganisms 4.152 37/135 (Q2) • Microbiology Link
Minerals 2.380 6/21 (Q2)
11/30 (Q2)
• Mining & Mineral Processing
• Mineralogy
Link
Molecules 3.267 70/177 (Q2)
141/297 (Q2)
• Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Link
Nanomaterials 4.324 89/314 (Q2)
42/103 (Q2)
• Materials Science, Multidisciplinary
• Nanoscience & Nanotechnology
Link
Nutrients 4.546 17/89 (Q1) • Nutrition & Dietetics Link
Pathogens 3.018 65/135 (Q2) • Microbiology Link
Pharmaceutics 4.421 44/270 (Q1) • Pharmacology & Pharmacy Link
Plants 2.762 58/234 (Q1) • Plant Sciences Link
Polymers 3.426 16/89 (Q1) • Polymer Science Link
Processes 2.753 59/143 (Q2) • Engineering, Chemical Link
Remote Sensing 4.509 9/30 (Q2) • Remote Sensing Link
Sensors 3.275 22/86 (Q2)
77/266 (Q2)
15/64 (Q1)
• Chemistry, Analytical
• Engineering, Electrical & Electronic
• Instruments & Instrumentation
Link
Sustainability 2.576 120/265 (Q2)
26/41 (Q3)

53/123 (Q2)
6/8 (Q3)
• Environmental Sciences (SCIE)
• Green & Sustainable Science & Technology (SCIE)
• Environmental Studies (SSCI)
• Green & Sustainable Science & Technology (SSCI)
Link
Symmetry 2.645 29/71 (Q2) • Multidisciplinary Sciences Link
Toxins 3.531 21/92 (Q1)
34/139 (Q1)
• Toxicology
• Food Science & Technology
Link
Universe 1.752 18/29 (Q3)
42/68 (Q3)
• Physics, Particles & Fields
• Astronomy & Astrophysics
Link
Vaccines 4.086 57/158 (Q2)
50/138 (Q2)
• Immunology
• Medicine, Research & Experimental
Link
Viruses 3.816 12/37 (Q2) • Virology Link
Water 2.544 31/94 (Q2) • Water Resources Link

Source: Clarivate 2020, InCites Journal Citation Reports®.

29 June 2020
Biomedicines Receives First Journal Impact Factor of 4.717

The editors are pleased to inform that Biomedicines has received a first Impact Factor of 4.717, as published in the 2019 Edition of the Journal Citation Reports® (Clarivate), released just now. Biomedicines ranks 30th out of 138 (Q1) titles in the 'Medicine, Research & Experimental' category, as well as 36th out of 270 (Q1) titles in 'Pharmacology & Pharmacy'.

Thank you to the authors, editorial board members and reviewers for their contribution in achieving this milestone for Biomedicines.

19 June 2020
Recruiting Editors for Biomedicines


Biomedicines
is currently recruiting Editorial Board Members.

Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. The website can be accessed at https://www.mdpi.com/journal/biomedicines.

As an Editorial Board Member, you would be responsible for the following:

  • Making decisions on whether a manuscript can be accepted or not based on the reports we collect;
  • Suggesting special topics or editing a Special Issue on a topic related to your research;
  • Promoting the journal and increasing its visibility at relevant academic conferences;
  • Advising on the journal’s development.

If you are interested in this position or know of potential candidates to recommend, please contact the Biomedicines Editorial Office (biomedicines@mdpi.com). We look forward to hearing from you soon.

13 May 2020
COVID-19 Academic Resources Center


Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.

The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.

COVID-19 Academic Resources Center contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.

For more information, please visit: https://www.mdpi.com/covid-19

9 April 2020
Free Open Platforms to Support Academics During the COVID-19 Pandemic

As a leading Open Access publisher, MDPI is committed to fostering open scientific exchange in all forms across all disciplines. Due to the outbreak of COVID-19, many researchers have to stay at home and many academic conferences have been cancelled or postponed. In light of these changes, MDPI has adopted numerous initiatives that may help accelerate scientific exchange and provide support to the academics during this period.

Scholarly Community—Encyclopedia

Encyclopedia is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

Comprehensive and Free Literature DatabaseScilit

Scilit is a comprehensive, free database for scientists that uses a new method to collate data and index scientific material. Our crawlers extract the latest data from CrossRef and PubMed on a daily basis. This means that newly published articles are immediately added to Scilit.

Display Academic AchievementsSciProfiles

SciProfiles is an innovative social network for researchers and scholars that is developed by MDPI. In line with our broad mission, the purpose of SciProfiles is to accelerate discovery and innovation by facilitating immediate access to research results and providing opportunities for academic networking.

Organize and Participate in Conferences OnlineSciforum

Sciforum is an event planning platform that supports open science by offering the opportunity to host and participate in academic conferences. It provides an environment for scholarly exchange, discussion of topics of current interest, building of networks, and establishing collaborations.

Post Early Versions of Research OutputsPreprints

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors at any time. Content on Preprints is not peer-reviewed, and feedback can be received from readers.

***

MDPI remains committed to open science and open data and has signed a statement, along with more than thirty scholarly publishers, showing our intention to facilitate sharing of new research findings as early on as possible. The initiative sees publishers collectively removing barriers to new research, in the face of a global healthcare crisis.

25 March 2020
MDPI Comment on the COVID-19 Virus

The world is currently suffering from a global pandemic of the corona virus COVID-19. MDPI expresses its sympathies for all of those affected by the virus and stands in solidarity with medical staff and researchers treating patients and searching for scientific solutions.

MDPI has previously published papers covering corona viruses in addition to new papers on the current outbreak, see all papers here. In particular, Viruses has published a number of Special Issues and papers on the topic (see here, here, and here) as well as a forthcoming Special Issue.

Alongside journal articles, MDPI has been a strong supporter of preprints, which are increasingly being used to rapidly disseminate the latest research, and we run the preprint server Preprints.org. Our database of research articles, Scilit, is free to use and covers all publishers including preprint servers. New papers are often in search results within hours of publication and users can set up alerts for new papers.

Our main priority during this period has been the health and safety of staff, and we continue to allow staff to work at home and closely monitor the situation in all locations in which we work. Despite the restrictions, we continue to provide a full publication service and, by close collaboration with our editorial boards and making use our in-house teams, ensure that there are no unnecessary delays in publishing vital research. Fast and open publication has always been at the core of MDPI values and is now more important than ever.

We hope that a solution to the current situation will emerge soon. In the meantime, we will do our best to continue communicating vital research in all fields.

20 March 2020
MDPI Backs Open Pharma Statement on Open Access

MDPI has endorsed Open Pharma’s Position Statement in support of open access publishing with the aim of advancing medical science and ultimately, improving patient care. Open pharma is a group of research funders, healthcare professionals, publishers, academics, and other healthcare stakeholders.

Since its inception in 1996, MDPI’s efforts have aligned with Open Pharma’s vision of more effective and transparent publishing, collaborating internationally with experts to deliver peer-reviewed online research journals to the scientific community and the general public. MDPI publishes 56 journals in the field of Medicine and Pharmacology and is planning to hold the World Pharma Forum in Basel in 2021.

Published under a Creative Commons License, MDPI’s articles can be freely shared and their content re-used, upon proper attribution. In support of the statement, MDPI will continue to uphold its open access policy and provide fast editorial services to ensure that new medical evidence can be read by everyone, without paywall restrictions.

18 March 2020
MDPI Co-Signed Position Statement on Transformative Agreements

The advantages of the open access model of scientific publishing are being increasingly recognized in the scientific community. It allows new scientific evidence to be accessed from the moment of publication for free by anyone around the globe, boosting the impact of new research. In response, many funders, libraries and universities have been adopting new principles to accelerate the transition to open access.

Recently, “transformative agreements” have been negotiated between traditional publishers and various institutions. While increasing the number of open access papers, these agreements lack binding commitments to a full transition to open access, their conditions vary across different regions, and access is still limited for many users.

MDPI is a co-signatory of the recent position statement raising concerns about potential downsides of transformative agreements and how they may delay a full transition to open access. The statement highlights that these models “risk perpetuating current limitations on access, transparency and market competitiveness, while simultaneously facilitating excessive charges on the public purse”.

As a pioneering open access journal publisher, MDPI is the first to promote the importance of science being made available to everyone. Our peer-reviewed journals, covering diverse academic disciplines, are fully accessible to the public free of charge under a Creative Commons Attribution License (CC BY). This is why, along with other open access publishers, MDPI is a proud signatory of the position paper and is committed to contributing to the replacement of weak transitional agreements with “agreements with publishers that are already fully committed to open science and who offer full, immediate and transparent Open Access”.

Read the position paper here

16 March 2020
Encyclopedia Outstanding Contributor Awards 2020 - Open for Application

We are pleased to announce that Encyclopedia will be awarding five Outstanding Contributor Awards for researchers in 2020. The nominations and applications will be assessed by an Evaluation Committee consisting of senior scholars from the Encyclopedia Editorial Board.

Prize for Winners

  1. An official certificate;
  2. A cash award of 500 CHF or an MDPI discount voucher of 800 CHF.


Application Deadline

31 December, 2020 (Please send your application email with a list of all entries you contributed to our office before the deadline: office@encyclopedia.pub)

Candidate Requirements

  1. Have a Ph.D. degree;
  2. Have more than three qualified entries published in Encyclopedia in 2020.

Evaluation Standards

  1. Number of entries published in Encyclopedia in 2020;
  2. Quality of entries online (including length, figure quality, and novelty);
  3. Impact of entries (including the number of likes, discussion contents, views, and downloads).

If you are a researcher and have not yet contribute entries to Encyclopedia, please do not miss this chance to highlight your research results.

20 December 2019
Professor Jackie Wilce Receiving 2019 Biomedicines Investigator Lectureship

In collaboration with Pacifichem 2020, we are delighted to announce Associate Professor Jackie Wilce, from Monash University, Melbourne, Australia, as the recipient of the Biomedicines Investigator Lectureship 2019. She will give a speech at the symposium “Advancing Frontiers in Peptide and Protein Science with Nano-to-Macro Molecular Solutions, New Technologies in Polyamide Synthesis and Applications” to be held in Hawaii in December.

Jackie Wilce’s research focuses on the biophysical analysis of macromolecular interactions that underlie important cellular processes in health and disease. These include protein–oligonucleotide interactions underlying translational control and innate immunity as well as interactions of signalling molecules in cancer. The characterisation of these interactions facilitate the design, synthesis, and testing of inhibitor molecules that have therapeutic potential. The techniques she employs include structural methods, binding studies, cellular assays, and chemical design and synthesis. Her research group at Monash University currently includes two postdoctoral researchers and four postgraduate students, and her research is conducted in collaboration with international, national, and institutional collaborators.

16 December 2019
Meet Us at SFFRI in Taoyuan, Taiwan, 17–20 March 2020


MDPI will be attending the 20th Biennial Meeting for the Society for Free Radical Research International (SFRRI 2020), Taoyuan, Taiwan, 17-20 March 2020.

The Society for Free Radical Research, founded in the United Kingdom in 1982, is an International Society and operates as a charitable voluntary, non-profit institution. The aims and objectives of the International Society are to advance education in free radical processes with particular reference to their industrial and medical importance, informing education for the benefit of the public. The Society promotes interest in all aspects of research into the reactions and properties of free radicals and into their physical, chemical, biological, medical, and industrial roles. Founded in 1982, and now with over 2500 members worldwide, the Society consists of five autonomous regional groups: SFRR Asia, SFRR Europe, SFRR Australasia, Society for Free Radical Biology and Medicine (SFRR Americas), and SFRR Africa. A number of regional groups have also been established within these areas.

The following MDPI journals will be represented:


If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the website: http://www.sfrri2020.org/.

15 November 2019
Biomedicines, Chemosensors and Pharmaceuticals Accepted for Inclusion in the Science Citation Index Expanded (SCIE) in Web of Science

 

We are pleased to inform the journals Biomedicines (ISSN 2227-9059), Chemosensors (ISSN 2227-9040) and Pharmaceuticals (ISSN 1424-8247) have been accepted for inclusion in the Science Citation Index Expanded (SCIE) in the Web of Science Core Collection, as well as in Current Contents. These journals are due to receive first Journal Impact Factors in the June 2020 release of the Journal Citation Reports.

biomedicines-logo
chemosensors-logo
pharmaceuticals-logo

The Science Citation Index Expanded (SCIE), Web of ScienceTM and Current Contents are Clarivate Analytics products.

11 October 2019
Introducing SciProfiles, an Academic Social Network

MDPI is pleased to announce the release of SciProfiles, its social network platform for researchers and scholars.

The purpose of SciProfiles is aligned with MDPI’s broad mission to accelerate discovery and innovation by facilitating immediate access to research results and to serve scholars and communities by providing opportunities for academic networking.

SciProfiles also ambitions to serve as a sustainable, transparent and community-driven research evaluation system aligned with the DORA principles (https://sfdora.org/). Through their scientific profiles, academics can highlight their contribution to research communities, and measure their impact on their field, beyond publication numbers and impact factors. SciProfiles is currently a beta version and will enrich to give researchers the possibility to highlight all of their contributions to science and their scientific communities as authors, reviewers, editors, conference organizers, conference panelists, conference keynote speakers, or even as lecturers or student mentors at their University.

The classic components of popular community social networks, including follower/following, classical metrics, endorsements and recommendations (https://www.mdpi.com/about/announcements/1690), comments (https://www.mdpi.com/about/announcements/1397) are or will be very soon highlighted in SciProfiles as open science contributions.

To help increase the impact and visibility of articles and their authors to an appropriate audience, the platform offers a NewsFeed that includes recommendations of relevant content based on interests, publication history, saved searches or colleagues’ recommendations.

SciProfiles’ avatars are now being integrated on several MDPI platforms, meaning that you will directly access researchers’ profiles from any of the MDPI platforms:

MDPI's journal publishing website: www.mdpi.com
MDPI's conference hosting and management website: www.sciforum.net
MDPI's pre-print website : www.preprints.org
MDPI's knowledge sharing website : www.encyclopedia.pub
MDPI's books store: www.mdpi.com/books
MDPI's literature database : www.scilit.net

SciProfiles aims to serve scientific communities at large. It can be embedded into third-party websites and also welcomes integration of data from third-parties.

Dr. Shu-Kun Lin: https://sciprofiles.com/profile/2
Dr. Franck Vazquez: https://sciprofiles.com/profile/FranckVazquez
Dr. Martyn Rittman: https://sciprofiles.com/profile/martynrittman

2 October 2019
Winners of the 2019 MDPI Writing Prize

We are delighted to announce the winners of the 2019 MDPI Writing Prize. Entrants were asked to write on the theme "Judging research: How should research and researchers be evaluated and rewarded?" We received a large number of excellent essays from PhD students and postdocs, and the process of shortlisting and choosing winners was not an easy one. The winners demonstrated excellent writing skills alongside interesting and thought-provoking ideas.

As last year, we will begin the process of collating all entries into a book that will be available in open access format. Alongside promoting good writing skills, we see the prize as a way to promote the voices of early career researchers within broader debates and policy discussions.

Congratulations to all of the participants and especially the winners. The winners are:

1st Prize (500 CHF):
Albin Nilsson (National Centre for Nuclear Research, Warsaw, Poland)
[Read here]

2nd Prize (250 CHF):
Qi Zhang (Shandong University, Jinan, China)
[Read here]
Igor Ogashawara (Indiana University, Indianapolis, US)
[Read here]

3rd Prize (100 CHF):
Margaret Sivapragasam (Universiti Teknologi Petronas, Perak, Malaysia)
[Read here]
Arvind Sharma (The University of Queensland, Gatton, Australia)
[Read here]
Jose Flores-Guerrero (University Medical Center Groningen, Groningen, The Netherlands)
[Read here]

The MDPI Writing Prize is an annual award supported by MDPI Author Services, which provides services including language editing, reformatting, plagiarism checks, and image editing.

20 September 2019
MDPI Now Gives Scholars the Possibility to Endorse and Recommend Articles

MDPI is pleased to announce the release of a new functionality giving the possibility for researchers and scholars to endorse, and formally recommend articles to their colleagues.

MDPI was an early signatory of the San Francisco Declaration on Research Assessment (https://sfdora.org/read/) which calls for improvement in how quality and impact of scholarly research outputs are evaluated, especially in moving beyond journal-based citation metrics (journal Impact Factor, Scopus Citescore, etc.).

MDPI supports the establishment of article-level impact metrics, including citations, views, downloads, and Altmetric scores. These measures serve as an impact indicator for research articles on a case–by-case basis, assessing paper on its own merit. However, these metrics are also subjective and can give a biased picture of the article impact: they do not directly reflect the quality or the intrinsic scientific value of the article.

In our view, community engagement with publications based on community-driven metrics can help to overcome this limitation. We have therefore launched an option for scholars to endorse articles, indicating their own assessment of its content and making a recommendation to their community. This follows our implementation of the open source Hypothesis commenting tool, which has been available for all articles published by MDPI for over a year (https://www.mdpi.com/about/announcements/1397). Both endorsement and commenting are available for all previously published and forthcoming MDPI articles.

In addition to potentially serving as a sustainable solution to article assessment, endorsements will help scientific communities to identify the most relevant articles, independently of the journal in which it was published.

The code for the endorsing functionality, which relies on DOIs and ORCIDs, will be made available on GitHub with an open source license.

Dr. Shu-Kun Lin, President and Founder
Dr. Franck Vazquez, Chief Scientific Officer
Dr. Martyn Rittman, Publishing Director

11 September 2019

Create an Entry in Encyclopedia to Get a 100 CHF Voucher in Publishing in MDPI Journals

Encyclopedia is pleased to announce that certain well-prepared entries are eligible for a 100 CHF voucher, which can be used for paper publication in any journals in MDPI. We believe that your contribution would be a great help in keeping up with scientific developments. Do not miss the chance to publish with us. Please clink here to find the detailed guideline.

Encyclopedia is a free online reference created and curated by active scholars. It aims to highlight the latest research results as well as provide a comprehensive record of scientific development. If you have any suggestions or questions, please feel free to contact us via office@encyclopedia.pub.

6 August 2019
Preprints Reaches 10,000 Posted Articles Milestone

We are pleased to announce that Preprints has passed the milestone of 10,000 posted preprints. We are delighted to have reached this after just over three years of operation. Our congratulations and thanks go to our authors and advisory board who have supported growth of the platform and been crucial to its operation.

You can find further details at https://www.preprints.org/announcement/show/37.

2 August 2019
DeepGreen Partnering with Publishers and Universities in Distributing Open Access Content to Institutional Repositories

Last week, the DeepGreen initiative in Germany started into an advanced test phase with the publishing partners S. Karger AG, SAGE Publishing, MDPI, Frontiers and De Gruyter, as well as 27 universities from all over Germany, from Hamburg University of Applied Sciences to University of Konstanz.

DeepGreen aims at lowering the barriers for open access publishing by automatically delivering metadata and full text publications from participating publishers to authorized repositories at German universities.

In preparation for a later live operation, the advanced test phase serves to gain experience with extensive data deliveries from publishers and also handling different repository software (including OPUS4, DSpace, EPrints, MyCoRe). DeepGreen thereby acts as a sophisticated platform, receiving articles published by authors affiliated with German universities and depositing these articles to respective university repositories, based on the affiliation metadata. For more information about DeepGreen: https://deepgreen.kobv.de

Karger AG has been a close cooperation partner of the DeepGreen consortium since 2016. S. Karger has more than 80 subscription-based and around 20 open access journals covering a wide spectrum in health science. DeepGreen will assign S. Karger articles to authorized institutions on the legal basis of German alliance and national licenses.

SAGE Publishing  was founded by Sara Miller McCune in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 600 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. SAGE Publishing has been a close cooperation partner of DeepGreen since 2016.

MDPI  is a scientific open access publisher and has been a partner of DeepGreen since 2017. MDPI comprises 205 peer-reviewed journals of various disciplines. All articles are published under a CC-BY license and are freely available without embargo period.

Frontiers  is a scientific open access publisher with 61 journals of over 600 academic disciplines. All articles are peer-reviewed and published freely available under CC-BY license.

De Gruyter  is an academic publisher with more than 700 subscription-based and open access journals of 29 disciplines. Articles provided by De Gruyter will be assigned to institutions with German alliance and national licenses.

There is promising communication with other publishers.

DeepGreen is funded by the German Research Foundation (DFG) and the consortium comprises six institutions: the Cooperative Library Network Berlin-Brandenburg, Bavarian State Library, Bavarian Library Network, University Library of the Technische Universität Berlin, University Library of Erlangen-Nuremberg and the Helmholtz Open Science Coordination Office at the GFZ German Research Centre for Geosciences.

If you would like to know in more detail which institutions take part in the advanced test phase of DeepGreen, you can find more information here.

17 July 2019
First Basel Sustainable Publishing Forum

The University of Basel and the MDPI Sustainability Foundation are organizing the First Basel Sustainable Publishing Forum on 9th September 2019.

The aim of this event is to provide background and perspectives on Plan S to Learned Societies, which have to make well-informed decisions to transition their journals to Open Access (OA).

The BSPF will bring together several representatives of Learned societies, Plan S architects as well as representatives from various publishers and publishing platforms. After getting the big picture from cOAlition S, panel discussions will allow to better understand the diverse challenges that Learned societies are facing to transition their journals to OA as well as to identify sustainable, implementable and scalable solutions for successful Open Access transition.

For program details and registration, please follow the link below:
https://sciforum.net/conference/SustainableSolutionsToOpenAccess

19 June 2019
Meet Us at Neuroscience 2019 in Chicago, IL, USA, 19–23 October 2019


MDPI will be attending Neuroscience 2019, to be held at McCormick Place in Chicago, IL, USA, 19–23 October 2019.

Join 30,000 colleagues from more than 70 countries at the world’s largest marketplace of ideas and tools for global neuroscience.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth #405). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.sfn.org/Meetings/Neuroscience-2019.

6 June 2019
Meet Us at European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019

MDPI will be attending the European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019.

The ESC Congress is the world’s largest conference in cardiovascular medicine. ESC Congress 2019 will take place in one of the world’s most alluring cities, Paris, and will be organised in conjunction with the World Heart Federation emphasizing the global reach of the event.

ESC Congress 2019 will build on the solid foundations of a congress that attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth C590). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: http://www.escexhibition.org/ESC2019/default.aspx.

31 May 2019
First-Timers: MDPI Journals Receiving a First CiteScore™ in Scopus

In addition to MDPI journals who received updated CiteScores for 2018, the titles listed below were added in Scopus recently and therefore received a first CiteScore in May 2019, based on last year's citation activity in the database.

For almost all of the newly added MDPI titles, their CiteScore ranks in the upper 50% of the distribution (Q1 or Q2) in at least one of the research areas. The following titles rank in the top 25% cited journals based on CiteScore: Actuators; Biomedicines; Coatings; Cosmetics; Fermentation; Journal of Fungi; Journal of Open Innovation: Technology, Market, and Complexity; Nanomaterials; and Publications.

To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.

New CiteScore for MDPI Journals

Journal Rank (Quartile)
Category Link CiteScore 2018 SNIP 2018
Actuators 9/92 (Q1)
60/232 (Q2)
• Control and Optimization
• Control and Systems Engineering
Link 2.80 1.542
Atmosphere 26/71 (Q2) • Environmental Science (miscellaneous) Link 2.27 0.855
Atoms 36/69 (Q3)
105/173 (Q3)

239/397 (Q3)
• Nuclear and High Energy Physics
• Atomic and Molecular Physics, and Optics
• Condensed Matter Physics
Link 1.20 0.707
Axioms 25/91 (Q2)
26/78 (Q2)
11/27 (Q2)
55/135 (Q2)
35/58 (Q3)
• Algebra and Number Theory
• Geometry and Topology
• Logic
• Analysis
• Mathematical Physics
Link 0.99 0.670
Bioengineering 42/139 (Q2) • Bioengineering Link 3.14 -
Biomedicines 40/189 (Q1)

47/206 (Q1)
• General Biochemistry, Genetics and Molecular Biology
• Medicine (miscellaneous)
Link 3.33 0.908
Chemosensors 34/110 (Q2)
50/160 (Q2)
• Analytical Chemistry
• Physical and Theoretical Chemistry
Link 2.77 0.770
Climate 53/109 (Q2) • Atmospheric Science Link 1.95 0.864
Coatings 27/116 (Q1)
63/271 (Q1)
15/53 (Q2)
• Surfaces, Coatings and Films
• Materials Chemistry
• Surfaces and Interfaces
Link 2.42 1.186
Computation 74/204 (Q2)
171/460 (Q2)
58/118 (Q2)
127/259 (Q3)
• General Computer Science
• Applied Mathematics
• Theoretical Computer Science
• Modeling and Simulation
Link 1.40 0.552
Computers 128/274 (Q2)

52/89 (Q3)
• Computer Networks and Communications
• Human-Computer Interaction
Link 1.59 -
Cosmetics 92/390 (Q1)
38/128 (Q2)
67/164 (Q2)
11/23 (Q2)

23/30 (Q4)
• Surgery
• Dermatology
• Pharmaceutical Science
• Chemical Engineering (miscellaneous)
• Aging
Link 1.81 1.689
Econometrics 339/595 (Q3) • Economics and Econometrics Link 0.82 -
Fermentation 91/404 (Q1)
76/273 (Q2)
10/24 (Q2)
• Plant Science
• Food Science
• Biochemistry, Genetics and Molecular Biology (miscellaneous)
Link 2.24 -
Fibers 86/288 (Q2)
34/103 (Q2)
118/352 (Q2)
49/83 (Q3)
• Civil and Structural Engineering
• Ceramics and Composites
• Mechanics of Materials
• Biomaterials
Link 2.01 0.889
Galaxies 46/76 (Q3) • Astronomy and Astrophysics Link 1.08 0.308
High-Throughput 181/257 (Q3)
153/205 (Q4)
108/139 (Q4)
340/407 (Q4)
• Biotechnology
• Biomedical Engineering
• Bioengineering
• Biochemistry
Link 0.88 0.295
Inorganics 35/69 (Q3) • Inorganic Chemistry Link 1.90 0.474
International Journal of Neonatal Screening 138/277 (Q3)

3/5 (Q3)

95/166 (Q3)
• Pediatrics, Perinatology and Child Health
• Immunology and Microbiology (miscellaneous)
• Obstetrics and Gynecology
Link 1.07 0.240
Journal of Developmental Biology 39/76 (Q3)
224/375 (Q3)
164/265 (Q3)
• Developmental Biology
• Molecular Biology
• Cell Biology
Link 2.36 0.813
Journal of Functional Biomaterials 11/83 (Q1)
26/205 (Q1)
• Biomaterials
• Biomedical Engineering
Link 5.10 2.234
Journal of Fungi 90/591 (Q1)

62/404 (Q1)
• Ecology, Evolution, Behavior and Systematics
• Plant Science
Link 2.84 0.982
Journal of Imaging 291/661 (Q2)

136/272 (Q3)

36/70 (Q3)

40/75 (Q3)
• Electrical and Electronic Engineering
• Radiology, Nuclear Medicine and Imaging
• Computer Graphics and Computer-Aided Design
• Computer Vision and Pattern Recognition
Link 1.47 -
Journal of Marine Science and Engineering 30/92 (Q2)
105/288 (Q2)
77/203 (Q2)
• Ocean Engineering
• Civil and Structural Engineering
• Water Science and Technology
Link 1.76 0.955
Journal of Open Innovation: Technology, Market, and Complexity 4/202 (Q1)
27/1111 (Q1)
9/214 (Q1)
• General Economics, Econometrics and Finance
• Sociology and Political Science
• Development
Link 4.26 2.138
Journal of Sensor and Actuator Networks 13/92 (Q1)
27/123 (Q1)
70/274 (Q2)
• Control and Optimization
• Instrumentation
• Computer Networks and Communications
Link 2.58 1.036
Lubricants 182/579 (Q2)
42/116 (Q2)
• Mechanical Engineering
• Surfaces, Coatings and Films
Link 1.87 1.321
Machines 104/323 (Q2)

33/92 (Q2)
214/579 (Q2)
21/53 (Q2)
262/661 (Q2)

109/232 (Q2)
• Industrial and Manufacturing Engineering
• Control and Optimization
• Mechanical Engineering
• Computer Science (miscellaneous)
• Electrical and Electronic Engineering
• Control and Systems Engineering
Link 1.63 0.769
Mathematics 86/339 (Q2) • General Mathematics Link 1.04 0.739
Nanomaterials 29/272 (Q1)
66/439 (Q1)
• General Chemical Engineering
• General Materials Science
Link 4.21 1.112
Processes 9/23 (Q2)

25/59 (Q2)
68/139 (Q2)
• Chemical Engineering (miscellaneous)
• Process Chemistry and Technology
• Bioengineering
Link 2.05 1.049
Proteomes 54/115 (Q2)
23/46 (Q2)
213/407 (Q3)
229/375 (Q3)
• Clinical Biochemistry
• Structural Biology
• Biochemistry
• Molecular Biology
Link 2.32 0.445
Publications 11/66 (Q1)
51/312 (Q1)
83/351 (Q1)

233/569 (Q2)
• Media Technology
• Communication
• Business and International Management
• Computer Science Applications
Link 1.96 1.068
Robotics 234/579 (Q2)
38/92 (Q2)
• Mechanical Engineering
• Control and Optimization
Link 1.53 0.722
Toxics 32/117 (Q2)
3/8 (Q2)
40/114 (Q2)
• Health, Toxicology and Mutagenesis
• Chemical Health and Safety
• Toxicology
Link 2.84 0.896

20 May 2019
Meet Us at the European Human Genetics Conference in Gothenburg, Sweden, 15–18 June 2019


MDPI will be attending the ESHG 2019, to be held in Gothenburg, Sweden, 15th-18th June 2019.

ESHG 2019 - The 53rd European Human Genetics Conference is everything you need in human genetics, whatever your professional background. The Scientific Program Committee (SPC) has worked hard to invite the best speakers from various sectors of human genetics, and to select the best abstracts for platform presentations.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth #492). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.eshg.org/

11 April 2019
Meet Us at the 46th Controlled Release Society Annual Meeting & Exposition

We will be attending the 46th Controlled Release Society Annual Meeting & Exposition. It is one of the biggest events in pharmaceutical field. Representatives of the following open access journals will attend:

Pharmaceutics
JCM
Biomolecules
Materials
IJMS
Molecules
Nanomaterials
Pharmaceuticals
Scientia Pharmaceutica
Vaccines
JPM
Genes
JFB
IJERPH
Biomedicines
Healthcare

If you are also attending this conference, please feel free to stop by our booth (Booth #303). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.controlledreleasesociety.org/

20 March 2019
Fostering Open Access Publishing Worldwide: New IOAP Participants in February and March 2019

We are pleased to welcome more universities from Poland, Italy, Germany, Brazil and other parts of the world to MDPI's Institutional Open Access Program (IOAP). A warm welcome to the institutions listed below, who have joined the Program in February and March this year.


James Madison University (JMU), Harrisonburg USA
Loughborough University UK
Lublin University of Technology Poland
Marquette University, Milwaukee USA
Massey University, Palmerston North New Zealand
Medical College of Wisconsin USA
Nicolaus Copernicus University, Toruń Poland
Poznań University of Life Sciences Poland
Robert Koch-Institut, Berlin Germany
Rothamsted Research, Harpenden UK
Santa Clara University (SCU)  USA
Technical University of Applied Sciences Wildau Germany
University of Aveiro Portugal
University of Brasília Brazil
University of Duisburg-Essen Germany
University of Greifswald Germany
University of Molise Italy
University of Naples Parthenope Italy
University of São Paulo (USP) - São Carlos Institute of Physics Brazil
University of Szczecin Poland
University of Warmia and Mazury, Olsztyn Poland
University West, Trollhättan Sweden
UTP University of Science and Technology, Bydgoszcz Poland
VTT - Technical Research Centre of Finland Finland


Authors affiliated with these institutions can now enjoy a discount on the APC for papers accepted for publication in any MDPI journal. If you would like to learn more about our program, please visit: https://www.mdpi.com/about/ioap or email us at ioap@mdpi.com.

5 March 2019
MDPI Joins Jisc’s Publications Router Service

We are delighted to announce our participation in Jisc’s Publication Router project, as of March 2019.

Publications Router is a Jisc service that automatically sends notifications about research articles to institutions' systems such as their repositories or CRISs, since May 2015. Through this agreement, MDPI will provide Jisc with daily feeds and information regarding published articles, which will be gathered by their system and delivered to institutions also registered to this service. Nearly all of our articles are published within 15 days of acceptance, so institutions will receive them quite promptly.

The feed will include the full text of the published version of record, with no embargo, so the articles can be exposed immediately for public view. They are accompanied by rich metadata, including confirmation of the immediate CC BY licence, minimising the need for any manual intervention or checking.

For more information about Publications Router, you may contact Jisc’s central helpdesk at help@jisc.ac.uk. For any queries about MDPI’s institutional agreements and collaborations, you may get in touch with MDPI’s Institutional Engagement team at ioap@mdpi.com, which would be very happy to hear from further UK institutions.

1 February 2019
2018 MDPI Top Reviewer AwardWinners Announced


Rigorous peer-review is the cornerstone of high quality academic publishing. Over 97,000 scholars served as reviewers for MDPI journals in 2018. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list all reviewers’ names to express our gratitude. In addition, this year the “MDPI Top Reviewer Awards” are announced, to recognize the very best reviewers for their expertise, dedication, high quality, and timely review reports. We are pleased to announce the following winners of the 2018 MDPI Top Reviewer Awards:

  • Ali Behnood
  • Andrea Pezzuolo
  • Angela Gorgoglione
  • Anna D'Auria
  • Antonio D'Andrea
  • Azhar Abbas
  • Bogdan Zagajewski
  • Chunhui Chen
  • Dominika Głąbska
  • Dominika Guzek
  • Dragan Pamucar
  • Francisco J. G. Silva
  • Frank Li
  • Gianluca Serafini
  • Gyorgy Szekely
  • Haozhi Pan
  • Helvi Heinonen-Tanski
  • José Manuel Gómez-Soberón
  • Kathy Lewis
  • Klara Kosova
  • Luis N. López De Lacalle
  • M. Z. Naser
  • Malwina Tytła
  • Masoume Amirkhani
  • Matteo Ghidelli
  • Moretti Laura
  • Petra Schneider
  • Roberto Cerchione
  • Spyros Papaefthymiou
  • Ştefan Cristian Gherghina

24 January 2019
JAMS Journals: A Low-Cost Publishing Platform


Since 2010, MDPI has run its own online submission system. More recently, we have made the software, with accompanying publishing services, available to other publishers as JAMS (Journal and Article Management System). We are now delighted to announce the launch of JAMS Journals, a standardized platform for operating open access journals at low cost.

JAMS Journals provides a comprehensive service, including a shared submission website, journal websites hosted at a URL provided by the publisher, and a full production service. There is a small setup fee and the cost for each published paper is just a few hundred Swiss francs.

The platform demonstrates that running an open access journal can be straightforward and affordable. The JAMS Journals platform is suitable for

  • small publishers or groups of scholars looking to launch their own journal;
  • existing publishers or societies seeking to explore open access options;
  • publishers looking to convert an existing subscription journal to open access.

JAMS journals launches with two journals from Canadian-based publisher Etcetera Publications:

Dr AJ Al-Rajab (President of Etcetera Publications) comments:

“In the past few months, we were working on our project to launch new open access scientific journals in the field of agricultural and environmental sciences. We decided to go with JAMS for this venture because of the high quality of their services, reasonable prices, professionalism and easy communication. Our portfolio is expected to grow rapidly during 2019 to include more titles covering different areas in agriculture and environment. MDPI earned already our complete satisfaction and we are looking for a long term cooperation.”

Alongside the new platform, we continue to provide flexible, tailored journal management solutions for existing publishers. For any questions or to request a quotation, contact Dr. Constanze Schelhorn (constanze.schelhorn@mdpi.com).

24 January 2019
Popularity of Preprints Continues to Grow

2018 was a great year for preprints, with increasing numbers of authors looking to make their papers available online before peer review. Along with other preprint servers, our platform Preprints.org  saw an increase in the uptake from authors, and more than double the number of announced papers compared to 2017. In fact, we recently passed two important milestones: 8000 preprints online and 30,000 authors. 

We believe that the whole research community has the opportunity to benefit from work being available online as early as possible. We thank and congratulate our authors for supporting us to make this goal a reality.

In 2019, we will be looking carefully at how to provide better value for authors, maintain efficiency while growing in size, and make sure we remain well-connected with the research community. 

If you want to participate, you can consider screening preprints or joining our advisory board. And, of course, posting your own work.

9 January 2019
Open Access Agreement between the Austrian Academic Library Consortium (KEMÖ), the Austrian Science Fund (FWF), and MDPI

We are delighted to announce the establishment of our national Open Access agreement with the Austrian Academic Library Consortium (KEMÖ) and the Austrian Science Fund (FWF). Through this national agreement, the Austrian institutions listed below as well as FWF will cover the Article Processing Charges (APC) of manuscripts published by eligible corresponding or funded authors in MDPI journals as long as central funds are available.

All participating institutions have gained access to the MDPI online submission system where they can find full article metadata and pricing information as well as Funder and Grant ID details for easy identification and additional transparency. At the same time eligible authors are benefited from an APC discount which comes at no cost for the institutions.

Eligible corresponding authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email address. To claim their discount, FWF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript. The institutions will then crosscheck the information and confirm the APC funding.

Eligible authors that have their APC covered by their institution or funder are advised to include the following sentence in their acknowledgments: "Open Access Funding by the [name of the institution/funder]".

The full text of the agreement is openly available online at: http://doi.org/10.5281/zenodo.2536007

For any questions about the agreement, please contact the KEMÖ Consortium at emedien@obvsg.at, FWF at Katharina.Rieck@fwf.ac.at, or the MDPI IOAP team at ioap@mdpi.com.

The Austrian institutions participating in this agreement are:

  • Austrian Science Fund (FWF)
  • University for Continuing Education Krems
  • University of Applied Sciences BFI Vienna
  • University of Applied Sciences Upper Austria
  • University of Applied Sciences Technikum Wien
  • Vorarlberg University of Applied Sciences
  • International Institute for Applied Systems Analysis (IIASA)
  • Institute of Science and Technology Austria
  • MCI Management Center Innsbruck
  • University of Graz
  • University of Linz
  • University of Salzburg
  • Graz University of Technology
  • TU Wien
  • University of Veterinary Medicine Vienna
  • University of Vienna

This is our first collective agreement with a national library consortium, while the individual institutions around the world participating in our IOAP are now more than 500 - see details here: https://www.mdpi.com/about/ioap. We would be mostly interested in discussing about possible collaborations with other consortia, funders, and institutions in our mutual efforts to accelerate Open Access.

2 January 2019
Encyclopedia—the Scholarly Community Encyclopedia

We are pleased to announce the new platform Encyclopedia, which is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

We encourage authors of review articles to quote and adapt the content of their published papers to create Encyclopedia entries. You can create completely new entries on topics in which you have knowledge and expertise. There is no limit on the topics or research fields. All of science and the humanities are included. Each entry will be published directly after submission.

We also have prepared a DOI application function in Encyclopedia. Once a DOI application is approved, the entry website will announce the DOI number and a pdf version with DOI information will be automatically created.

We look forward to your contributions and hope you will make use of this service. Find more about the service at: https://encyclopedia.pub/

30 October 2018
Institutional Open Access Agreement between Bill and Melinda Gates Foundation and MDPI


We are delighted to announce that the Bill and Melinda Gates Foundation (BMGF) is now a participant of our Institutional Open Access Program (IOAP). Authors funded by the BMGF can enjoy discounts on the APC, while the funder covers the costs of eligible articles centrally. BMGF also has access to the MDPI online submission system where they can find full article metadata and pricing information as well as Grant ID details for easy identification and additional transparency.

We hope that funded authors find the programme beneficial and we are happy to offer our IOAP to other funders that need a streamlined workflow of compliance checking and APC coverage. 

To claim their discount, BMGF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript.

For any questions about the BMGF agreement, please contact the funder at support@chronos-oa.com or the MDPI IOAP team at ioap@mdpi.com.

2 October 2018
MDPI Welcomes Plan S

Recently, it was announced that a group of European funders supported 10 principles that will help to expand open access, known as Plan S. MDPI warmly welcomes this move as a step towards achieving more open and accessible communication of research across all disciplines. Some aspects remain to be clarified, however the details given so far match the aims and values that MDPI has held over the past two decades.

We believe that open access publishers should be active participants in discussions around Plan S, particularly regarding potential new business models and practical aspects of implementation. MDPI supports APCs as a transparent unit of payment for article publishing, however we are committed to exploring other measures and recently signed the Jussieu Call. Sustainability is a key value for MDPI, and future funding models should have at their heart the sustainability of knowledge and research dissemination. Plan S provides an opportunity for funders and publishers to directly discuss funding of open access journals in ways that are beneficial to all parties involved.

30 August 2018
MDPI establishes Open Access agreement with Qatar National Library

We are happy to announce the establishment of an Open Access (OA) agreement with Qatar National Library (QNL). QNL is committed to supporting and helping Qatar authors publish OA at no cost. Through this national agreement, QNL will cover the Article Processing Charges (APC) of manuscripts published by Qatar-based corresponding authors in MDPI journals.

Eligible corresponding authors affiliated with Qatar research centers and universities are prompted to choose QNL as part of our Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email and/or a computer registered with the institution’s IP range. QNL will then crosscheck the information and confirm the APC funding.

Qatar authors that have their APC covered by QNL are advised to include the following sentence in their acknowledgments: "The publication of this article was funded by Qatar National Library".

For more information, please visit Open Access at QNL or email the QNL Open Access team at openaccess@qnl.qa.

6 June 2018
Meet Us at the 18th World Congress of Basic and Clinical Pharmacology in Kyoto


We will be attending the 18th World Congress of Basic and Clinical Pharmacology, which will be held in Kyoto, Japan, 1–6 July 2018, and representing the following open access journals:

JCM
Pharmaceuticals
Biomedicines
Brain Sciences
Diseases

Pharmacy
Tropical Medicine and Infectious Disease
Cancers
Marine Drugs

Please come along to our booth (#3-6) to chat with our delegates about our journals. We'll gladly answer any questions about our journals and about open access publishing. We look forward to meeting you in person in Edmonton!

For more information on the conference, please visit:
http://www.wcp2018.org/

31 May 2018
2017 CiteScore™ Metrics Released

The 2017 CiteScore™ data is available now, based on citation data in the Scopus® database. The current CiteScore reflects citation activity in 2017 for articles published in 2014‒2016. Please note that the list below includes journals assigned a CiteScore in this year’s release. For a full list of journals indexed in Scopus, please see our journal list.

Thirteen of our journals received a CiteScore which is in the top 10% of the distribution in at least one of the categories (marked with * in the table below), while a further 32 journals exhibit scores that are in the first quartile of the respective categories.

To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.

Unlike CiteScores and the widely used Journal Impact Factors, the Source Normalized Impact per Paper (SNIP) metrics are normalized in order to correct for differences in citation practices between scientific fields. Therefore, the SNIP allows direct comparison between journals specialized in different fields.

According to 2017 data, MDPI publishes six journals with an average citation impact, or SNIP, in excess of 1.500. These journals are Biomolecules, Cancers, Journal of Clinical Medicine (JCM), Marine Drugs, Remote Sensing and Sensors (see the last column in the table below).

CiteScore Data for MDPI Journals

Journal Rank (Quartile)
Category Link CiteScore 2017
2016

2015
SNIP 2017
Aerospace 43/116 (Q2) • Aerospace Engineering Link 1.23 - -  1.152
Agriculture 69/309 (Q1)

91/398 (Q1)
78/255 (Q2)
• Agronomy and Crop Science
• Plant Science
• Food Science
Link 1.93 - -  1.133
Agronomy 46/309 (Q1) • Agronomy and Crop Science Link 2.38 - -  1.115
Algorithms 22/46 (Q2)
61/125 (Q2)

60/107 (Q3)

64/114 (Q3)
• Numerical Analysis
• Computational Mathematics
• Computational Theory and Mathematics
• Theoretical Computer Science
Link 1.03 1.15 1.07  0.749
Animals 12/154 (Q1) *
48/367 (Q1)
• General Veterinary
• Animal Science and Zoology
Link 2.02 1.46 1.66  1.099
Antibiotics 6/68 (Q1) *


62/263 (Q1)
55/230 (Q1)
31/108 (Q2)
47/134 (Q2)
139/398 (Q2)
• General Pharmacology, Toxicology and Pharmaceutics
• Infectious Diseases
• Pharmacology (medical)
• Microbiology (medical)
• Microbiology
• Biochemistry
Link 2.85 1.65 -  0.975
Antibodies 43/143 (Q2)
61/164 (Q2)
85/189 (Q2)
• Drug Discovery
• Immunology and Allergy
• Immunology
Link 2.85 - -  0.844
Antioxidants 23/119 (Q1)
35/169 (Q2)
100/398 (Q2)
119/367 (Q2)
102/264 (Q2)
• Clinical Biochemistry
• Physiology
• Biochemistry
• Molecular Biology
• Cell Biology
Link 3.42 - -  1.361
Applied Sciences 48/270 (Q1)
15/66 (Q1)

31/116 (Q2)
18/53 (Q2)

151/434 (Q2)

186/535 (Q2)
• General Engineering
• Fluid Flow and Transfer Processes
• Instrumentation
• Process Chemistry and Technology
• General Materials Science
• Computer Science Applications
Link 1.90 - -  0.801
Biology 12/177 (Q1)*

32/186 (Q1)


10/40 (Q1)
• General Agricultural and Biological Sciences
• General Biochemistry, Genetics and Molecular Biology
• General Immunology and Microbiology
Link 3.48 3.02 2.78  0.961
Biomolecules 31/398 (Q1) *
41/367 (Q1)
• Biochemistry
• Molecular Biology
Link 5.72 1.67 3.08  1.542
Biosensors 20/119 (Q1) • Clinical Biochemistry Link 3.59 2.83 2.37  1.122
Brain Sciences 47/111 (Q2) • General Neuroscience Link 2.56 - -  0.695
Cancers 26/323 (Q1) *
23/191 (Q1)
• Oncology
• Cancer Research
Link 5.82 5.02 4.07  1.567
Catalysts 32/151 (Q1)

21/46 (Q2)
• Physical and Theoretical Chemistry
• Catalysis
Link 3.23 3.44 3.45  0.954
Crystals 76/272 (Q2)

140/434 (Q2)

127/398 (Q2)

26/64 (Q2)
• General Chemical Engineering
• General Materials Science
• Condensed Matter Physics
• Inorganic Chemistry
Link 1.97 1.89 1.47  0.745
Diagnostics 49/119 (Q2) • Clinical Biochemistry Link 2.43 - -  0.788
Diversity 30/124 (Q1)

14/52 (Q2)


83/306 (Q2)
11/29 (Q2)
• Nature and Landscape Conservation
• Agricultural and Biological Sciences (miscellaneous)
• Ecology
• Ecological Modelling
Link 2.15 2.03 1.96  1.300
Electronics 109/644 (Q1)

26/148 (Q1)

42/224 (Q1)

50/259 (Q1)

23/96 (Q1)
• Electrical and Electronic Engineering
• Hardware and
Architecture
• Control and Systems Engineering
• Computer Networks and Communications
• Signal Processing
Link 2.97 - -  1.227
Energies 6/73 (Q1) *
31/192 (Q1)

103/644 (Q1)

4/16 (Q1)
47/140 (Q2)
• Control and Optimization
• Energy Engineering and Power Technology
• Electrical and Electronic Engineering
• Energy (miscellaneous)
• Renewable Energy, Sustainability and the Environment
Link 3.11 2.50 2.87  1.340
Entropy 35/202 (Q1) • General Physics and Astronomy Link 2.41 1.87 1.99  1.189
Forests 17/129 (Q1) • Forestry Link 2.31 2.06 1.76  0.990
Future Internet 132/259 (Q3) • Computer Networks and Communications Link 1.25 - - -
Games 132/187 (Q3)
78/110 (Q3)

305/418 (Q3)
• Statistics and Probability
• Statistics, Probability and Uncertainty
• Applied Mathematics
Link 0.61 0.87 0.57  1.038
Genes 21/91 (Q1)
74/311 (Q1)
• Genetics (clinical)
• Genetics
Link 3.49 3.62 3.18  0.374
Geosciences 32/182 (Q1)

• General Earth and Planetary Sciences Link 1.97 1.67 1.29  0.856
Information 143/251 (Q3) • Information Systems Link 1.16 0.78 0.94  1.146
Insects 27/135 (Q1) • Insect Science Link 1.85 1.81 1.38  0.719
International Journal of Environmental Research and Public Health (IJERPH) 80/478 (Q1)


34/106 (Q2)
• Public Health, Environmental and Occupational Health
• Health, Toxicology and Mutagenesis
Link 2.41 2.38 2.42  0.931
International Journal of Molecular Sciences (IJMS) 7/69 (Q1) *
61/535 (Q1)

20/163 (Q1)
9/64 (Q1)
26/151 (Q1)

89/367 (Q2)
17/46 (Q2)
• Spectroscopy
• Computer Science Applications
• Organic Chemistry
• Inorganic Chemistry
• Physical and Theoretical Chemistry
• Molecular Biology
• Catalysis
Link 3.86 3.73 3.37  0.998
ISPRS International Journal of Geo-Information (IJGI) 79/605 (Q1)

22/82 (Q2)

13/36 (Q2)
• Geography, Planning and Development
• Earth and Planetary Sciences (miscellaneous)
• Computers in Earth Sciences
Link 2.10 1.62 1.52  1.062
Journal of Clinical Medicine (JCM) 10/841 (Q1) * • General Medicine Link 7.07 - -  1.535
Journal of Functional Biomaterials (JFB) 43/199 (Q1)
23/77 (Q2)
• Biomedical Engineering
• Biomaterials
Link 3.47 - -  1.344
Journal of Low Po-
wer Electronics and Applications (JLPEA)
301/644 (Q2) • Electrical and Electronic Engineering Link 1.12 0.98 0.83  0.367
Journal of Personalized Medicine (JPM) 54/189 (Q2) • Medicine (miscellaneous) Link 2.61 - -  0.944
Land 50/124 (Q2)

129/306 (Q2)
36/65 (Q3)
• Nature and Landscape Conservation
• Ecology
• Global and Planetary Change
Link 1.44 - -  0.658
Life 4/94 (Q1) *
70/561 (Q1)

40/186 (Q1)


20/80 (Q2)
• Palaeontology
• Ecology, Evolution, Behavior and Systematics
• General Biochemistry, Genetics and Molecular Biology
• Space and Planetary Science
Link 3.16 2.95 1.68  0.935
Marine Drugs 17/146 (Q1) • Drug Discovery Link 4.58 3.83 3.66  1.537
Materials 83/434 (Q1) • General Materials Science Link 3.02 3.26 3.11  1.285
Membranes 5/18 (Q2)

15/53 (Q2)

4/10 (Q2)
• Chemical Engineering (miscellaneous)
• Process Chemistry and Technology
• Filtration and Separation
Link 2.69 2.19 2.95  0.880
Metabolites 47/209 (Q1)

103/398 (Q2)
127/367 (Q2)
• Endocrinology, Diabetes and Metabolism
• Biochemistry
• Molecular Biology
Link 3.35 - -  0.925
Metals 155/434 (Q2) • General Materials Science Link 1.87 - -  0.955
Micromachines 105/554 (Q1)
154/644 (Q1)

64/224 (Q2)
• Mechanical Engineering
• Electrical and Electronic Engineering
• Control and Systems Engineering
Link 2.31 1.83 1.78  0.987
Minerals 33/175 (Q1)


45/208 (Q1)
• Geotechnical Engineering and Engineering Geology
• Geology
Link 2.21 2.13 1.77  1.149
Molecules 4/25 (Q1)

25/172 (Q1)
18/104 (Q1)
31/163 (Q1)
30/151 (Q1)

31/146 (Q1)
55/160 (Q2)
• Chemistry (miscellaneous)
• Pharmaceutical Science
• Analytical Chemistry
• Organic Chemistry
• Physical and Theoretical Chemistry
• Drug Discovery
• Molecular Medicine
Link 3.27 3.09 2.65  1.146
Nutrients 11/255 (Q1) *
9/112 (Q1) *
• Food Science
• Nutrition and Dietetics
Link 4.35 4.29 4.07  1.403
Pathogens 38/263 (Q1)
20/108 (Q1)
9/40 (Q1)

40/164 (Q1)
110/367 (Q2)
• Infectious Diseases
• Microbiology (medical)
• General Immunology and Microbiology
• Immunology and Allergy
• Molecular Biology
Link 3.52 - -  1.166
Pharmaceuticals 14/172 (Q1) *
33/160 (Q1)
• Pharmaceutical Science
• Molecular Medicine
Link 4.12 4.90 3.64  1.370
Pharmaceutics 21/172 (Q1) • Pharmaceutical Science Link 3.68 3.83 2.68  1.092
Photonics 30/116 (Q1)
80/270 (Q2)

53/160 (Q2)
• Instrumentation
• Radiology Nuclear Medicine and Imaging
• Atomic and Molecular Physics, and Optics
Link 1.96 - -  0.817
Plants 73/561 (Q1)

48/389 (Q1)
44/306 (Q1)
• Ecology, Evolution, Behavior and Systematics
• Plant Science
• Ecology
Link 3.13 - -  0.969
Polymers 17/142 (Q1)
63/359 (Q1)
• Polymers and Plastics
• General Chemistry
Link 3.30 3.74 3.37  1.213
Religions 26/389 (Q1) * • Religious Studies Link 0.56 - -  0.676
Remote Sensing 13/182 (Q1) * • General Earth and Planetary Sciences Link 4.03 3.56 3.76  1.559
Resources 19/142 (Q1)

39/261 (Q1)
• Nature and Landscape Conservation
• Management, Monitoring, Policy and Law
Link 2.69 - -  1.387
Scientia Pharmaceutica 92/172 (Q3) • Pharmaceutical Science Link 0.86 - -  0.513
Sensors 9/116 (Q1) *
25/160 (Q1)

100/644 (Q1)

19/104 (Q1)
113/398 (Q2)
• Instrumentation
• Atomic and Molecular Physics, and Optics
• Electrical and Electronic Engineering
• Analytical Chemistry
• Biochemistry
Link 3.23 2.78 2.21  1.550
Social Sciences 81/213 (Q2) • General Social Sciences Link 0.60 - -  0.445
Sustainability 61/605 (Q1) *

55/261 (Q1)

60/140 (Q2)
• Geography, Planning and Development
• Management, Monitoring, Policy and Law
• Renewable Energy, Sustainability and the Environment
Link 2.37 1.96 1.78  1.030
Symmetry 44/327 (Q1)
17/45 (Q2)

16/40 (Q2)

14/25 (Q2)
• General Mathematics
• Computer Science (miscellaneous)
• Physics and Astronomy (miscellaneous)
• Chemistry (miscellaneous)
Link 1.32 1.12 0.95  0.802
Toxins 18/106 (Q1)

21/111 (Q1)
• Health, Toxicology and Mutagenesis
• Toxicology
Link 3.32 3.34 3.76  1.136
Vaccines 5/230 (Q1) *
13/263 (Q1) *
18/302 (Q1) *
11/146 (Q1) *
32/189 (Q1)
• Pharmacology (medical)
• Infectious Diseases
• Pharmacology
• Drug Discovery
• Immunology
Link 4.88 1.23 3.76  1.255
Viruses 29/263 (Q1)
16/68 (Q1)
• Virology
• Infectious Diseases
Link 3.88 3.60 3.74  1.130
Water 66/605 (Q1)

37/191 (Q1)

43/199 (Q1)
193/398 (Q2)
• Geography, Planning and Development
• Water Science and Technology
• Aquatic Science
• Biochemistry
Link 2.29 2.05 1.96  1.007

30 April 2018
Winners of the First MDPI Writing Prize

We are pleased to announce the results of the first MDPI Writing Prize. We received a large number of entries from across the globe on the theme of “The Global Benefits of Open Research”. It was a pleasure to read so many original, well-researched and well-presented ideas, and the final choice was not an easy one. We are pleased to announce that the winners are as follows:

1st prize (500 CHF, Swiss knife and certificate)

Edmond Sanganyado, Shantou University, China

2nd prizes (250 CHF, Swiss knife and certificate)

Kamala T. Rajahgopal, Asia e University, Malaysia
Yin Zhixuan, Qingdao University of Technology, China

3rd prizes (100 CHF, Swiss knife and certificate)

Alexandra Ticea, Carol Davila University of Medicine and Pharmacy, Romania
Ankur Sarker, University of Virginia, USA
Daniel Attoye, United Arab Emirates University, UAE

Congratulations to all of them! The winning entries can be downloaded by clicking on the names above. A compilation of all entries will soon be available as an open access book.

The writing prize is sponsored by the MDPI English editing service.

23 March 2018
Check for Updates: A New Function in the Article PDF Version

At MDPI, we always want to keep you up to date. Even for already published articles, some corrections or minor changes may occur. To prevent you from missing any updates, from now on you will be able to access the latest version of any manuscript by clicking on the “check for updates” logo that you can find in the PDF file, even if you have saved the file on your computer.

13 March 2018
MDPI Becoming a Member of UKSG

We are proud to announce that MDPI is now a member of UKSG, the UK´s largest scholarly communications community. Through UKSG, different stakeholders share their knowledge and experience in order to improve the knowledge and information environment for researchers. UKSG´s members include universities, publishers, content providers, intermediaries, and other similar organisations. Members participate in discussions and events on issues around scholarly communications.

The UKSG Annual Conference and Exhibition is a flagship initiative from the UKSG and one of the most stimulating events in the scholarly communications calendar. It is held annually and attracts a large number of delegates. More information is available at https://www.uksg.org/events/annualconference

MDPI is delighted to be a part of this active community and we look forward to making our own contribution. We will continue to support organisations and initiatives that boost collaboration and vision within scholarly communication.

More information about UKSG can be found at https://www.uksg.org/. The full membership list is available at: https://www.uksg.org/members.

1 February 2018
MDPI Signed the San Francisco Declaration on Research Assessment (DORA)

The DORA initiative addresses the need for advanced approaches in the evaluation and measurement of the quality of scientific research outputs. It is a worldwide initiative covering all scholarly disciplines. MDPI proudly joins a list of more than 400 organizations around the world which support DORA’s recommendations for improving the way the quality of research results is evaluated.

More info can be found at http://www.ascb.org/dora/

22 January 2018
Meet Us at the Experimental Biology 2018 (2125 April 2018) in San Diego, CA, USA


MDPI will be attending the Experimental Biology 2018 annual meeting in San Diego, CA, USA from 21 to 25 April 2018, representing the following open access journals:

Antibiotics
Antioxidants
Behavioral Sciences
Bioengineering
Biology
Biomedicines
Brain Sciences

Cancers
Cells
Dentistry Journal

Diagnostics
Diseases
Epigenomes
Fermentation
Genes
High-Throughput

International Journal of Molecular Sciences (IJMS)
International Journal of Environmental Research and Public Health (IJERPH)
Journal of Clinical Medicine (JCM)
Journal of Developmental Biology (JDB)
Journal of Functional Morphology and Kinesiology (JFMK)
Metabolites
Methods and Protocols
Microorganisms
Non-Coding RNA

Nutrients
Pharmaceuticals
Pharmaceutics
Proteomes
Sports

Veterinary Sciences
Viruses

Experimental Biology is the annual meeting of five societies comprised of more than 14,000 scientists and 25 guest societies.

The areas of primary focus include anatomy; biochemistry and molecular biology; investigative pathology; nutrition; pharmacology; physiology. Attendees represent scientists from academic institutions, government agencies, non-profit organizations and industry.

Conference details:
San Diego Convention Center
San Diego CA
USA
21­–25 April 2018

Do you want to learn more about MDPI open access journals? Don’t miss this opportunity to discuss them with our editors and MDPI delegates. If you are at Experimental Biology 2018, just come visit our booth for a moment to have a chat. We have some gifts for you to take home and will answer any questions that you have about the open access journal (booth # 1034).

For more information, please visit:
http://experimentalbiology.org/2018/Home.aspx

29 December 2017
Ten Journals Added in Scopus®

We are pleased to inform that ten MDPI journals (shown below) have been found suitable for inclusion in Scopus over the course of the past few months. As varied as the topical focus for these journals may be, their editorial teams do share a passion for serving research communities around the world.

The coverage in Scopus starts from 2017 volumes, with the articles expected to be indexed within the next few months.

Fibers Logo
Journal of Developmental Biology Logo
Atoms Logo
Aerospace Logo
Biomedicines Logo
Chemosenosrs Logo
Actuators Logo
Proteomes Logo
Computation Logo
Veterinary Sciences Logo

21 December 2017
Meet Us at the AACR Annual Meeting 2018 in Chicago, IL, USA


We will be attending the AACR Annual Meeting 2018, to be held in Chicago, IL, USA, 14-18 April 2018. The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. The AACR gives the opportunity to gain visibility for your organization among more than 21,000 scientists and other cancer professionals who are projected to attend from around the world. Representatives of the following MDPI open access journals will attend:

Antibodies (https://www.mdpi.com/journal/antibodies)
Biomedicines (https://www.mdpi.com/journal/biomedicines)
Cancers (https://www.mdpi.com/journal/cancers)
Cells (https://www.mdpi.com/journal/cells)
Children (https://www.mdpi.com/journal/children)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Genes (https://www.mdpi.com/journal/genes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
IJERPH (https://www.mdpi.com/journal/ijerph)
JCM (https://www.mdpi.com/journal/jcm)
IJMS (https://www.mdpi.com/journal/ijms)
JPM (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicines (https://www.mdpi.com/journal/medicines)
Metabolites (https://www.mdpi.com/journal/metabolites)
ncRNA (https://www.mdpi.com/journal/ncrna)
Pharmaceuticals (https://www.mdpi.com/journal/pharmaceuticals)
Pharmaceutics (https://www.mdpi.com/journal/pharmaceutics)
Scientia Pharmaceutica (https://www.mdpi.com/journal/scipharm)
Vaccines (https://www.mdpi.com/journal/vaccines)

Please come along to our stand, No.1339, to have a chat with our delegates about the journals, and information on online publishing as well as our editorial procedures. You may also learn more about the various awards offered by the journals, including the Best Paper Awards, the Young Investigator Awards, Travel Awards, etc. Some useful handouts are also available. We look forward to meeting you in person to answer any questions you may have.

Conference address:
AACR Annual Meeting 2018
McCormick Place North/South
Chicago, IL, USA

Conference date:
14-18 April 2018

For more information on the conference, please visit:
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136

19 December 2017
Announcing the MDPI English Writing Prize

 

The competition is still open until end of March! Please check out the banner for more details: https://mdpi-res.com/data/english-prize.pdf

15 December 2017
UCL Press Adopts the MDPI Editorial Platform JAMS

We are delighted to announce that UCL Press has adopted MDPI's Journal Article & Management System, JAMS, including production services. JAMS is a modular, integrated editorial platform for academic publishers. It offers flexibility, ease-of-use, and is a fully integrated solution for the end-to-end management of scholarly journals. JAMS is based on the software used to publish MDPI’s portfolio of journals. 

Ian Caswell, UCL Press Journals Manager, says he is "excited to see UCL Press and MDPI partner together to implement the JAMS submission system for all UCL Press journals. The system offered a flexible, efficient and straightforward solution for our processes from author submission to ready for publication. I am grateful for the valuable experience and support MDPI have offered and look forward to developing our programme with an effective submission system in place.” Dr Martyn Rittman, MDPI’s Publishing Services Manager, adds, “We are proud to support one of the UK’s premier university presses in their publishing operation. This is an excellent way for us at MDPI to share our experience and knowledge, and benefit the research community beyond our own journals.”

JAMS combines services that are kept separate for many publishers. The entire editorial process, production and invoicing (e.g. for open access article processing charges) are fully integrated into a single platform. This allows for efficient, fast manuscript processing. For further information about JAMS, see https://www.mdpi.com/publishing_services

23 November 2017
New Participants in the Institutional Open Access Program (IOAP)

We are pleased to welcome new participants to MDPI's Institutional Open Access Program (IOAP), designed to help institutions manage the transition to the Open Access publishing model. Researchers affiliated with participating universites benefit from a 10% discount on the Article Processing Charges (APC) for any paper published in an MDPI journal, while the participating library or university incurs no basic fee for participating in the program.

The IOAP set of free services, provided by MDPI to institutions that sign up, include:
  • No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
  • Authors affiliated with the university will receive a 10% discount on the APC.
  • The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
  • By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
  • Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.

More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap

Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form

The following North American universities have signed up to the IOAP program recently:

Connecticut College, USA
Emory University, USA
Florida International University, USA
Johns Hopkins University, USA
Mississippi State University, USA
Northeastern University, USA
Rice University, USA
University of Ontario Institute of Technology, Canada
University of Rhode Island, USA
University of Texas Southwestern Medical Center, USA
University of Toronto, Canada
University of Windsor, Canada
University of Wisconsin–Madison, USA
Wellesley College, USA
West Virginia University, USA

Many prestigious institutions from Europe and Asia have joined as well:

Asia Pacific University of Technology & Innovation, Malaysia
Czech Technical University in Prague, Czech Republic
Gdansk University of Technology, Poland
Martin-Luther-Universität Halle-Wittenberg, Germany
National Chung Hsing University, Taiwan
Newcastle University, UK
Northumbria University, UK
Southwest University, China
Technical University of Crete, Greece
University Malaya, Malaysia
University of Antwerp, Belgium
University of Cyprus, Cyprus
University of Manchester, UK
University of Reading, UK
University of Sussex, UK
University of Warwick, UK
West Pomeranian University of Technology Szczecin, Poland

We offer a warm welcome to the new participants!

10 November 2017
Available Journal Awards at MDPI

In order to reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields, for example, Young Investigator Awards, Travel Awards, Best Paper Awards, and Best Poster Awards, etc. The awardees range from PhD students to junior scientists.

Currently, the following 44 awards given by MDPI journals are accepting applications. Please click on the award title below to check whether you are eligible for it and start the application process.

Subject

Journal

Award

Intended Awardee

Biology & Life Sciences

Animals

Travel Award 2018

PhD students or postdoctoral researchers

Antioxidants

Travel Awards 2018

Postdoctoral researchers or PhD students

Biology

Travel Award 2018

PhD or postdoctoral fellows

Forests

2019 Travel award

Postdocs or PhD students

International Journal of Molecular Sciences (IJMS)

Outstanding Contribution Awards 2018

Ground-breaking contribution in the fields of Molecular Biology, and Molecular Pathology

Journal of Fungi (JoF)

Travel Awards 2018

PhD graduate students, and postdoctoral fellows

Life

Travel Award 2018

PhD students or postdoctoral fellows

Metabolites

Travel Award 2018

PhD students

Pharmaceuticals

Travel Award 2018

PhD students

Toxins

Travel Award 2018

Postdoctoral fellows

Viruses

Best Oral Presentation Award 2018

Viruses 2018 participants

Viruses

Best Poster Award 2018

Viruses 2018 participants

Water

2018 Young Investigator Award

Young investigators

Chemistry & Materials Science

Biomimetics

 

Travel Award 2018

Graduate Student or Postdoctoral Trainee / Research Associate

Catalysts

Travel Award 2018

PhD students

Chemosensors

Travel Award 2018

PhD or postdoctoral fellows

Entropy

Young Investigator Award 2018

Young investigators

Fibers

2018 Travel award

Postdocs or PhD students

Magnetochemistry

Travel Award 2018

Postdocs

Materials

Travel Award 2018

PhD or postdoctoral fellows

Metals

Travel Award 2018

PhD or postdoctoral fellows

Minerals

Travel Awards 2018

PhD or postdoctoral fellows

Sensors

Travel Award 2018

PhD or postdoctoral fellows

Sensors

Outstanding Reviewer Awards 2017

Sensors' reviewers in 2017

Sensors

Young Investigator Award 2018

Young investigators

Technologies

Travel Award 2018

PhD students

Computer Science & Mathematics

Multimodal Technologies and Interaction (MTI)

Travel Awards 2018

Postdoctoral researchers or PhD students

ISPRS International Journal of Geo-Information(IJGI)

2018 Travel Award

Postdocs

Journal of Sensor and Actuator Networks (JSAN)

Travel Award 2018

Postdoctoral fellows and PhD students

Journal of Imaging

Travel Award 2018

Postdoctoral fellows and PhD students

Engineering

Actuators

Travel Award 2018

PhD or postdoctoral fellows

Remote Sensing

Best Paper Awards 2019

Authors

Machines

Travel Award 2018

PhD or postdoctoral fellows

Micromachines

Travel Awards 2018

PhD or postdoctoral fellows

Fluids

Travel Award 2018

Postdoctoral fellows and PhD students

ChemEngineering

Travel Award 2018

Postdoctoral researchers and PhD students

Environmental & Earth Sciences

Diversity

Travel Awards 2018

Postdoctoral fellows

International Journal of Environmental Research and Public Health (IJERPH)

Best Paper Award 2018

Authors who submit from 1 Nov 2017 to 31 Oct 2018

Resources

Travel Award 2018

Postdocs or PhD students

Geosciences

Travel Award 2018

Postdoctoral fellows and PhD students

Physical Sciences & Astronomy

Galaxies

Travel Award 2018

Ph.D. students, postdoctoral fellows, or lecturers in cosmology or galaxies physics

Applied Science

Travel Award 2018

Postdocs

Medicine & Pharmacology; Public Health & Healthcare

Journal of Clinical Medicine (JCM)

2018 Travel Award

PhD or postdoctoral fellows

Medicines

Travel Award 2018

Postdocs

7 November 2017
MDPI has signed the Jussieu Call for Open Science and Bibliodiversity

The Jussieu Call aims to develop and implement alternative models to meet the aims of open science while promoting bibliodiversity. In particular it wishes to promote new business models for funding open access publication. It was drafted on the Jussieu campus in Paris by a group of French researchers and scientific publishing professionals.

MDPI supports scholarly communities and initiatives that innovate and further promote Open Access publishing. There is a need to explore different frameworks to fund open access in ways that ensure that excessive funds are not diverted from research towards publishing. Many fair funding models already exist, and they can be further developed and extended. These include institutional support, library contributions or subsidies, premium services, participatory funding, etc. For this reason, MDPI has signed up to the Jussieu call and welcomes its aims.

More information can be found at http://jussieucall.org/ (archived here)

 

6 October 2017
Dr. Franck Vazquez, MDPI CEO, Interviewed by Scholarly Kitchen

The Society for Scholarly Publishing’s popular blog about topics in academic publishing, Scholarly Kitchen, recently interviewed MDPI’s CEO, Dr. Franck Vazquez. He shared some thoughts and information on the past and future of MDPI and open access publishing in general:

“In the long run, we aim to anchor MDPI in research communities. We recently developed and launched the preprint platform Preprints, revamped our free-to-use conference hosting platform Sciforum, and are working on other projects, such as Scilit, our bibliographic database.”

Read the full interview here.

25 September 2017
Meet Us at the ICONAN 2017 Conference in Barcelona

We will attend the International Conference On Nanomedicine And Nanobiotechnology (ICONAN 2017) that will be held in Barcelona, Spain, 25–27 September 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:

Bioengineering
Biomedicines
Biomimetics
Biomolecules
Journal of Functional Biomaterials
Journal of Personalized Medicine
High-Throughput
Medical Sciences
Scientia Pharmaceutica

Please stop by our booth to chat with our delegates about our journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Barcelona!

For more information on the conference, please visit:
http://premc.org/conferences/iconan-nanomedicine-nanobiotechnology/

19 September 2017
A Warm Welcome to the New IOAP Participants

We are delighted to have welcomed 24 new participants to our Institutional Open Access Programme (IOAP) since the beginning of September this year. These are University libraries and Research Institutions located around the world; from the USA and Canada to the UK, and from Norway and Spain to Greece. Well respected Universities, such as the University of Denver, the University of Colorado Boulder, and the University of Arizona in the US, have signed up, while their researchers can now benefit from a 10% discount on the Article Processing Charges (APC) for any papers they publish in MDPI journals, at no cost for the library or the University.

We are more than happy to see the Open Access movement growing stronger and wider every day and we appreciate the vital role which librarians, repository managers, and other scholarly communications professionals play in the field. Our communication with and service to this community is, therefore, one of our principal priorities. The IOAP is our way to support academic and scientific Institutions as well as their scholars in managing, administrating, and publishing research in an Open Access world.

The IOAP set of free services, provided by MDPI to institutions that sign up, include:

  • No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
  • Authors affiliated with the university will receive a discount on the article processing charge (APC).
  • The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
  • By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
  • Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.

More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap

Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form

 The full list of the Institutions that signed up in September is as follows:

  1. University of Denver, USA
  2. University of Colorado Boulder, USA
  3. University of Arizona, USA
  4. Institute of Metrology of Bosnia and Herzegovina, Bosnia and Herzegovina
  5. Middlebury College, USA
  6. Touro College, USA
  7. University of New Orleans, USA
  8. University of Leicester, UK
  9. Indiana University-Purdue University Indianapolis, USA
  10. University of Strathclyde, UK
  11. Cranfield University, UK
  12. Hope College, USA
  13. Oregon State University, USA
  14. Drew University, USA
  15. Swansea University, UK
  16. University of South Florida, USA
  17. University of Georgia, USA
  18. Arizona State University, USA
  19. University of Southern Mississippi, USA
  20. Université du Québec à Chicoutimi, Canada
  21. Grinnell College, USA
  22. Norwegian University of Science and Technology, Norway
  23. University of Patras, Greece
  24. Public University of Navarre, Spain

19 September 2017
Find Us at ConBio2017: Consortium of Biological Sciences 2017, Kobe Port Island, Japan, 6–9 December 2017

MDPI will be attending the ConBio 2017: Consortium of Biological Sciences 2017 in Kobe, Japan, from 6 to 9 December 2017 representing the open access journals:

International Journal of Molecular Sciences (IJMS)
Biomedicines
Fermentation
Biology

Do you want to learn more about IJMS and other MDPI open access journals? Don’t miss this opportunity to discuss them with our editors such as Masatoshi Maki, Michihiro Mutoh, Hideyuki Yamawaki, Hideaki Itoh, Hitoshi Shimano, Toshiyuki Fukada as well as MDPI delegates. If you are at ConBio2018, just come visit our booth for a moment to have a chat. We have some gifts for you to take home and will answer any questions that you have about the open access journal. Our booth number is B07, located in Building No. 1.

Conference details:
Kobe Port Island
Japan
6–9 December 2017
http://www.aeplan.co.jp/conbio2017/english/index.html

23 June 2017

Congratulations for Publishing the 100,000th Peer-Reviewed Article

Congratulations to the authors Javier Monroy and Javier Gonzalez-Jimenez from Universidad de Malaga, Spain, Victor Hernandez-Bennets, Han Fan and Achim Lilienthal from Örebro University, Sweden for publishing the 100,000th peer-reviewed article.

The article is published in the Chemical Sensors section of Sensors.

GADEN: A 3D Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments

Evermore pressing environmental concerns have led global actors and decision-makers to search for stricter emission monitoring approaches. As part of novel monitoring systems, robots with gas and environmental sensors are a promising solution. However, validation of such robotic inspectors is expensive, time consuming, and plagued by repeatability issues. In this article, we present GADEN (the short form for Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments), which combines gas dispersion and robotics simulation in a common framework. Developed under the widely used Robot Operating System (ROS), GADEN enables validation of sensing strategies with gas dispersion being simulated using computational fluid dynamics and filament dispersion theory. GADEN allows simulating complex, realistic, 3D environments for reproducible testing of robotic gas sensing algorithms. Through qualitative and quantitative evaluations, we show that GADEN is a versatile and user-friendly evaluation tool and emphasize its enormous potential for the mobile robot olfaction community.

 

Read the full article here: https://www.mdpi.com/1424-8220/17/7/1479/htm

12 June 2017
Meet us at ETOX 18: The European Workshop on Bacterial Protein Toxins, Paris, 26-30 June 2017

We will be attending the ETOX 18: The European Workshop on Bacterial Protein Toxins, which will be held at the Institute Pasteur, Paris, 26-30 June 2017, representing the following open access journals:

Toxins
Pathogens
IJMS
Vaccines
Biomedicines
Biology

Please come along to our booth to talk to our delegates concerning the above journals and the travel awards that you might be interested in. The Editorial Board Members of Toxins, Professors Holger Barth, Emmanuel Lemichez, Cesare Montecucco and Michel R. Popoff will also be there to answer your questions about the journal and publishing. We look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit http://www.etox18.org/.

6 June 2017
CiteScore™ Metrics Released for Scopus Journals

The CiteScore, the new citation metric for journals covered in the Scopus® database, was released on 1 June 2017, reflecting the citation activity in 2016 for articles published during the three previous years. Please note that the list below does not contain all MDPI journals covered in Scopus. For the CiteScore to serve as a reliable metric at least three volumes of articles need to be indexed in Scopus; journals which have not met this criterion have been omitted here.

Ten MDPI journals received a CiteScore which is in the Top 10% of scores in at least one of the categories, while a further 21 journals exhibit scores that are in the first quartile of the respective categories.

CiteScore Data for MDPI Journals

Journal Rank Category Link CiteScore 2016
2015

2014
Algorithms 44/112 (Q2)
49/111 (Q2)
19/42 (Q2)

52/113 (Q2)
• Numerical Analysis
• Computational Mathematics
• Computational Theory and Mathematics
• Theoretical Computer Science
Link 1.15 1.07 1.06
Animals 69/343 (Q1)
21/146 (Q1)
• Animal Science and Zoology
• General Veterinary
Link 1.46 1.66 0.74
Biology 13/92 (Q1)

34/81 (Q1)

10/75 (Q1)

• General Agricultural and Biological Sciences
• General Biochemistry, Gene-
tics and Molecular Biology
• General Immunology and Microbiology
Link 3.02 2.78 1.74
Biomolecules 234/382 (Q3)
260/353 (Q3)
• Biochemistry
• Molecular Biology
Link 1.67 3.08 1.00
Biosensors 36/118 (Q2)
209/2156 (Q1)
• Clinical Biochemistry
• General Medicine
Link 2.83 2.37 2.04
Cancers 29/196 (Q1)
27/321 (Q1)
• Cancer Research
• Oncology
Link 5.02 4.07 2.31
Catalysts 18/44 (Q2)
27/144 (Q1)
• Catalysis
• Physical and Theoretical Chemistry
Link 3.44 3.45 2.17
Crystals 70/270 (Q2)

25/64 (Q2)
118/398 (Q2)
131/424 (Q2)
• General Chemical Engineering
• Inorganic Chemistry
• Condensed Matter Physics
• General Materials Science
Link 1.89 1.47 1.03
Diversity 10/41 (Q1)

9/25 (Q2)
76/291 (Q2)
24/109 (Q1)
• Agricultural and Biological Sciences (miscellaneous)
• Ecological Modelling
• Ecology
• Nature and Landscape Conservation
Link 2.03 1.96 1.82
Energies - - Link 2.50 2.87 2.66
Entropy 51/198 (Q2) • General Physics and Astronomy Link 1.87 1.99 1.69
Forests 17/127 (Q1) • Forestry Link 2.06 1.76 1.84
Games 204/398 (Q3)
83/181 (Q2)
48/105 (Q2)
• Applied Mathematics
• Statistics and Probability
• Statistics, Probability and Uncertainty
Link 0.87 0.57 0.64
Genes 62/300 (Q1)
18/90 (Q1)
• Genetics
• Genetics (clinical)
Link 3.62 3.18 1.33
Geosciences 36/169 (Q1)

• General Earth and Planetary Sciences Link 1.67 1.29 1.13
Information 156/237 (Q3) • Information Systems Link 0.78 0.94 0.74
Insects 28/131 (Q1) • Insect Science Link 1.81 1.38 1.23
International Journal of Environmental Research and Public Health (IJERPH) 67/446 (Q1)

31/102 (Q2)
• Public Health, Environmental and Occupational Health
• Health, Toxicology and Mutagenesis
Link 2.38 2.42 2.47
International Journal of Molecular Sciences (IJMS) 23/157 (Q1)
8/64 (Q1)
90/353 (Q1)
22/144 (Q1)

16/44 (Q1)
8/62 (Q1)
• Organic Chemistry
• Inorganic Chemistry
• Molecular Biology
• Physical and Theoretical Chemistry
• Catalysis
• Spectroscopy
Link 3.73 3.37 3.06
ISPRS International Journal of Geo-Information 12/29 (Q2)
28/79 (Q2)

96/587 (Q1)
• Computers in Earth Sciences
• Earth and Planetary Sciences (miscellaneous)
• Geography, Planning and Development
Link 1.62 1.52 -
Journal of Low Power Electronic Applications (JLPEA) 301/645 (Q2) • Electrical and Electronic Engineering Link 0.98 0.83 0.83
Life 65/525 (Q1)

36/186 (Q1)

5/92 (Q1)
20/80 (Q2)
• Ecology, Evolution, Behavior and Systematics
• General Biochemistry, Gene-
tics and Molecular Biology
• Palaeontology
• Space and Planetary Science
Link 2.95 1.68 1.20
Marine Drugs 18/145 (Q1) • Drug Discovery Link 3.83 3.66 3.59
Materials 63/424 (Q1) • General Materials Science Link 3.26 3.11 2.69
Membranes 103/424 (Q1) • Materials Science Link 2.19 2.95 2.42
Micromachines 173/645 (Q2)

69/211 (Q2)

113/526 (Q1)
• Electrical and Electronic Engineering
• Control and Systems Engineering
• Mechanical Engineering
Link 1.83 1.78 2.10
Minerals 45/206 (Q1)
29/167 (Q1)
• Geology
• Geotechnical Engineering and Engineering Geology
Link 2.13 1.77 -
Molecules 32/157 (Q1) • Organic Chemistry Link 3.09 2.65 2.62
Nutrients 12/247 (Q1) • Food Science Link 4.29 4.07 3.78
Pharmaceuticals 8/168 (Q1)
21/158 (Q1)
• Pharmaceutical Science
• Molecular Medicine
Link 4.90 3.64 1.92
Pharmaceutics 19/168 (Q1) • Pharmaceutical Science Link 3.83 2.68 2.46
Polymers 13/138 (Q1)
44/354 (Q1)
• Polymers and Plastics
• General Chemistry
Link 3.74 3.37 4.10
Remote Sensing 13/169 (Q1) • General Earth and Planetary Sciences Link 3.56 3.76 3.23
Sensors 25/96 (Q2)
25/159 (Q1)

124/382 (Q2)
103/645 (Q1)
• Analytical Chemistry
• Atomic and Molecular Physics, and Optics
• Biochemistry
• Electrical and Electronic Engineering
Link 2.78 2.21 2.40
Sustainability 49/129 (Q2)

68/587 (Q1)

56/236 (Q1)
• Renewable Energy, Sustai-nability and the Environment
• Geography, Planning and Development
• Management, Monitoring, Policy and Law
Link 1.96 1.78 1.52
Symmetry 17/42 (Q2)
49/111 (Q2)
• Numerical Analysis
• Computational Mathematics
Link 1.12 0.95 1.02
Toxins 16/102 (Q1)

16/108 (Q1)
• Health, Toxicology and Mutagenesis
• Toxicology
Link 3.34 3.76 2.85
Vaccines 146/184 (Q4)
151/250 (Q3)
93/145 (Q3)
186/299 (Q3)
130/232 (Q3)
• Immunology
• Infectious Diseases
• Drug Discovery
• Pharmacology
• Pharmacology (medical)
Link 1.23 3.76 2.85
Viruses 15/68 (Q1)
34/250 (Q1)
• Virology
• Infectious Diseases
Link 3.60 3.74 3.80
Water 33/184 (Q1)

48/195 (Q1)
62/587 (Q1)

198/382 (Q3)
• Water Science and Technology
• Aquatic Science
• Geography, Planning and Development
• Biochemistry
Link 2.05 1.96 1.45

17 May 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the Goethe University of Frankfurt, the Technical University of Hamburg (TU Hamburg-Harburg), as well as the Humboldt University of Berlin, in Germany, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

          

 

4 May 2017
MDPI Supports the Initiative for Open Citations (I4OC)

As an open access publisher, we are keen to support openness and transparency in the research process. Citation data is very important for assessing the value of individual papers and the contribution of researchers. As such, we support the recently launched Initiative for Open Citations (I4OC). The initiative recognizes that citations should be freely available and machine-readable. By doing so, authors gain the maximum benefit from having their work cited.

MDPI now uploads citation data with metadata uploaded to Crossref when registering digital object identifiers (DOIs) for published papers. We are delighted to take this step to support a truly open research environment.

2 May 2017
Publons Peer Review Academy Goes Live

Getting high quality review reports is critical for any journal’s editorial process. At MDPI we have put in place several measures to motivate reviewers and reward them for their work. We are proud of the quality of reviewer reports we receive and grateful for the hours put in by active researchers from across the globe.

Reviewers of MDPI’s largest journals can get recognition via Publons, a website dedicated to rewarding peer reviewers. They have now taken this one step further and launched the Publons Reviewer Academy to help train reviewers to provide useful feedback. Through the academy, researchers can be trained and tutored in various aspects of how to provide structured feedback that will be of genuine help to editors and authors. We support this initiative and recommend it to potential MDPI reviewers, especially early career researchers. See the Publons announcement for further information.

More information on reviewing for MDPI, including how to volunteer as a reviewer, can be found here.

24 April 2017
Two New Institutional Memberships Established

Inst Member

We are pleased to announce that the following universities have joined MDPI's institutional membership program: Trinity University, San Antonio, Texas, USA and the University of New South Wales (UNSW), Sydney, Australia. Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 Trinity    UNSW

 

30 March 2017
Credit for Preprints Comments via Publons

Preprints.org is a platform run by MDPI that allows authors to make early versions of manuscripts available before peer review has been completed.

One of the major benefits of putting a preprint online is to get feedback before journal submission. Until now, however, the feedback has been on a voluntary basis. Preprints is delighted to be the first preprint server to collaborate with Publons to acknowledge substantial comments as reviews and give commentators the opportunity to receive credit for their efforts. 

When you add a comment to any article, there is a check box to click for it to appear on Publons. If you have already linked your account it will be passed on automatically. If you don't already have a Publons account, you will be contacted soon afterwards with instructions on how to create one.

We appreciate the enthusiasm and cooperation of Publons in this project and expect it to be of great benefit to authors and commenters alike.

20 March 2017
MDPI 2016 Annual Report Released

We are pleased to announce that our annual report for the year 2016 has now been published. 

It contains information regarding company and journal performance, conferences and other publishing services that we provided throughout 2016. 

To read the report in full or download a copy, please click here.

15 March 2017
Our 100,000th Article Could be Yours!

After the 20th anniversary of MDPI in 2016, we will reach another milestone this year and will publish the 100,000th peer-reviewed article in one of our 170+ open access journals.

100,000th

We would like you to be part of this great achievement and so are offering to publish the 100,000th accepted paper free of charge.

To be in with a chance, select a journal in one of our 10 scientific subject areas and submit your paper.

Access the live tracker on published articles here.

100000tracker

 

 

3 March 2017
1000 Preprints Online

We are delighted that Preprints now has 1000 papers online since its launch on 3 May 2016.

For more information, see the editorial here.

 

9 February 2017
Minister and State Secretaries Visit MDPI Office at STP, Belgrade, Serbia

Earlier this week the Science Technology Park in Belgrade, Serbia was visited by Swiss Secretary of State Dr. Mauro Dell’Ambrogio, as well as Serbian Minister of Public Administration and Local Self-Government Ana Brnabic, State Secretary Dr. Vladimir Popovic and Mayor of Belgrade Mr. Siniša Mali.

During the visit to the STP they had a short presentation from MDPI’s CEO Dr. Franck Vazquez and IT Manager Mr. Miloš Čučulović, and further discussed important issues such as Open Access and Open education. Dr. Dell'Ambrogio said he was impressed with the potential for development and ideas for business.

For more information please see:

http://bit.ly/2kpIu7k and http://bit.ly/2kpUQfz

   

7 February 2017
The 6th World Sustainability Forum: Final Press Release

Basel, 29 January 2017

The 6th World Sustainability Forum #WSF2017SA: African universities critical to achieving the Sustainable Development Goals

Jeffrey and Sonia Sachs win first World Sustainability Award.

Universities need to take the lead in solving the greatest challenges the world faces today, particularly in Africa. They need to do this not only through education – teaching the next generation to think critically and creatively to find sustainable solutions – but also through research that cuts across a range of disciplines. To ensure these solutions are implemented, they need to partner with the private sector and with government.

This was the key message from the 6th World Sustainability Forum (WSF2017), which took place in Cape Town on 27 and 28 January 2017. Sponsored by MDPI and the journal Sustainability under the patronage of the Universities of the Western Cape (UWC), Cape Town (UCT), University of Basel and the National Research Foundation (NRF) of South Africa, the conference was attended by key national and international speakers, including world-leading economist Professor Jeffrey D. Sachs, senior United Nations (UN) advisor and director of the Earth Institute at Columbia University.

The WSF is an annual sustainability conference which addresses research in a range of areas related to sustainable development and sustainability globally. This was the first WSF to take place on the African continent. Discussions at the 2017 conference were driven by the 17 sustainable development goals (SDGs) adopted as part of the 2030 Agenda for Sustainable Development by the UN in September 2015.

Achieving the SDGs “is the moonshot for our generation,” said Sachs. “Like the moonshot [moon landing] of the 1960s, these are tough, bold and achievable objectives.”

This is a nasty, tough world we live in, and our world agrees on very little. So when 193 governments agree on something, that is important. And when they agree on something as important as sustainable development, that is really something for us to grab hold of – that is a lifeline.”

There was agreement at the WSF that the SDGs are particularly important for Africa, and that African universities in particular have a role to play in achieving them.

Said Professor Tyrone Pretorius, vice-chancellor of UWC: “The quest for sustainable development can only be met through education. Universities today are the oil that fuels the knowledge economy.”

As part of the drive to develop academic capacity to provide the knowledge needed to meet the SDGs, WSF2017 was preceded by the 1st Postgraduate Forum on Sustainability. “A series of workshops for postgraduate education linked to WSF are important, in order to equip postgraduates with the skills necessary to promote sustainability,” said Professor Thandi Mgwebi, director for research at UWC. A second postgraduate forum will take place alongside the WSF2018 in Beijing.

This capacity development is particularly critical to Africa. Said Sachs: “African universities need to do research to find solutions to Africa’s development challenges, because no other university will.”

The UN set a target of achieving the SDGs by 2030: “I regard this as the breakthrough period to end extreme poverty on the continent,” said Sachs, “and for Africa to become one of the most dynamic centres of the world economy.”

It is a critical time for South African universities, said Professor Mamokgethi Phakeng, deputy vice-chancellor for research and internationalisation at UCT: “Higher education is at a crossroads, and there is much polarisation. We need to think carefully about how this sustainable development agenda is owned by all so that it is inclusionary.”

There was also strong emphasis on public–private partnerships – for universities, business and government to work together to achieve the goals.

Said Professor Francis Petersen, deputy vice-chancellor at UCT and vice-chancellor designate at the University of the Free State: “Business sustainability has become critical, because there is increasing demand and complexity of demand on business from the natural, social and economic environment. Sustainability cannot be a standalone issue, divorced from business as usual. Sustainability needs to be embedded into business.”

Environmental crises and climate change was also high on the WSF agenda. In his keynote address, Sachs noted the irreversibility of the climate- and environmental-related challenges.

If we don’t get our act together, we lose the chance of safety,” he said.

Said Professor Mark New, pro vice-chancellor and director of the African Climate and Development Initiative at UCT: “We have a fundamental challenge in responding to climate change, and we must go further than just putting a plaster on a wound. We need to address the deep structural issues, to move from our current model of development into climate-compatible development.”

This requires researchers to find the evidence for the correct development pathways to take, and then support the ability of policymakers at all levels to enable the shift to climate-compatible development planning.”

Said Dr. Aldo Stroebel, executive director of international relations and cooperation at the NRF, in closing: “We have seen over the past two days an urgency towards the next step of thinking, that critical type of framework that we all must engage with, not only from an academic perspective, but further up into the policy environment and into rural-based environments where one can clearly see the links and effectiveness of the work.”

World Sustainability Awards

The first World Sustainability Award and the first Emerging Sustainability Leader Awards were presented by Prof. Thandi Mgwebi, Director of Research at UWC, and Dr. Franck Vazquez, CEO of MDPI, during the ceremony on 27 January 2017 as part of the gala dinner of the 6th World Sustainability Forum in South Africa.after day one of proceedings of the 2017 World Sustainability Forum South Africa.

Professor Jeffrey D. Sachs and Dr. Sonia Ehrlich Sachs are the joint recipients of the first World Sustainability Award. Jeffrey Sachs is a world-renowned economist and senior United Nations (UN) advisor and director of the Earth Institute at Columbia University. Sonia Sachs is a paediatrician and public health specialist, and director of the Health Centre at the Centre for Sustainable Development, also at Columbia University.

The joint recipients of the first Emerging Sustainability Leader Award are Dr. Esther Ngumbi and Dr. Xiaosong Hu. Esther Ngumbi is a postdoctoral researcher at Auburn University in Alabama USA and serves as a 2015 Clinton Global University Mentor for agriculture. Xiaosong Hu is a professor at the Chongqing University in China and specialises in automotive control systems and mechanical engineering.

The World Sustainability Award and the Emerging Sustainability Leader Awards are funded to encourage new initiatives and developments in sustainability with the ultimate aim of fostering the transition to sustainable practices and societies.

The World Sustainability Award is funded by the MDPI Sustainability Foundation, and included a monetary prize of USD 100,000 to Jeffrey and Sonia Sachs. The Emerging Sustainability Leader Award is funded by the journal Sustainability, awarded to researchers under 40, and included a monetary prize of USD10,000.

Issued jointly by: UCT Global Strategy and Visibility, Research Office, UWC Communications & Media and MDPI AG

Conference photos are free available at: https://sciforum.net/conference/wsf-6/page/175 Photo credit: Matthias Burkhalter

Carla Bernardo
Tel: (021) 650 1277
Cell: 071 407 6105
E-mail: carla.bernardo@uct.ac.za
University of Cape Town

Luthando Tyhalibongo
Tel: (021) 959 2625
Cell: 082 472 69 61
079 880 4655
E-mail: xtyhalibongo@uwc.ac.za
University of the Western Cape

Matthias Burkhalter
Conferences Manager
MDPI AG - www.mdpi.com
St. Alban-Anlage 66, 4052 Basel,
Switzerland
Tel. +41 61 683 77 34
Email: burkhalter@mdpi.com

Banner

31 January 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the Chalmers University of Technology, Sweden, the University of Manitoba, Canada and the Technical University of Cartagena, Spain, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

Tex      HIT    

 

Darmstadt  

27 January 2017
6th World Sustainability Forum under way in South Africa

The 6th World Sustainability Forum is currently being held at the Cape Sun Hotel until 28 January 2017. 

The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100,000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10,000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI.

Here are some pictures from the forum so far:

To see the full WSF2017 program and schedule, please see here: https://sciforum.net/conference/wsf-6/page/schedule

19 January 2017
Cape Town to Host the 6th World Sustainability Forum

Banner

Cape Town will host the 6th World Sustainability Forum at the Cape Sun Hotel on 27 and 28 January 2017. This prominent event, held for the first time in Africa, will include many illustrious South African and international experts, such as Her Excellency Graça Machel (Sustainable Development Advocate for the United Nations, Mozambique), Joyene Isaacs (HoD Agriculture Western Cape Government), Jeffrey Sachs (Columbia University, USA), Max Bergman (SRaM, University of Basel), Mark New (Pro Vice-Chancellor, University of Cape Town), Frans Swanepoel (FutureAfrica, University of Pretoria) and Francis Petersen (Vice-Chancellor-designate, University of the Free State). The Forum will provide a stage for national and international debates on sustainability in South Africa, the African continent, and about international perspectives on sustainability. It brings together researchers and representatives from government and the business sector to discuss a wide-ranging set of issues associated with sustainability, including food security, water and energy scarcity, mining, poverty reduction, climate change, and urbanisation.

The next few decades will be marked by profound changes in the relationships between global economics, national societies, and the environment. We have entered what some call the Anthropocene, an age in which human activity dominates the climate and the environment. These changes will have numerous consequences on societies around the globe. South Africa and Africa will play a central role, for better or worse, in creating opportunities and risks during these changing times as Africa is profoundly influencing and being influenced by global developments.

The adoption of the 17 United Nations Sustainable Development Goals and the 2030 Agenda for Sustainable Development in September 2015 was accompanied by what insiders considered an optimism they have not experienced in relation to UN resolutions before. The relative efficiency in the drafting, the lack of trenches between East and West, or between North and South, and the unanimity of support of the 193 countries speak volumes. In stark contrast, sustainability seems to go against a changing economic and political tide, where waves of nationalism and protectionism from some of the most powerful countries risk the wellbeing of the rest of the world. The 6th World Sustainability Forum will enable fruitful exchanges, which sensitise South African and international communities to the global urgency and specifics of sustainability.

The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100 000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10 000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI. The World Sustainability Forum is preceded by the Postgraduate Forum on Sustainability, which will introduce more than 100 young scholars from South Africa and the African continent to sustainability research. Both events are organized and sponsored by the University of Cape Town, the University of the Western Cape, the University of Basel, MDPI, and by the National Research Foundation of South Africa.

Contacts:

Scientific Matters: Prof Manfred Max Bergman, Social Research and Methodology Group (SRaM), University of Basel, Switzerland; Email:  max.bergman@unibas.ch

Press Accreditation and General Enquiries: Mr Matthias Burkhalter, MDPI AG, Basel, Switzerland; Email: burkhalter@mdpi.com; Tel. +41 61 683 77 34 

Follow us on Twitter

twitter logo

#WSF2017SA

 

6 January 2017
MDPI Supports the OA2020 Initiative

MDPI is now a proud supporter of the OA2020 Initiative.

Open Access 2020 is an international initiative that aims to induce the swift, smooth and scholarly-oriented transformation of today’s scholarly journals from subscription to open access publishing.

MDPI is participating in the upcoming Berlin13 conference in March 2017, where we are contributing to the initiative by aiding in the design of the roadmap which will make OA the default publishing model.

For more information please see here.

 

5 January 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the University of Texas at Arlington, USA, the Harbin Institute of Technology, China and TU Darmstadt, Germany, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Tex      HIT    Darmstadt  

22 December 2016
Happy Festive Season!

Season's greetings from everyone at MDPI!

22 December 2016
Two New Institutional Memberships Established

Inst Member

We are pleased to announce that the Otto-von-Guericke-Universität Magdeburg, Germany and the University of California, Berkeley, USA, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

  

19 December 2016
MDPI and Wellcome Trust Compliance

The Wellcome Trust has, for a number of years, required that the results of its funded projects are published in open access format. Recently it announced criteria that publishers must fulfil for publication fees to be paid by the Trust. MDPI is pleased to have been added to the list of compliant publishers.

Only publishers who have confirmed their compliance by 16 December 2016 will be eligible to receive payment of APCs by the Wellcome Trust as of 1 April 2017. For more information on the criteria and a full list of publishers that meet them, see here.

13 December 2016
Meet MDPI at the 2016 AGU Fall Meeting

MDPI is currently attending the 2016 AGU Fall Meeting (12–16 December, 2016)

If you are also attending the conference, please feel free to stop by our booth (Booth #1147) and meet the representative editors.

Conference details:

2016 AGU Fall Meeting
12–16 December 2016
Moscone Center
747 Howard St
San Francisco, CA 94103, USA

 

8 December 2016
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that Purdue University, USA, the Universitat Politécnica de Valencia, Spain and the Queensland University of Technology, Australia, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UNM            UPM             ShanghaiJT  

16 November 2016
World Sustainability Award - Final Extension

The deadline for the World Sustainability Award has been extended for one last time! You now have one more month to nominate an individual researcher, group or project! The final deadline for nominations will be December 15, 2016. 

For full details, please visit here.

11 November 2016
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the University of Minnesota, USA, the Universidad Politécnica de Madrid, Spain and Shanghai Jiao Tong University, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UNM            UPM             ShanghaiJT  

4 November 2016
MDPI Joins the United Nations Global Compact

MDPI has become a member of the United Nations Global Compact to support corporate sustainability and have committed ourselves to the ten principles associated with the Compact.

Sustainability has always been at the core of MDPI’s values, starting with the collection and preservation of rare chemical samples that started in 1996 and led to the first journal, Molecules. Sustainability has become one of our flagship journals and we have supported and organized several conferences and events based on Sustainability, including the upcoming 6th World Sustainability Forum. As a global enterprise, we see it as our duty to promote responsible practices that will ensure a bright future for our planet. Given this, the choice to join the Global Compact was an easy one and we will do our utmost to fully implement it.

 

3 November 2016
MDPI Now a Member of SPARC Europe

We are delighted to announce that MDPI has become a member of SPARC Europe, an organization that works for open scholarship in Europe, including support of open access publication.

As one of the few publishers to join SPARC Europe to date, MDPI looks forward to making a contribution that puts open scholarship on a positive and sustainable path. We fully support the goals of open scholarship that allow the largest number of people possible to benefit from work of researchers in all disciplines. We hope that our membership will enable us to work with other stakeholders to find the best possible solution.

2 November 2016
World Sustainability Award Deadline Extension

The deadline for the World Sustainability Award has been extended! You now have until November 15, 2016 to nominate an individual researcher, group or project!

For full details, please visit here.

.

26 October 2016
Four New Institutional Memberships Established

Inst Member

We are pleased to announce that the Wuppertal Institut, Germany, the University of Girona, Spain and Central South University and Huazhong University of Science and Technology, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

CSUCSU

CSU  CSU

24 October 2016
International Open Access Week 2016

Meet us during International Open Access Week 2016! We will be presenting at various locations in Europe and China. 

To get involved and for full details see the complete list of events organised by MDPI here.

 

18 October 2016
Institutional Membership established with Universitat Pompeu Fabra, Spain and Aalto University, Finland

Inst Member

We are pleased to announce that the Universitat Pompeu Fabra, Spain and Aalto University, Finland, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Pompeu   Aalto

12 October 2016
Institutional Membership Established with Iowa State University and the University of North Texas, USA

Inst Member

We are pleased to announce that the Iowa State University and the University of North Texas, USA, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Iowa  UNT

7 October 2016
MDPI at Open Access Days in Munich, 10-11 October 2016

Meet MDPI during the Open Access Days held from 10-11 October 2016 at Ludwig Maximilian University of Munich, Germany. 

The two-day event will feature experts from the open access sector, scientists from all disciplines, publishing representatives and supporters of scientific research and communication from libraries as well as research institutes and funding institutions. Join us!

For more information about the event and to see the program, visit the event webpage.

OATageMunich

7 October 2016
Institutional Membership Established with the University of Sevilla and the University of Alicante, Spain

Inst Member

We are pleased to announce that the University of Sevilla and the University of Alicante, Spain have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Sevilla  Alicante

29 September 2016
Institutional Membership Established with the University of Delaware

Inst Member

We are pleased to announce that the University of Delaware, USA, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Delaware

19 September 2016
Peer Review Week 2016

As an open access publisher indebted to the work of our peer reviewers, we are proud to support Peer Review Week 2016. As part of the week's activities and to celebrate this year's theme "Recognition for Review", MDPI will host two webinars that anyone can join.

These webinars will explore the role and value of reviewers and the recognition they receive from a publishers perspective, with examples from MDPI's experience in publishing nearly 80,000 peer reviewed papers, along with evidence from reviewer surveys. It will also touch upon potential changes in how review is carried out and tips for early career researchers who want to be involved in the review process.

Details and links to join can be found below:

Wednesday September 21, 08:00 (CEST)

Friday September 23, 16:00 (CEST)

For more information about all the activites taking place, please visit the Peer Review Week website.

 

6 September 2016
Institutional Membership established with Kansas State University and Northwestern University, USA

Inst Member

We are pleased to announce that Kansas State University and Northwestern Universty, USE, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

KState  NWest

5 September 2016
Institutional Membership Established with University College Cork

Inst Member

We are pleased to announce that University College Cork, Ireland, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UCC

22 August 2016
MDPI New Office Location

We are pleased to announce that MDPI has now moved to a new permanent address:

MDPI AG
St. Alban Anlage 66
CH-4052 Basel
Postfach, CH-4020 Basel
Switzerland

Telephone and fax numbers remain unchanged.

10 August 2016
Institutional Membership established with the University of Texas at Austin, USA, the Wroclaw University of Science and Technology, Poland and the University of Granada and the Compultense University of Madrid, Spain

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in August 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

            

18 July 2016
Institutional Membership established with Louisiana State University and Florida State University, USA, Royal College of Surgeons, Ireland, University of Rostock, Germany, AGH University of Science and Technology, Poland and Southeast University, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in July 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

                    

12 July 2016
MDPI Moving to New Office Location in Basel (Switzerland) in August 2016

As of 20 August 2016, MDPI's new address in Basel will be:

MDPI AG
St. Alban-Anlage 66
CH-4052 Basel
Switzerland

Telephone and fax numbers remain unchanged.

St. Alban-Anlage 66 was built from 1947 to 1948 and initially the home of the "Bühler AG", a book printing business. 

 


For more information about this building, see: https://www.mdpi.com/about/headquarters

21 June 2016
"Behind the Scenes of Academic Publishing—A Publisher's Perspective" - MDPI's Lecture at the University of Basel

From the 15-16 September, 2016, MDPI will run a course on Academic Publishing at the University of Basel.

In this two day workshop, MDPI will look in detail at the role performed by academic journal publishers and how they interact with academics. Ethical dimensions, what happens when problems occur and how the publisher coordinates all aspects of the submission process will also be covered. 

For more detailed information about the program, trainers and registration please visit the course webpage.

 

 

14 June 2016
2015 Impact Factors Released

We are pleased to report the 2015 Journal Impact Factors in the latest Journal Citation Reports® Science Edition, published by Thomson Reuters in June 2016. Twenty out of 25 journals have seen an increase in their Impact Factor and two journals (Crystals and IJGI) received a first Impact Factor. Coatings was recently added to SCIE and will receive its first Impact Factor in next year’s JCR.

Updated Impact Factors for Journals in the Science Citation Index Expanded (SCIE)

Journal 2015 Impact Factor Details Category Rank
Applied Sciences 1.726 Link 83/163 (Q3) in ‘Chemistry, Multidisciplinary’;
129/271 (Q2) in ‘Materials Science, Multidisciplinary’;
64/145 (Q2) in ‘Physics, Applied’
Atmosphere 1.221 Link 66/84 (Q4) in ‘Meteorology & Atmospheric Sciences’
Catalysts 2.964 Link 53/144 (Q2) in ‘Chemistry, Physical’
Energies 2.077 Link 43/88 (Q2) in ‘Energy & Fuels’
Entropy 1.743 Link 25/79 (Q2) in ‘Physics, Multidisciplinary’
Forests 1.583 Link 19/66 (Q2) in ‘Forestry’
Genes 3.242 Link 60/165 (Q2) in ‘Genetics & Heredity’
International Journal of Environmental Research and Public Health (IJERPH) 2.035 Link 101/225 (Q2) in ‘Environmental Sciences’
International Journal of Molecular Sciences (IJMS) 3.257 Link 110/289 (Q2) in ‘Biochemistry & Molecular Biology’;
51/163 (Q2) in ‘Chemistry, Multidisciplinary’
Marine Drugs 3.345 Link 13/59 (Q1) in ‘Chemistry, Medicinal’
Materials 2.728 Link 63/271 (Q1) in ‘Materials Science, Multidisciplinary’
Metals 1.574 Link 18/73 (Q1) in ‘Metallurgy & Metallurgical Engineering’;
145/271 (Q3) in ‘Materials Science, Multidisciplinary’
Micromachines 1.295 Link 30/56 (Q3) in ‘Instruments & Instrumentation’
63/83 (Q4) in ‘Nanoscience & Nanotechnology’
Minerals 1.468 Link 9/21 (Q2) in ‘Mining & Mineral Processing;
14/29 (Q2) in ‘Mineralogy’
Molecules 2.465 Link 24/59 (Q2) in ‘Chemistry, Organic’
Nanomaterials 2.690 Link 64/271 (Q1) in ‘Materials Science, Multidisciplinary’;
36/83 (Q2) in ‘Nanoscience & Nanotechnology’
Nutrients 3.759 Link 16/78 (Q1) in ‘Nutrition & Dietetics’
Polymers 2.944 Link 20/85 (Q1) in ‘Polymer Science’
Remote Sensing 3.036 Link 5/28 (Q1) in ‘Remote Sensing’
Sensors 2.033 Link 36/75 (Q2) in ‘Chemistry, Analytical’;
16/27 (Q3) in ‘Electrochemistry’;
12/56 (Q1) in ‘Instruments & Instrumentation’
Sustainability 1.343 Link 146/225 (Q3) in ‘Environmental Sciences’;
22/29 (Q4) in ‘Green & Sustainable Science & Technology’
Symmetry 0.841 Link 31/63 (Q2) in ‘Multidisciplinary Sciences’
Toxins 3.571 Link 16/89 (Q1) in ‘Toxicology’
Viruses 3.042 Link 14/33 (Q2) in ‘Virology’
Water 1.687 Link 33/85 (Q2) in ‘Water Resources’

Journals with First Impact Factors

Journal 2015 Impact Factor Details Category Rank
Crystals 2.075 Link 13/26 (Q2) in ‘Crystallography’
ISPRS International Journal of Geo-Information 0.651 Link 45/49 (Q4) in ‘Geography, Physical’;
26/28 (Q4) in ‘Remote Sensing’.

 

8 June 2016
Bioengineering, Biomedicines, Children, Magnetochemistry and Resources added to the Emerging Sources Citation Index in Web of Science

We are pleased to announce that the journals Bioengineering, Biomedicines, Children, Magnetochemistry and Resources have been accepted for inclusion in the Emerging Sources Citation Index (ESCI) in Web of Science.

The ESCI serves to highlight promising journals which are still under consideration for the Science Citation Index Expanded (SCIE) or the Social Sciences Citation Index (SSCI).

The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), and Web of Science™ (WoS) are Thomson Reuters products.

Thomson Reuters Logo

Bioeng Logo Biomed LogoChildren LogoMagchem LogoResources Logo

26 May 2016
Institutional Membership established with University of Bremen, Germany, Koç University, Turkey, IIASA, Austria and Jilin University and Kunming Institute of Botany, CAS, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in May 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

                

23 May 2016
Institutional Membership Established with the KTH Royal Institute of Technology, Sweden and the South China University of Technology, Beijing University of Technology and Southern Medical University, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in April and May 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

            

26 April 2016
New Section on www.mdpi.com - Latest Books

You may have noticed a new section that is now visible on our home page. This section is called "Latest Books" and showcases recent publications from MDPI Books, our book publishing service.

Books Section

By clicking on the hyperlink "More Books" you will be taken to the MDPI Books Home Page. There you will find more information about the service, as well as the "Recent Publications" list. 

Clicking on any of the book images in this list will take you to detailed information about that book (shown below). Here you can also download a PDF version of the book, or order a hardcover printed copy.

For further information about the MDPI Books service, please visit the webpage or contact books@mdpi.com.

 Individual Book Page

 

31 March 2016
Axioms, Behavioral Sciences, Photonics, Separations and Toxics added to the Emerging Sources Citation Index in Web of Science

We are pleased to announce that the journals Axioms, Behavioral Sciences, Photonics, Separations and Toxics were recently accepted for inclusion in the newly launched Emerging Sources Citation Index (ESCI) in Web of Science.

ESCI serves to highlight promising journals which are still under consideration for the Science Citation Index Expanded (SCIE) or the Social Sciences Citation Index (SSCI).

 

The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index
(SSCI), and Web of Science™ (WoS) are Thomson Reuters products.

Thomson Reuters Logo

 

 

 

30 March 2016
Institutional Membership established with the University of Winchester, UK, Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China

Inst Member

We are pleased to announce that the University of Winchester, UK, the Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China, have joined our Institutional Membership program. Primary authors from these universities will benefit from a 10% discount on article processing charges.

Additional details can be found on our institutional membership page.

Winchester Silesian Beijing Jiaotong Zhejiang

24 March 2016
New Editorial Office in Barcelona, Spain

We are excited to announce the opening of our new editorial office in Barcelona, Spain. The launch team is led by a Senior Editor and comprises further staff holding doctoral degrees with several years of research experience. The new editorial team will help us to get closer to European research communities and progress Sciforum, the platform to support the scientific community via conference hosting and other functions. They will also help spread the word about Open Access and meet academics at scientific events.

We are in the process of hiring more doctoral and masters graduates to join the editorial team and welcome applications via jobs@mdpi.com. For contact details about the office, see our contact page.

22 February 2016
Membership Established with the Max Planck Society

We are pleased to announce that the Max Planck Digital Library (MPDL) has signed an agreement with MDPI to support authors associated with the Max Planck Society (Max-Planck-Gesellschaft). As of 22 February 2016, corresponding authors will receive full funding from the MPDL for articles published in MDPI journals, with a 10% discount applied to the Article Processing Charges. Additional details can be found at our institutional membership page.

Founded in 1948, The Max Planck Society is one of Germany’s leading research organizations, and is currently made up of 83 institutes conducting basic research in natural sciences, life sciences, social sciences and humanities. 18 Nobel laureates have emerged from its ranks of scientists and the society has more than 15,000 publications in scientific journals each year.

 

5 February 2016
Institutional Membership Extension: Wageningen University, CSIC, University of Zürich, ETH Zürich, University of Tübingen and Osnabrück University

We are pleased to announce that Wageningen University, the Netherlands, the Spanish National Research Council (CSIC), Spain, the University of Zürich and ETH Zürich, Switzerland, and the University of Tübingen and Osnabrück University, Germany, have not only renewed their institutional memberships with MDPI after two years of successful cooperation, but have also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.

Additional details can be found on our institutional membership page.

WageningenCISCZurich ETHZurichTuebingen Osnabrück 

5 February 2016
Institutional Membership established with Brock University, Canada and the University of Pisa, Italy

Inst Member

We are pleased to announce that Brock University, Cananda, and the University of Pisa, Italy, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges as of 01 February 2016. 

Additional details can be found on our institutional membership page.

Brock Pisa

25 January 2016
MDPI Sponsors diss:kurs with the University of Basel

 

MDPI is pleased to announce its newly established sponsorship of diss:kurs, an event coordinated by the University of Basel to support their doctorate program. For more information about the event and how to register, please visit the diss:kurs webpage.

 

7 January 2016
New Institutional Memberships Established with Tsinghua University, the Chinese Society of Micro-Nano Technology, Ruhr University Bochum and the University of Ulm

We are pleased to announce that the following institutions have joined MDPI's institutional membership program as of 1 January 2016:

  • Tsinghua University, China
  • Chinese Society of Micro-Nano Technology (CSMNT)
  • Ruhr University Bochum, Germany
  • University of Ulm, Germany

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

 

5 January 2016
Safety, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae Released Their First Issue in December 2015

We are pleased to announce that MDPI's open access journals Safety, Journal of Imaging, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae released their first issue at the end of December 2015.

  

23 December 2015
Happy Festive Season!

Season's greetings from everyone at MDPI!

style="width:304px;height:228px;"

17 December 2015
Institutional Membership Extension: University of Bern, Switzerland

We are pleased to announce that the University of Bern, Switzerland has not only renewed their institutional membership with MDPI after two years of successful cooperation, but also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.

 

17 December 2015
Institutional Membership with the University of Ulm and Helmholtz Zentrum Munich

We are pleased to announce that University of Ulm, Germany and Helmholtz Zentrum Munich, Germany has joined MDPI's institutional membership program:

Primary authors from the University of Ulm and Helmholtz Zentrum Munich will benefit from a 10% discount on the article processing charges as of 1 January 2016. Additional details can be found on our institutional membership page.

 

style="width:150px;height:228px;"         style="width:304px;height:228px;"

9 December 2015
Membership Established with the Virginia Polytechnic Institute and State University (Virginia Tech)

We are pleased to announce that Virginia Tech has joined MDPI's institutional membership program. Authors from Virginia Tech will benefit from a 10% discount on the article processing charges as of 1 December 2015. Additional details can be found on our institutional membership page.

1 December 2015
Membership Established with the Technical University of Denmark and the University of North Florida

We are pleased to announce that the following universities have joined MDPI's institutional membership program:

  • Technical University of Denmark (as of 1 November 2015)
  • University of North Florida, USA (as of 15 November 2015)

Primary authors from the Technical University of Denmark and the University of North Florida will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

2 October 2015
Membership Established with the University of Freiburg and the University of Regensburg

We are pleased to announce that the following universities have joined MDPI's institutional membership program:

University of Freiburg, Germany
University of Regensburg, Germany

Primary authors from the University of Freiburg and the University of Regensburg will benefit from a 10% discount on the article processing charges as of 1 October 2015 and 1 November 2015.

Additional details can be found on our institutional membership page.

Back to TopTop